
<html lang="en"     class="pb-page"  data-request-id="a67464f6-ef2e-4489-a876-ef6ffdb64f5b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2021.64.issue-8;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.0c02249"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Synthesis and Characterization of the Novel Rodent-Active and CNS-Penetrant P2X7 Receptor Antagonist Lu AF27139" /></meta><meta name="dc.Creator" content="Allen T.  Hopper" /></meta><meta name="dc.Creator" content="Martin  Juhl" /></meta><meta name="dc.Creator" content="Jorrit  Hornberg" /></meta><meta name="dc.Creator" content="Lassina  Badolo" /></meta><meta name="dc.Creator" content="John Paul  Kilburn" /></meta><meta name="dc.Creator" content="Annemette  Thougaard" /></meta><meta name="dc.Creator" content="Gennady  Smagin" /></meta><meta name="dc.Creator" content="Dekun  Song" /></meta><meta name="dc.Creator" content="Londye  Calice" /></meta><meta name="dc.Creator" content="Veena  Menon" /></meta><meta name="dc.Creator" content="Elena  Dale" /></meta><meta name="dc.Creator" content="Hong  Zhang" /></meta><meta name="dc.Creator" content="Manuel  Cajina" /></meta><meta name="dc.Creator" content="Megan E.  Nattini" /></meta><meta name="dc.Creator" content="Adarsh  Gandhi" /></meta><meta name="dc.Creator" content="Michel  Grenon" /></meta><meta name="dc.Creator" content="Ken  Jones" /></meta><meta name="dc.Creator" content="Tanzilya  Khayrullina" /></meta><meta name="dc.Creator" content="Gamini  Chandrasena" /></meta><meta name="dc.Creator" content="Christian  Thomsen" /></meta><meta name="dc.Creator" content="Stevin H.  Zorn" /></meta><meta name="dc.Creator" content="Robb  Brodbeck" /></meta><meta name="dc.Creator" content="Suresh Babu  Poda" /></meta><meta name="dc.Creator" content="Roland  Staal" /></meta><meta name="dc.Creator" content="Thomas  Möller" /></meta><meta name="dc.Description" content="There remains an insufficient number of P2X7 receptor antagonists with adequate rodent potency, CNS permeability, and pharmacokinetic properties from which to evaluate CNS disease hypotheses precli..." /></meta><meta name="Description" content="There remains an insufficient number of P2X7 receptor antagonists with adequate rodent potency, CNS permeability, and pharmacokinetic properties from which to evaluate CNS disease hypotheses precli..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 6, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c02249" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c02249" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c02249" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c02249" /></link>
        
    
    

<title>Synthesis and Characterization of the Novel Rodent-Active and CNS-Penetrant P2X7 Receptor Antagonist Lu AF27139 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c02249" /></meta><meta property="og:title" content="Synthesis and Characterization of the Novel Rodent-Active and CNS-Penetrant P2X7 Receptor Antagonist Lu AF27139" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/large/jm0c02249_0007.jpeg" /></meta><meta property="og:description" content="There remains an insufficient number of P2X7 receptor antagonists with adequate rodent potency, CNS permeability, and pharmacokinetic properties from which to evaluate CNS disease hypotheses preclinically. Herein, we describe the molecular pharmacology, safety, pharmacokinetics, and functional CNS target engagement of Lu AF27139, a novel rodent-active and CNS-penetrant P2X7 receptor antagonist. Lu AF27139 is highly selective and potent against rat, mouse, and human forms of the receptors. The rat pharmacokinetic profile is favorable with high oral bioavailability, modest clearance (0.79 L/(h kg)), and good CNS permeability. In vivo mouse CNS microdialysis studies of lipopolysaccharide (LPS)-primed and 2′(3′)-O-(benzoylbenzoyl)adenosine-5′-triphosphate (BzATP)-induced IL-1β release demonstrate functional CNS target engagement. Importantly, Lu AF27139 was without effect in standard in vitro and in vivo toxicity studies. Based on these properties, we believe Lu AF27139 will be a valuable tool for probing the role of the P2X7 receptor in rodent models of CNS diseases." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c02249"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02249">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c02249&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c02249&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c02249&amp;href=/doi/10.1021/acs.jmedchem.0c02249" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 4891-4902</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c02247" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.1c00005" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Characterization of the Novel Rodent-Active and CNS-Penetrant P2X7 Receptor Antagonist Lu AF27139</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Allen T. Hopper</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Allen T. Hopper</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroinflammation Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#4e2f3a26213e3e2b3c0e2f2122602d2123"><span class="__cf_email__" data-cfemail="80e1f4e8eff0f0e5f2c0e1efecaee3efed">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Allen+T.++Hopper">Allen T. Hopper</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8797-7882" title="Orcid link">http://orcid.org/0000-0001-8797-7882</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Martin Juhl</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martin Juhl</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Process Research Lundbeck A/S, Ottiliavej 9, 2500 Valby, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Juhl">Martin Juhl</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jorrit Hornberg</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jorrit Hornberg</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Toxicology Research Lundbeck A/S, Ottiliavej 9, 2500 Valby, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jorrit++Hornberg">Jorrit Hornberg</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lassina Badolo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lassina Badolo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemistry and DMPK Lundbeck A/S, Ottiliavej 9, 2500 Valby, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lassina++Badolo">Lassina Badolo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John Paul Kilburn</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John Paul Kilburn</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemistry and DMPK Lundbeck A/S, Ottiliavej 9, 2500 Valby, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John+Paul++Kilburn">John Paul Kilburn</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Annemette Thougaard</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Annemette Thougaard</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Toxicology Research Lundbeck A/S, Ottiliavej 9, 2500 Valby, Denmark</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Annemette++Thougaard">Annemette Thougaard</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gennady Smagin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gennady Smagin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroinflammation Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gennady++Smagin">Gennady Smagin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dekun Song</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dekun Song</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroinflammation Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dekun++Song">Dekun Song</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Londye Calice</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Londye Calice</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroinflammation Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Londye++Calice">Londye Calice</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Veena Menon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Veena Menon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroinflammation Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Veena++Menon">Veena Menon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Elena Dale</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elena Dale</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroinflammation Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elena++Dale">Elena Dale</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hong Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hong Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroinflammation Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Zhang">Hong Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Manuel Cajina</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Manuel Cajina</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroinflammation Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Manuel++Cajina">Manuel Cajina</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Megan E. Nattini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Megan E. Nattini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroinflammation Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Megan+E.++Nattini">Megan E. Nattini</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Adarsh Gandhi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Adarsh Gandhi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroinflammation Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Adarsh++Gandhi">Adarsh Gandhi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michel Grenon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michel Grenon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroinflammation Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michel++Grenon">Michel Grenon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ken Jones</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ken Jones</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroinflammation Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ken++Jones">Ken Jones</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tanzilya Khayrullina</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tanzilya Khayrullina</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroinflammation Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tanzilya++Khayrullina">Tanzilya Khayrullina</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gamini Chandrasena</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gamini Chandrasena</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroinflammation Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gamini++Chandrasena">Gamini Chandrasena</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christian Thomsen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christian Thomsen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroinflammation Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christian++Thomsen">Christian Thomsen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stevin H. Zorn</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stevin H. Zorn</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroinflammation Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stevin+H.++Zorn">Stevin H. Zorn</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Robb Brodbeck</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robb Brodbeck</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroinflammation Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robb++Brodbeck">Robb Brodbeck</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Suresh Babu Poda</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Suresh Babu Poda</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroinflammation Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Suresh+Babu++Poda">Suresh Babu Poda</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Roland Staal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Roland Staal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroinflammation Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Roland++Staal">Roland Staal</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Thomas Möller</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thomas Möller</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroinflammation Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++M%C3%B6ller">Thomas Möller</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c02249&amp;href=/doi/10.1021%2Facs.jmedchem.0c02249" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 4891–4902</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 6, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 December 2020</li><li><span class="item_label"><b>Published</b> online</span>6 April 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 April 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c02249" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02249</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4891%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAllen%2BT.%2BHopper%252C%2BMartin%2BJuhl%252C%2BJorrit%2BHornberg%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D8%26contentID%3Dacs.jmedchem.0c02249%26title%3DSynthesis%2Band%2BCharacterization%2Bof%2Bthe%2BNovel%2BRodent-Active%2Band%2BCNS-Penetrant%2BP2X7%2BReceptor%2BAntagonist%2BLu%2BAF27139%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4902%26publicationDate%3DApril%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c02249"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">930</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c02249" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Characterization of the Novel Rodent-Active and CNS-Penetrant P2X7 Receptor Antagonist Lu AF27139&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Allen&quot;,&quot;last_name&quot;:&quot;T. Hopper&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Juhl&quot;},{&quot;first_name&quot;:&quot;Jorrit&quot;,&quot;last_name&quot;:&quot;Hornberg&quot;},{&quot;first_name&quot;:&quot;Lassina&quot;,&quot;last_name&quot;:&quot;Badolo&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Paul Kilburn&quot;},{&quot;first_name&quot;:&quot;Annemette&quot;,&quot;last_name&quot;:&quot;Thougaard&quot;},{&quot;first_name&quot;:&quot;Gennady&quot;,&quot;last_name&quot;:&quot;Smagin&quot;},{&quot;first_name&quot;:&quot;Dekun&quot;,&quot;last_name&quot;:&quot;Song&quot;},{&quot;first_name&quot;:&quot;Londye&quot;,&quot;last_name&quot;:&quot;Calice&quot;},{&quot;first_name&quot;:&quot;Veena&quot;,&quot;last_name&quot;:&quot;Menon&quot;},{&quot;first_name&quot;:&quot;Elena&quot;,&quot;last_name&quot;:&quot;Dale&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Manuel&quot;,&quot;last_name&quot;:&quot;Cajina&quot;},{&quot;first_name&quot;:&quot;Megan&quot;,&quot;last_name&quot;:&quot;E. Nattini&quot;},{&quot;first_name&quot;:&quot;Adarsh&quot;,&quot;last_name&quot;:&quot;Gandhi&quot;},{&quot;first_name&quot;:&quot;Michel&quot;,&quot;last_name&quot;:&quot;Grenon&quot;},{&quot;first_name&quot;:&quot;Ken&quot;,&quot;last_name&quot;:&quot;Jones&quot;},{&quot;first_name&quot;:&quot;Tanzilya&quot;,&quot;last_name&quot;:&quot;Khayrullina&quot;},{&quot;first_name&quot;:&quot;Gamini&quot;,&quot;last_name&quot;:&quot;Chandrasena&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;Thomsen&quot;},{&quot;first_name&quot;:&quot;Stevin&quot;,&quot;last_name&quot;:&quot;H. Zorn&quot;},{&quot;first_name&quot;:&quot;Robb&quot;,&quot;last_name&quot;:&quot;Brodbeck&quot;},{&quot;first_name&quot;:&quot;Suresh&quot;,&quot;last_name&quot;:&quot;Babu Poda&quot;},{&quot;first_name&quot;:&quot;Roland&quot;,&quot;last_name&quot;:&quot;Staal&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Möller&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;06&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;4891-4902&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c02249&quot;},&quot;abstract&quot;:&quot;There remains an insufficient number of P2X7 receptor antagonists with adequate rodent potency, CNS permeability, and pharmacokinetic properties from which to evaluate CNS disease hypotheses preclinically. Herein, we describe the molecular pharmacology, safety, pharmacokinetics, and functional CNS target engagement of Lu AF27139, a novel rodent-active and CNS-penetrant P2X7 receptor antagonist. Lu AF27139 is highly selective and potent against rat, mouse, and human forms of the receptors. The rat pharmacokinetic profile is favorable with high oral bioavailability, modest clearance (0.79 L/(h kg)), and good CNS permeability. In vivo mouse CNS microdialysis studies of lipopolysaccharide (LPS)-primed and 2′(3′)-O-(benzoylbenzoyl)adenosine-5′-triphosphate (BzATP)-induced IL-1β release demonstrate functional CNS target engagement. Importantly, Lu AF27139 was without effect in standard in vitro and in vivo toxicity studies. Based on these properties, we believe Lu AF27139 will be a valuable tool for probing the rol&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02249&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02249" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02249&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02249" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02249&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02249" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c02249&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02249&amp;href=/doi/10.1021/acs.jmedchem.0c02249" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c02249" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c02249" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c02249%26sid%3Dliteratum%253Aachs%26pmid%3D33822617%26genre%3Darticle%26aulast%3DHopper%26date%3D2021%26atitle%3DSynthesis%2Band%2BCharacterization%2Bof%2Bthe%2BNovel%2BRodent-Active%2Band%2BCNS-Penetrant%2BP2X7%2BReceptor%2BAntagonist%2BLu%2BAF27139%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D8%26spage%3D4891%26epage%3D4902%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/jmcmar.2021.64.issue-8/20210422/jmcmar.2021.64.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/medium/jm0c02249_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/large/jm0c02249_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02249&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">There remains an insufficient number of P2X7 receptor antagonists with adequate rodent potency, CNS permeability, and pharmacokinetic properties from which to evaluate CNS disease hypotheses preclinically. Herein, we describe the molecular pharmacology, safety, pharmacokinetics, and functional CNS target engagement of Lu AF27139, a novel rodent-active and CNS-penetrant P2X7 receptor antagonist. Lu AF27139 is highly selective and potent against rat, mouse, and human forms of the receptors. The rat pharmacokinetic profile is favorable with high oral bioavailability, modest clearance (0.79 L/(h kg)), and good CNS permeability. <i>In vivo</i> mouse CNS microdialysis studies of lipopolysaccharide (LPS)-primed and 2′(3′)-<i>O</i>-(benzoylbenzoyl)adenosine-5′-triphosphate (BzATP)-induced IL-1β release demonstrate functional CNS target engagement. Importantly, Lu AF27139 was without effect in standard <i>in vitro</i> and <i>in vivo</i> toxicity studies. Based on these properties, we believe Lu AF27139 will be a valuable tool for probing the role of the P2X7 receptor in rodent models of CNS diseases.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83286" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83286" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The P2X7 receptor (P2X7R) is an adenosine triphosphate (ATP) gated nonselective cation channel with a relatively high km for ATP in the 100–1000 μM range <i>in vitro</i>.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Existing as a homotrimer, P2X7Rs are widely expressed throughout the CNS including the spinal cord with cellular localization predominantly on microglia.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Peripherally, P2X7R is expressed on immune cells (e.g., monocytes, neutrophils, T, B, NK cells), Schwann cells, and satellite glia. Activation of the P2X7R ion channel by ATP leads to immediate calcium influx and a variety of associated downstream signaling events, including triggering the maturation and release of the cytokines IL-1β and IL-18.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">Owing to its localization on microglia and importance in regulating inflammatory cytokines, P2X7R has been suggested to play an important role in neuroinflammation<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and has been implicated in a variety of CNS-based diseases<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5−8)</a> including neuropathic pain (NPP),<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> multiple sclerosis (MS), Alzheimer’s disease (AD), epilepsy, Huntington’s disease, and major depressive disorder (MDD).<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> While significant progress has been made in the identification of human selective P2X7 antagonists, at the start of this work, there remained an insufficient number of CNS-permeable P2X7 receptor antagonist tools from which to probe rodent CNS pharmacology.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Significant cross-species differences in molecular pharmacology and insufficient CNS permeability hampered the use of many P2X7 receptor antagonists for this purpose.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Lacking were a sufficient number of structurally distinct tools with optimized pharmacokinetic (PK) and safety profiles, to establish the role of the P2X7R in models where chronic dosing paradigms and near-complete target engagement would be required to adequately test biological hypotheses. Herein, we report the structure, synthesis, molecular pharmacology, ADMET, and safety data for Lu AF27139 (<b>1</b>), a rodent-active CNS-penetrant and highly selective P2X7R antagonist.</div><div class="NLM_p">As part of our drug discovery research related to neuroinflammation, we desired to probe the role of the P2X7R in a variety of CNS disease models (e.g., major depressive disorder, epilepsy, multiple sclerosis, and neuropathic pain). In this vein, we required suitable CNS-penetrant P2X7R antagonist tools capable of giving near-complete functional inhibition of the ion channel under a subchronic dosing paradigm. We evaluated a variety of literature-reported compounds and found them to be generally inadequate for this purpose, as they either lacked sufficient rodent P2X7R potency, did not appreciably enter the CNS, were of poor metabolic stability, or lacked appropriate target selectivity. Therefore, part of our medicinal chemistry work focused on identifying compounds with appropriate characteristics to probe in preclinical rodent models of neuroinflammation and CNS disease. To bolster this effort, the Neurogen P2X7R patent estate was licensed by Lundbeck. The racemic form of compound <b>1</b> was previously reported as having an IC<sub>50</sub> < 2 μM.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> While we synthesized and tested numerous compounds within and near those within the Neurogen patent estate, racemic <b>1</b> stood out as having good potency and properties consistent with good CNS permeability and PK, leading to the desire to separate the two enantiomers giving <b>1</b> and <b>2</b>.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_p last">Subsequent to the conclusion of this work, several valuable CNS-penetrant rodent-active tool compounds were described.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The clinical candidate JNJ-54175446 (<b>3</b>), with a tetrahydro-triazolopyridine core, was reported to have near-equal rat and human P2X7R potencies with pIC<sub>50</sub>’s of 8.8 and 8.5, respectively, and a brain-to-plasma ratio of 1.1 (<i>K</i><sub>p,uu,brain</sub> 0.46).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> A similar tetrahydro-imidazolopyridine analogue, JNJ-54166060 (<b>4</b>), has rat and human P2X7R pIC<sub>50</sub>’s of 8.4 and 6.9, respectively, and a <i>K</i><sub>p,uu,brain</sub> of 0.84.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> In addition, a series of CNS-penetrant and rat-active 1,2,4-triazolopiperidines were described, as exemplified by <b>5</b>.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Compound <b>5</b> has rat and human P2X7R pIC<sub>50</sub>’s of 7.10 and 9.15. Further, <b>5</b> has good CNS permeability, as demonstrated by its activity in an <i>ex vivo</i> receptor occupancy assay in rat hippocampus with an ED<sub>50</sub> of 0.8 mg/kg. Compound <b>1</b> adds structural diversity to the growing list of tool P2X7R inhibitors of potential utility to probe in preclinical rodent models of neuroinflammation and CNS diseases.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20747" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20747" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compound <b>1</b>,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> its enantiomer Lu AF27138 (<b>2</b>) and comparator P2X7R antagonists A-804598 (<b>6</b>),<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> CE224,535 (<b>7</b>),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> AZD9056 (<b>8</b>),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> GSK1482160 (<b>9</b>),<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> AFC5128 (<b>10</b>),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Actelion compound (<b>11</b>),<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> A-740003 (<b>12</b>),<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> A-438079 (<b>13</b>),<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Abbott compound (<b>14</b>),<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Pfizer compound (<b>15</b>),<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> JNJ-47965567 (<b>16</b>),<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> JNJ-42253432 (<b>17</b>),<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and BBG (<b>18</b>)<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> were tested <i>in vitro</i> against mouse, rat, and human forms of the receptor for inhibiting 2′(3′)-<i>O</i>-(benzoylbenzoyl)adenosine-5′-triphosphate (BzATP)-induced calcium-flux using fluorescent imaging plate reader (FLIPR)-based assays (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). While ATP is the endogenous agonist for the P2X7 receptor, BzATP is a more stable, potent, and selective agonist of the P2X7 receptor and therefore commonly used to activate the receptor in a variety of assays.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Compound <b>1</b> was found to have similar P2X7R potency against rat (IC<sub>50</sub> 2.2 nM, Ki 13 nM), mouse (IC<sub>50</sub> 22 nM, Ki 180 nM), and human (IC<sub>50</sub> 12 nM, Ki 38 nM) forms of the receptors. Since <i>S</i>-enantiomer <b>1</b> was 7.5- and 40-fold more potent against human and rat forms of the receptor, respectively, than <i>R</i>-enantiomer <b>2</b>, additional work focused only on enantiomer <b>1</b>. Binding experiments were performed in cell membranes isolated from HEK293 cells stably transfected with human, rat, or mouse P2X7R. Compound <b>1</b> was about 5-fold less potent in the binding assays than in the functional FLIPR assays. While many of the reference compounds have similarly low nanomolar potency against human P2X7R, compounds <b>7</b>, <b>9</b>, <b>10</b>, <b>11</b>, and <b>15</b>, are from 100- to 1000-fold less potent at the rodent receptor, thus limiting their usefulness to probe rodent <i>in vivo</i> pharmacology. Potency shifts between mouse and rat P2X7R were also observed, such as for <b>8</b> and <b>12</b> with 390- and 60-fold shifts in potency between rodent species, respectively. Notable differences between the measured binding Ki and FLIPR IC<sub>50</sub>’s for some compounds may reflect differences in on and off rates. For example, <b>1</b> and <b>8</b> are 5- and 30-fold more potent in the rat FLIPR assay than rat binding Ki, respectively, while <b>13</b> and <b>14</b> have rat binding Ki’s 4.5- and 4.4-fold more potent than their respective rat FLIPR IC<sub>50</sub>’s. These compounds were also evaluated for their ability to inhibit IL-1β release in THP-1 cells, a human cell line. With a few exceptions, the IC<sub>50</sub> for inhibiting IL-1β release was within 3-fold of the human P2X7 FLIPR data IC<sub>50</sub>’s. Compound <b>1</b> was 3-fold less potent at inhibiting IL-1β release in THP-1 cells with an IC<sub>50</sub> of 38 nM, than inhibiting Ca<sup>++</sup> flux in the human P2X7 FLIPR assay. A few compounds, such as <b>6</b>, <b>8</b>, <b>13</b>, and <b>18</b>, were more potent at inhibiting IL-1β release than in the human FLIPR assay. Despite these differences, a reasonable correlation between the two assays was observed.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/medium/jm0c02249_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/large/jm0c02249_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of Lu AF27139 (<b>1</b>), Lu AF27138 (<b>2</b>), and P2X7R comparator compounds JNJ-54175446 (<b>3</b>), JNJ-54166060 (<b>4</b>), JNJ analogue (<b>5</b>), A-804598 (<b>6</b>), CE224,535 (<b>7</b>), AZD9056 (<b>8</b>), GSK1482160 (<b>9</b>), AFC5128 (<b>10</b>), Actelion compound (<b>11</b>), A-740003 (<b>12</b>), A-438079 (<b>13</b>), Abbott compound (<b>14</b>), Pfizer compound (<b>15</b>), JNJ-47965567 (<b>16</b>), JNJ-42253432 (<b>17</b>), and BBG (<b>18</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/large/jm0c02249_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02249&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. P2X7 Receptor <i>In Vitro</i> Molecular Pharmacology, Metabolic Stability, and Permeability Data</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±"> </th><th class="rowsep1 colsep0" align="center" char="±">P2X7 FLIPR data IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center">P2X7 binding Ki (nM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center">IL-1β IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">liver microsomal stability (L/(h kg))<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">MDCK-1 Papp (cm/s × 10<sup>–6</sup>)<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char="±">human</th><th class="colsep0 rowsep0" align="center" char="±">rat</th><th class="colsep0 rowsep0" align="center" char="±">mouse</th><th class="colsep0 rowsep0" align="center">human</th><th class="colsep0 rowsep0" align="center">rat</th><th class="colsep0 rowsep0" align="center">mouse</th><th class="colsep0 rowsep0" align="center">human</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center" char=".">A:B</th><th class="colsep0 rowsep0" align="center" char=".">ER</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="±">12 ± 0.52</td><td class="colsep0 rowsep0" align="char" char="±">2.4 ± 0.094</td><td class="colsep0 rowsep0" align="char" char="±">22 ± 1.2</td><td class="colsep0 rowsep0" align="left">55 ± 9.8</td><td class="colsep0 rowsep0" align="left">13 ± 2.4</td><td class="colsep0 rowsep0" align="left">180 ± 71</td><td class="colsep0 rowsep0" align="left">38 ± 2.5</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">0.81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char="±">90 ± 6.5</td><td class="colsep0 rowsep0" align="char" char="±">95 ± 6.2</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char="±">32 ± 4.1</td><td class="colsep0 rowsep0" align="char" char="±">6.1 ± 0.60</td><td class="colsep0 rowsep0" align="char" char="±">34 ± 2.8</td><td class="colsep0 rowsep0" align="left">8.9 ± 0.61</td><td class="colsep0 rowsep0" align="left">3.9 ± 0.36</td><td class="colsep0 rowsep0" align="left">60 ± 17</td><td class="colsep0 rowsep0" align="left">15 ± 5.7</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td><td class="colsep0 rowsep0" align="char" char=".">9.3</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char="±">0.76 ±0.08</td><td class="colsep0 rowsep0" align="char" char="±">470 ± 57</td><td class="colsep0 rowsep0" align="char" char="±">660 ± 69</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">7.2</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char="±">3.5 ±0.75</td><td class="colsep0 rowsep0" align="char" char="±">4.4 ± 1.1</td><td class="colsep0 rowsep0" align="char" char="±">1700 ±340</td><td class="colsep0 rowsep0" align="left">15 ± 1.9</td><td class="colsep0 rowsep0" align="left">130 ± 22</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char="±">20 ±1.8</td><td class="colsep0 rowsep0" align="char" char="±">1900 ± 440</td><td class="colsep0 rowsep0" align="char" char="±">2300 ±450</td><td class="colsep0 rowsep0" align="left">5.7 ± 1.8</td><td class="colsep0 rowsep0" align="left">510 ± 12</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">300</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">0.72</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char="±">72 ±19</td><td class="colsep0 rowsep0" align="char" char="±">1500 ± 230</td><td class="colsep0 rowsep0" align="char" char="±">240 ± 21</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char="±">5.5 ±0.81</td><td class="colsep0 rowsep0" align="char" char="±">260 ± 19</td><td class="colsep0 rowsep0" align="char" char="±">320 ± 53</td><td class="colsep0 rowsep0" align="left">5.6 ± 1.2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">100 ± 28</td><td class="colsep0 rowsep0" align="left">27 ± 9.0</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">0.83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char="±">81 ±5.5</td><td class="colsep0 rowsep0" align="char" char="±">4.0 ± 0.20</td><td class="colsep0 rowsep0" align="char" char="±">250 ± 75</td><td class="colsep0 rowsep0" align="left">130 ± 21</td><td class="colsep0 rowsep0" align="left">59 ± 1.9</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">290</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char="±">2100 ±390</td><td class="colsep0 rowsep0" align="char" char="±">910 ± 160</td><td class="colsep0 rowsep0" align="char" char="±">2900 ±490</td><td class="colsep0 rowsep0" align="left">68 ± 37</td><td class="colsep0 rowsep0" align="left">200 ± 42</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">150</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char="±">57 ±15</td><td class="colsep0 rowsep0" align="char" char="±">71 ± 6.9</td><td class="colsep0 rowsep0" align="char" char="±">300 ± 35</td><td class="colsep0 rowsep0" align="left">7.4 ± 1.6</td><td class="colsep0 rowsep0" align="left">16 ± 2.0</td><td class="colsep0 rowsep0" align="left">48 ± 13</td><td class="colsep0 rowsep0" align="left">140 ± 16</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">0.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="char" char="±">21 ±1.5</td><td class="colsep0 rowsep0" align="char" char="±">5500 ± 1300</td><td class="colsep0 rowsep0" align="char" char="±">>10 000</td><td class="colsep0 rowsep0" align="left">53 ± 3.0</td><td class="colsep0 rowsep0" align="left">4800 ± 63</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">0.47</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="char" char="±">35 ±2.3</td><td class="colsep0 rowsep0" align="char" char="±">4.7 ± 0.82</td><td class="colsep0 rowsep0" align="char" char="±">0.65 ± 0.12</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">98</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char="±">5800 ±1700</td><td class="colsep0 rowsep0" align="char" char="±">200 ± 63</td><td class="colsep0 rowsep0" align="char" char="±">1300 ± 65</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">1000 ± 36</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">700</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">P2X7R FLIPR data were determined in HEK293 cells stably transfected with either human, rat, or mouse P2X7R. The cells were preincubated with antagonist and then stimulated with an EC<sub>80</sub> concentration of BzATP.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">P2X7R binding was performed in membranes prepared from the same cells using [<sup>3</sup>H]-A-804598 as the radio-ligand. Values are expressed as mean ± standard error of the mean (SEM) for <i>n</i> ≥ 3 experiments.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">IL-1β inhibition data in THP-1 cells primed with lipopolysaccharide (LPS) and stimulated with BzATP.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Rat and human liver microsomal intrinsic clearance (Clint) was determined by assessing the disappearance of test compounds at six time points over a 60 min incubation period. The compounds (1 μM) were incubated in a 1 mL reaction volume containing rat or human liver microsomes (purchased from Becton Dickinson, MA) at a concentration of 0.7–1.0 mg protein/mL and fortified with NADPH.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">MDR1-MDCK cell permeability of the test compounds from A to B direction or B to A direction was determined in triplicate, and the efflux ratio (ER) is the ratio of B:A/A:B permeation. Experimental details are described in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c02249/suppl_file/jm0c02249_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div></div></div><div class="NLM_p">Beyond species selectivity, ADME properties associated with low brain permeability and high intrinsic clearance have ultimately led to insufficient exposure for hypothesis testing with many P2X7R antagonists. Liver microsomal stability and permeability in the MDR1-MDCK cell assay were evaluated for representative tools (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Compounds <b>10</b>, <b>13</b>, <b>14</b>, <b>16</b>, and <b>17</b> have particularly high rates of intrinsic clearance measured in rat liver microsomes at 4- to 10-fold above rat hepatic blood flow. Metabolic instability is undesirable as it may preclude from running subchronic dosing studies and could produce large amounts of interfering metabolites, thus complicating interpretation of <i>in vivo</i> efficacy studies. The MDR1-MDCK cell permeability assay is a useful predictor of CNS permeability and Pgp efflux liabilities. Compounds <b>7</b>, <b>8</b>, <b>12</b>, and <b>17</b> have low permeability with apical to basolateral permeation being less than 1.0 × 10<sup>–6</sup> cm/s with varying efflux ratios, defined as the rate going from basolateral to apical divided by the rate moving from apical to basolateral direction. However, compounds <b>1</b>, <b>9</b>, <b>11</b>, <b>14</b>, <b>15</b>, and <b>16</b> have desired moderate to high permeability with Pgp efflux ratios below 2.</div><div class="NLM_p">P2X7R antagonist <b>6</b> appeared to be an excellent tool compound candidate owing to its good rodent potency, permeability, and metabolic stability properties. However, possibly due to its low solubility, a formulation and dosing paradigm to give sufficient and reproducible exposures could not be identified, despite considerable efforts to do so (unpublished data). During our discovery efforts, the novel compound <b>1</b> was found to have similar P2X7R potency to rat (IC<sub>50</sub> 2.2 nM, Ki 13 nM), mouse (IC<sub>50</sub> 22 nM, Ki 180 nM), and human (IC<sub>50</sub> 12 nM, Ki 38 nM) forms of the receptors. And compound <b>1</b> with high permeability in the MDR1-MDCK assay without efflux and suitable metabolic stability became a compound of interest for additional profiling.</div><div class="NLM_p">To evaluate the effects of <b>1</b> on the P2X7R ion channel, it was profiled in several additional P2X7R functional cell-based assays. In electrophysiology experiments, <b>1</b> inhibited 100 μM BzATP-induced current in HEK293 cells stably transfected with the rat P2X7R (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A) in a dose response manner with an IC<sub>50</sub> of 66 nM. Similarly, <b>1</b> inhibited 300 μM BzATP-induced current in primary rat microglia (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B) with 80% inhibition occurring at a 100 nM dose. This experimental paradigm reveals a slow off-rate of the compound, as it took 17.6 min to regain 50% of the normal response to repeated application of 300 μM BzATP. This can be observed in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B, where the first two repeat applications of 300 μM BzATP are administered after repeated 80 s of washout with a slow rate of current recovery. The difference in potency for <b>1</b> between the rat FLIPR assay (IC<sub>50</sub> 2.3 nM) and the electrophysiology experiments may be due to the different levels of BzATP used. The rat FLIPR assay was run by stimulating cells with an EC<sub>80</sub> of BzATP (c.a. ∼ 4 μM), which is 25- to 75-fold below that used in the electrophysiology experiments. Data from the electrophysiology assays along with that from the binding assay (rat Ki 13 nM) confirm that <b>1</b> antagonizes P2X7R through direct receptor interaction. The finding that <b>1</b> is effective in primary rat microglia confirms the presence of functional P2X7R on microglia.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/medium/jm0c02249_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/large/jm0c02249_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>1</b> inhibits BzATP-induced currents in (A) HEK293 cells stably transfected with rat P2X7R and (B) rat primary microglia. Repeated administration of 300 μM BzATP demonstrates a slowly reversible effect of a single 60 s administration of 100 nM <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/large/jm0c02249_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02249&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Beyond its ion channel function, P2X7R activation has long been known to regulate IL-1β.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> IL-1β is carefully regulated <i>in vivo</i>, and its production requires two steps: a priming step via activation of the TLR4 receptor to generate pro-IL-1β and subsequent activation of the P2X7R with ATP or the agonist BzATP, thereby triggering inflammasome assembly and activation of caspase 1, which cleaves pro-IL-1β to give mature active IL-1β.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Consistent with being a P2X7R antagonist, <b>1</b> inhibits LPS-primed and BzATP-induced IL-1β release from THP-1 cells with an IC<sub>50</sub> of 38 ± 2.5 nM. Similarly, P2X7R antagonist <b>1</b> concentration-dependently blocked IL-1β release in rat and mouse primary cortical microglia primed with LPS and induced with 1 mM BzATP with IC<sub>50</sub>’s of 38 ± 19 nM in rat and 26 ± 6 nM in mice (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/medium/jm0c02249_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/large/jm0c02249_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>1</b> concentration-dependently inhibits IL-1β release in rat and mouse primary cortical microglia primed with LPS and induced with 1 mM BzATP (A) rat microglia IL-1β release with an average IC<sub>50</sub> of 38 ± 19 nM (<i>n</i> = 4). The rat IC<sub>50</sub> of the example curve is 2.2 nM, and (B) mouse IL-1β release with an IC<sub>50</sub> of 26 ± 6 nM (<i>n</i> = 3). The mouse IC<sub>50</sub> for the example curve is 21.9 nM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/large/jm0c02249_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02249&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The cross-reactivity of <b>1</b> was evaluated at a 10 μM concentration against a combination of 84 binding, cellular, and nuclear receptor functional and enzyme assays at CEREP and in the KINOMEscan screen against 468 kinases at DiscoveRx. In the CEREP screen, a minor signal from the A2A binding assay (34% inhibition of agonist binding) was followed up, but no agonistic or antagonistic activity could be detected. In the KINOMEscan, five kinases were inhibited by 65–90% relative to controls in the initial screen, but these hits were not confirmed upon retesting, suggesting that the initial findings were false-positives. Compound <b>1</b> was also clean when tested (n = 4) against the available P2X and P2Y receptors at Axxam. Testing was performed in both agonist and antagonist modes in an eight-point dose response starting at a top dose of 10 μM against hP2RX1, hP2RX2, hP2RX3, hP2RX2/3, hP2RX4, rat P2RX4, hP2RY1, hP2RY2, hP2RY6, hP2RY11, hP2RY12, and hP2RY13. In summary, <b>1</b> was without significant effect against the targets tested. The likelihood of off-target activity contributing to the pharmacology of <b>1</b> is low based on its selectivity profile.</div><div class="NLM_p">Compound <b>1</b> was further characterized in a variety of physical–chemical and ADME assays. Thermodynamic solubility is 16 μg/mL (32 μM), measured using the shake flask high-performance liquid chromatography (HPLC) method. The TPSA is 80, <i>c</i> log <i>P</i> is 2.2 (determined by Daylight software version 2.2), and the measured log D is 3.3. Intrinsic clearances for <b>1</b> in rat and human liver microsomes are 5.1 and 2.6 L/(h kg) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), and in rat and human hepatocytes are 4.8 and 0.85 L/(kg h), respectively. Compound <b>1</b> does not inhibit CYP3A4, 1A2, 2C9, 2C19, 2D6, 2B6, or 2C8 at up to 25 μM, nor is there a time-dependent inhibition against these cyps at a similar concentration based on a high-throughput assay developed for a parallel measure of both reversible and time-dependent inhibition. However, compound <b>1</b> does have mild to moderate CYP3A4 induction potential at 10 μM, as measured in human hepatocytes with a relative increase of 26.9% in CYP3A4 mRNA. This is comparable to levels obtained with the clinically relevant CYP3A inducer, rifampin, at a concentration of 10 μM.</div><div class="NLM_p">The rat pharmacokinetics of plasma concentration–time profile of <b>1</b> following intravenous (iv) (1 mg/kg) and per os (po) (2 mg/kg) administration was characterized by a noncompartment model. The modeling parameter estimates show a low plasma clearance (Cl) of 0.79 L/(h kg) and a moderate volume of distribution at a steady state (<i>V</i><sub>ss</sub>) of 0.95 L/kg, resulting in a modest terminal half-life (<i>T</i><sub>1/2</sub>) of 2.7 h. Following oral administration, <b>1</b> was rapidly absorbed (<i>T</i><sub>max</sub> = 0.58 h) with a high <i>C</i><sub>max</sub> (2.7 μM) and high absolute oral bioavailability (<i>F</i>% ≥ 100).</div><div class="NLM_p">Compound <b>1</b> is considered to have desirable physical–chemical and DMPK properties supportive of good oral bioavailability and CNS permeability. Two issues however, high liver microsomal clearance and mild to moderate CYP3A4 induction potential, were identified. Concerns related to the rate of rat liver microsomal clearance (1.5-fold rat liver blood flow, LBF) are tempered owing to the observed low rate of <i>in vivo</i> plasma clearance of 0.79 L/(h kg) (0.25-fold rat LBF) and high oral bioavailability in rat.</div><div class="NLM_p">Exposure assessment was performed in rat (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), and drug concentrations were measured in plasma, brain, and spinal cord at 1 and 2 h after oral administration of <b>1</b> at 1, 3, 10, 30, and 100 mg/kg. Exposure was dose-proportional, achieving greater than 700 nM free drug levels in the CNS 1 h and 2 h after a 100 mg/kg, po dose. Based on unbound drug concentrations (<i>C</i><sub>u</sub>), the brain-to-plasma ratio varied from about 25% at 1 mg/kg to near 75% at 30 and 100 mg/kg doses. It remains unclear if the observed differences in B/P ratios across doses are due to efflux mechanisms only apparent at low concentrations. Drug concentrations did not vary between 1 and 2 h post-dose nor did they vary between brain and spinal cord tissue. Importantly, the <i>C</i><sub>u,brain</sub> and <i>C</i><sub>u,spinal cord</sub> values were reasonably dose-proportional. Unbound concentrations of <b>1</b> are presented for better comparisons of drug exposure across matrices and in line with the free-drug hypothesis where only the unbound concentration of drug is available to bind to the target. Since nonspecific binding of compounds varies in different tissues, ratios such as the brain-to-plasma ratio of drug should be based on the unbound concentrations.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Fraction unbound (<i>f</i><sub>u</sub>) of <b>1</b> was determined <i>ex vivo</i> for rat plasma, brain, and spinal cord tissues utilizing an equilibrium dialysis method (see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c02249/suppl_file/jm0c02249_si_001.pdf" class="ext-link">Supporting Information</a>). The <i>f</i><sub>u</sub>’s in plasma, brain, and spinal cord for <b>1</b> are 0.02, 0.09, and 0.07, respectively.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Exposure of Lu AF27139 (<b>1</b>) in Rat after Oral Administration</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" align="center" char=".">dose</th><th class="rowsep1 colsep0" colspan="2" align="center" char="±"><i>C</i><sub>u, plasma</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center" char="±"><i>C</i><sub>u, brain</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center" char="±"><i>C</i><sub>u, spinal cord</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">(mg/kg, po)</th><th class="colsep0 rowsep0" align="center" char="±">(1 h)</th><th class="colsep0 rowsep0" align="center" char="±">(2 h)</th><th class="colsep0 rowsep0" align="center" char="±">(1 h)</th><th class="colsep0 rowsep0" align="center" char="±">(2 h)</th><th class="colsep0 rowsep0" align="center" char="±">(1 h)</th><th class="colsep0 rowsep0" align="center" char="±">(2 h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char="±">22.4 ± 4.2</td><td class="colsep0 rowsep0" align="char" char="±">22.8 ± 10</td><td class="colsep0 rowsep0" align="char" char="±">5.4 ± 2.6</td><td class="colsep0 rowsep0" align="char" char="±">6.4 ± 2.0</td><td class="colsep0 rowsep0" align="char" char="±">5.20 ± 0.80</td><td class="colsep0 rowsep0" align="char" char="±">10.0 ± 2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="±">71.2 ± 14</td><td class="colsep0 rowsep0" align="char" char="±">91.4 ± 20</td><td class="colsep0 rowsep0" align="char" char="±">42.2 ± 4.6</td><td class="colsep0 rowsep0" align="char" char="±">30.4 ± 9.4</td><td class="colsep0 rowsep0" align="char" char="±">33.0 ± 3.8</td><td class="colsep0 rowsep0" align="char" char="±">38.2 ± 9.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char="±">381 ± 97</td><td class="colsep0 rowsep0" align="char" char="±">164 ± 63</td><td class="colsep0 rowsep0" align="char" char="±">89.6 ± 16</td><td class="colsep0 rowsep0" align="char" char="±">94.2 ± 53</td><td class="colsep0 rowsep0" align="char" char="±">106 ± 19</td><td class="colsep0 rowsep0" align="char" char="±">96.8 ± 22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char="±">414 ± 100</td><td class="colsep0 rowsep0" align="char" char="±">556 ± 67</td><td class="colsep0 rowsep0" align="char" char="±">272 ± 53</td><td class="colsep0 rowsep0" align="char" char="±">436 ± 61</td><td class="colsep0 rowsep0" align="char" char="±">283 ± 100</td><td class="colsep0 rowsep0" align="char" char="±">293 ± 130</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="±">1460 ± 240</td><td class="colsep0 rowsep0" align="char" char="±">497 ± 140</td><td class="colsep0 rowsep0" align="char" char="±">1120 ± 180</td><td class="colsep0 rowsep0" align="char" char="±">743 ± 110</td><td class="colsep0 rowsep0" align="char" char="±">705 ± 87</td><td class="colsep0 rowsep0" align="char" char="±">647 ± 110</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Free plasma, brain, and spinal cord concentrations of Lu AF27139 in rat were determined by the formula (Ct*<i>f</i><sub>u</sub>), where Ct is the total tissue (plasma, brain, or spinal cord) drug concentration and <i>f</i><sub>u</sub> is the fraction unbound in these tissues as determined by <i>ex vivo</i> equilibrium dialysis. Values are expressed as mean ± SEM for <i>n</i> = 3 animals. <i>f</i><sub>u, plasma</sub> = 0.02 ± 0.00, <i>f</i><sub>u, spinal cord</sub> = 0.07 ± 0.03, and <i>f</i><sub>u, brain</sub> = 0.09 ± 0.03. Values are expressed as mean ± SEM for <i>n</i> ≥ 3 experiments.</p></div></div></div><div class="NLM_p"><i>In vivo</i> CNS functional activity was evaluated by measuring IL-1β in the frontal cortex (FC) of freely moving rats and mice using microdialysis (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Orally administered <b>1</b> reduced intracerebroventricular (icv) administered LPS-primed and BzATP-triggered IL-1β release in the frontal cortex of rats and mice. In contrast to other reports,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> we did not observe any IL-1β release without LPS priming (data not shown). This is most likely due to the use of low endotoxin human serum albumin (HSA) in the microdialysis perfusion medium. Other investigators report the use of bovine serum albumin (BSA), which is frequently contaminated with endotoxin.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Compound <b>1</b> was dosed orally 1 h prior to icv BzATP administration and produced minimal effective doses of 3 mg/kg and 10 mg/kg in rats and mice, respectively.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/medium/jm0c02249_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/large/jm0c02249_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Oral administration of <b>1</b> inhibits icv administered LPS-primed and icv BzATP-stimulated IL-1β production in (A) rat and (B) mouse cortex. LPS was administered at time 1 h, compound <b>1</b> at time 0, and BzATP at time 1 h. Microdialysis samples were collected every 60 min and IL-1β in the microdialysate samples analyzed using a V-PLEX assay from MesoScale Discovery (Rockville, MD), <i>n</i> = 6 or 7 per time-point. The lower limit of detection was 2 pg/mL for IL-1β. Graphical and statistical analyses performed using GraphPad Prism software (version 5.01). Area under the curve (AUC) was calculated from baseline for each animal between time 0 and 5 h. Analysis of variance (ANOVA) with Dunnett’s multiple comparison test was used to determine the significance between treatment groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/large/jm0c02249_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02249&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As part of a strategy to identify and mitigate potential safety issues as early as possible during the drug discovery process, <b>1</b> was characterized in an exploratory toxicology screening battery.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In high content screening and oxidative stress assays, which identify roughly 50% of idiosyncratic hepatotoxic drugs,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a><b>1</b> did not test positive for any of the parameters, including mitochondrial membrane potential, cell count, cell membrane integrity, lysosomal activity, and ROS formation when tested in a dose response manner up to 100 μM. There were no signs of genotoxicity in the miniaturized Ames,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a><i>in vitro</i> micronucleus,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and GreenScreen<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> assays. At 30 μM, <b>1</b> showed 44% inhibition of the hERG ion channel. Other cardiac ion channels tested (i.e., hNav1.5, hCav1.2, and hKCNQ1/min K) were not inhibited at 10 μM.</div><div class="NLM_p">Compound <b>1</b> was well tolerated up to 150 mg/kg, po in a 7-day exploratory toxicology study in rats, as well as up to 100 mg/kg, po bid in a 14-day exploratory toxicology study in mice. No macroscopic pathology, histological lesions, or adverse hematological changes were observed up to the indicated doses. In male rats, there was a dose-proportional increase in exposure (AUC<sub>0–8 h</sub>) between 3 mg/kg (day 7, <i>C</i><sub>max</sub> 4640 nM, <i>T</i><sub>max</sub> 1 h, AUC<sub>0–8 h</sub> 7160 nM*h) and 150 mg/kg (day 7, <i>C</i><sub>max</sub> 39 600 nM, <i>T</i><sub>max</sub> 4 h, AUC<sub>0–8 h</sub> 210 000 nM*h). The exposure also increased in a dose-proportional manner between 3 and 30 mg/kg in female rats, but at 150 mg/kg, the exposure did not increase compared with that at 30 mg/kg. Exposures decreased in both sexes after repeated dosing at 30 mg/kg, as the AUC<sub>0–8 h</sub> values after 7-day dosing were 55 and 74% of that obtained after a single dose in male and female rats, respectively. In female mice, repeated dosing at 100 mg/kg (day 14, <i>C</i><sub>max</sub> 61 640 nM, <i>T</i><sub>max</sub> 1 h, AUC<sub>0–8 h</sub> 131 000 nM*h) also reduced the exposure to 33% of that obtained after a single 100 mg/kg dose (day 1, <i>C</i><sub>max</sub> 140 000 nM, <i>T</i><sub>max</sub> 1 h, AUC<sub>0–8 h</sub> 399 000 nM*h). Additional exposure data can be found in <a href="/doi/suppl/10.1021/acs.jmedchem.0c02249/suppl_file/jm0c02249_si_001.pdf" class="ext-link">Table S1a,b</a> in the Supporting Information.</div><div class="NLM_p">The reduced exposure after repeated dosing suggests that <b>1</b> is enhancing its own rate of clearance, possibly through CYP induction of the rat CYP3A4 orthologue as was observed with human hepatocytes. Induction of metabolism might also explain why the exposure in female rats did not increase at the highest dose. The impact of repeat dosing on exposure should be considered if planning to run repeat dosing experiments. Overall, <b>1</b> is considered to have a good safety and tolerability profile supportive of subchronic dosing studies.</div><div class="NLM_p">To synthesize <b>1</b> in sufficient amounts to broadly support its use as a tool, development of scalable routes toward the two coupling partners, thiazole carboxylic acid <b>23</b> and diamine <b>22</b>, was developed. The optimized synthesis of <b>1</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) was initiated with a 1,4-conjugated addition of morpholine to nitroolefin <b>19</b>, and the corresponding adduct precipitated directly by the addition of 2 M hydrochloric acid. The resulting white solid was isolated via filtration of the reaction mixture affording hydrochloride salt <b>20</b>. Attempts to dry hydrochloride <b>20</b> in a vacuum oven at 40 °C resulted in the elimination of morpholine affording back nitroolefin <b>19</b>; therefore, hydrochloride salt <b>20</b> was used directly in the next step. Reduction of the nitro moiety by exposure to zinc in an aqueous ethanolic solution provided racemic diamine <b>21</b> in 87% yield. After extensive screening, an enantioselective crystallization resolution method of diamine <b>21</b> using <i>N</i>-acetyl-<span class="smallcaps smallerCapital">l</span>-leucine in a mixture of acetonitrile and water was discovered to afford the <i>S</i>-enantiomer <b>22</b> in 30% yield and >97% ee. Diamine <b>22</b> was subsequently coupled with corresponding carboxylic acid <b>23</b> to afford <b>1</b> in 16% overall yield, 99% UV purity, and >97% ee.</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/medium/jm0c02249_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/large/jm0c02249_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Lu AF27139 (<b>1</b>); Reagents and Conditions: (a) (i) Morpholine, Tetrahydrofuran (THF); (ii) 2M HCl in Ether; (b) Zn, HCl, EtoH, 87% Crude Yield, Two Steps; (c) <i>N</i>-Acetyl-<span class="smallcaps smallerCapital">l</span>-leucine, MeCN/H<sub>2</sub>O (30:1), 30% Yield, 97% ee; (d) <b>20</b>, 2,4,6-Tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide (T3P), Triethanolamine (TEA), THF, Room Temperature (RT), 3 h, 62% Yield</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/large/jm0c02249_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02249&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">While a synthesis for intermediate thiazole carboxylic acid <b>20</b> was previously reported,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> an alternative inexpensive, robust, and scalable procedure was developed to support large-scale production of <b>1</b> (see Supporting Information <a href="/doi/suppl/10.1021/acs.jmedchem.0c02249/suppl_file/jm0c02249_si_001.pdf" class="ext-link">Scheme S1</a> and the associated synthetic procedures).</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48101" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48101" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In conclusion, herein, we provide molecular pharmacology, ADME/PK, <i>in vivo</i> CNS functional activity, and safety data for <b>1</b>, which support its utility as a brain-penetrant chemical probe to interrogate the role of the P2X7R in preclinical models of neuroinflammation and CNS diseases. Importantly, a robust synthetic route for this novel small molecule is also described, thus enabling its availability. We believe <b>1</b> will be a valuable addition to the existing tools for evaluating the role of the P2X7 receptor in rodent models of CNS diseases.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17005" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17005" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Materials and Methods</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> Drugs</h4><div class="NLM_p last">The synthesis of Lu AF27139, (<i>S</i>)-<i>N</i>-(2-(4-chlorophenyl)-2-morpholinoethyl)-2-(pyrimidin-2-yl)-4-(trifluoromethyl)thiazole-5-carboxamide <b>1</b>, and enantiomer <b>2</b> is described below. The final products have >97% enantiomeric excess (ee) as determined by chiral HPLC or supercritical fluid chromatography (SFC). The comparator P2X7R antagonists A-804598 (<b>6</b>),<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> CE224,535 (<b>7</b>),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> AZD9056 (<b>8</b>),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> GSK1482160 (<b>9</b>),<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> AFC5128 (<b>10</b>),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Actelion compound (<b>11</b>),<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> A-740003 (<b>12</b>),<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> A-438079 (<b>13</b>),<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Abbott compound (<b>14</b>),<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Pfizer compound (<b>15</b>),<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> JNJ-47965567 (<b>16</b>),<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> JNJ-42253432 (<b>17</b>),<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and BBG (<b>18</b>)<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> were either synthesized as previously described or were readily available from commercial vendors. The <sup>1</sup>H NMR and liquid chromatography–mass spectrometry (LC/MS) data for all compounds were consistent with the structure and literature reports. All compounds were greater than 97% pure based on <sup>1</sup>H NMR and LC/MS data.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> General Methods</h3><div class="NLM_p">Analytical LC–MS and HPLC data were obtained using one of the methods described below.</div><div class="NLM_p">Method A: System controller, Shimadzu CBM-20A; UV detector, Shimadzu SPD-M20A. Column: C-18 4.6 × 30 mm, 3.5 μm symmetry; column temperature: 60 °C. Mobile phase gradient: solvent A: H<sub>2</sub>O with 0.05% v/v trifluoroacetic acid (TFA) and solvent B: Methanol with 0.05% TFA. Flow: 3.0 mL/min</div><div class="NLM_p">Method B: A Waters Acquity UPLC-MS was used. Column: Acquity UPLC BEH C18 1.7 μm; 2.1 × 50 mm; column temperature: 60 °C; solvent system: A = water/TFA (99.95:0.05) and solvent B = acetonitrile/water/TFA (94.965:5:0.035); Method: Linear gradient elution with A:B = 90:10 to 0:100 in 1.0 min and with a flow rate of 1.2 mL/min.</div><div class="NLM_p">Method C: HPLC column: Merck LiChroCart 250-4, LiChroSorb RP-8, 5 μm, 250 ×4.6 mm Mobile phase: 20 mM triethylamine/phosphate buffer in water/acetonitrile 50/50, pH = 3.0. Flow: 1.0 mL/min. Temp.: 30 °C.</div><div class="NLM_p">Method D: Chiral HPLC column: Chiralpak AD-H, 5 my, 250 × 4.6 mm eluent: heptane:ethanol:diethylamine = 90:10:0.1, flow 1.0 mL/min. Temp: 30 °C</div><div class="NLM_p last"><sup>1</sup>H NMR spectra were recorded at 500 or 600 MHz on Bruker Avance instruments. Tetramethylsilane (TMS) was used as internal reference standard. Chemical shift values are expressed in ppm. The following abbreviations are used for multiplicity of NMR signals: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet in accordance with the ACS Style Guide.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Synthesis of Lu AF27139</h3><div class="NLM_p">The synthesis of racemic (±)-<i>N</i>-(2-(4-chlorophenyl)-2-morpholinoethyl)-2-(pyrimidin-2-yl)-4-(trifluoromethyl)thiazole-5-carboxamide has previously been described.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Herein is a convenient enantiomeric synthesis protocol for the preparation of (<i>S</i>)-<i>N</i>-(2-(4-chlorophenyl)-2-morpholinoethyl)-2-(pyrimidin-2-yl)-4-(trifluoromethyl)thiazole-5-carboxamide (<b>1</b>).</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> 1-Chloro-4-((<i>E</i>)-2-nitro-vinyl)-benzene (<b>19</b>)</h4><div class="NLM_p last">4-Chlorobenzaldehyde (200.0 g, 1423 mmol) was dissolved in acetic acid (600.0 mL, 10 550 mmol) and nitromethane (308.2 mL, 5691 mmol) was added, then acetic anhydride (26.85 mL, 284.6 mmol) and ammonium acetate (120.6 g, 1565 mmol) was added. The reaction was heated at reflux for 2 h, then volatiles were removed by evaporation and water was added (400 mL, 20 000 mmol) followed by ethyl acetate (400 mL, 4000 mmol). The solids were filtered and dried to yield the title compound <b>19</b> as a brown solid (178.8 g). <sup>1</sup>H NMR (CDCl<sub>3</sub> 500 MHz): δ ppm 6.88 (d, 1H), 6.48 (d, 1H), 6.47-6.32 (m, 4H). HPLC, <i>t</i><sub>R</sub> (min, Method A) = 1.48.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> 4-[1-(4-Chlorophenyl)-2-nitro-ethyl]-morpholine Hydrochloride Salt (<b>20</b>)</h4><div class="NLM_p last">1-Chloro-4-((<i>E</i>)-2-nitro-vinyl)-benzene <b>19</b> (178.8 g, 973.9 mmol) was dissolved in tetrahydrofuran (383.9 mL, 4733 mmol). Morpholine (84.93 mL, 973.9 mmol) was added, and the mixture was stirred for 30 min at RT. Diethyl ether (1329 mL, 12660 mmol) was added followed by 2.0 M HCl in diethyl ether (584.3 mL). Internal temperature increased to 36 °C, and the slurry was stirred for 15 min before being cooled on an ice bath with stirring for 15 min. The solids were filtered and washed with diethyl ether. The resulting title compound <b>20</b> was used without further purification in the next step.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> 2-(4-Chlorophenyl)-2-morpholin-4-yl-ethylamine (<b>21</b>)</h4><div class="NLM_p last">4-[1-(4-Chloro-phenyl)-2-nitro-ethyl]-morpholine, hydrochloride salt <b>20</b> (59.0 g, 192 mmol), was suspended in ethanol (680 mL, 12 000 mmol), then 37% aqueous HCl solution (200 mL) was added followed by the addition of zinc (42.8 g, 654 mmol) in four portions. The mixture was stirred for 50 min, during which the mixture became a clear almost colorless solution. The volatiles were removed by evaporation, and the aqueous mixture was quenched by pouring into 32% aqueous ammonia solution (400 mL). The organics were extracted with iPrOAc (2 × 100 mL). The combined organic phases were dried (sodium sulfate), filtered, and evaporated to dryness in vacuo using MeCN (3 × 100 mL) to co-evaporate, affording the title compound <b>21</b> (45.1 g). <sup>1</sup>H NMR (CDCl<sub>3</sub> 600 MHz): δ ppm 7.31 (d, 2H), 7.20 (d, 2H), 3.71–3.65 (m, 4H), 3.26 (t, 1H), 3.09–3.04 (m, 1H), 2.96–2.91 (m, 1H), 2.43–2.37 (m, 4H).</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> (<i>S</i>)-2-(4-Chlorophenyl)-2-morpholin-4-yl-ethylamine-(<i>S</i>)-2-acetylamino-4-methyl-pentanoate</h4><div class="NLM_p last">To a solution of 2-(4-chlorophenyl)-2-morpholinoethylamine <b>21</b> (106.7 g, 0.443 mol) dissolved in acetonitrile (3005 mL) was added (<i>S</i>)-2-acetamido-4-methylpentanoic acid (<i>N</i>-acetyl-<span class="smallcaps smallerCapital">l</span>-leucine 76.80 g, 0.443 mol), and the mixture was heated to reflux and water (105 mL) was added, giving a clear solution. The heating was stopped, and the solution was allowed to cool slowly to room temperature. At ca. 45 °C, crystallization started and continued over 4 h while cooling slowly to 20 °C. The product was isolated by filtration and washed on the filter with acetonitrile (2 × 100 mL) and dried in vacuo. The solid was resuspended in 240 mL of acetonitrile:water (v/v 96.5:3.5). The slurry was then heated slowly to reflux for 1 h, heating was removed, and stirring was continued while slowly cooling to room temperature (RT). The slurry was stirred for 16 h at RT. The precipitated compound was isolated by filtration, washed on the filter with 2 × 20 mL of acetonitrile:water (v/v 96.5/3.5) and 1 × 30 mL of acetonitrile, and dried. The product was then dried to constant weight in vacuo at 40 °C to yield the title compound as a white solid (55.1 g). <sup>1</sup>H NMR (CDCl<sub>3</sub> 600 MHz): δ ppm 7.68 (d, 1H), 7.44 (d, 2H), 7.26 (d, 2H), 4.08–4.03 (m, 1H), 3.71–3.68 (m, 1H), 3.58–3.52 (m, 4H), 3.38–3.32 (m, 1H), 2.88–2.83 (m, 1H), 2.40–2.35 (m, 2H), 2.22–2.15 (m, 2H), 1.81 (s, 3H), 1.62–1.55 (m, 1H), 1.50–1.45 (m, 1H), 1.41–1.36 (m, 1H), 0.85 (d, 3H), 0.81 (d, 3H). HPLC <i>t</i><sub>R</sub> (min, Method C) = 2.53.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> (<i>S</i>)-2-(4-Chlorophenyl)-2-morpholinoethylamine (<b>22</b>)</h4><div class="NLM_p last">To a solution of 2-(4-chlorophenyl)-2-morpholinoethylamine (<i>S</i>)-2-acetamido-4-methylpentanoate (55.1 g) in iPrOAc/H<sub>2</sub>O (400 mL) was added 24% aqueous ammonia. The phases were separated, and the water phase was extracted once more with iPrOAc (50 mL) and the combined organic phases were washed with water (2 ×50 mL), dried over MgSO<sub>4</sub>, and the solvent was removed in vacuo. NaCl (ca. 20 g) was dissolved in the water phase and then extracted with iPrOAc (3 × 100 mL). The combined organic phases were washed with brine (2 × 50 mL), dried over MgSO<sub>4</sub>, evaporated, and dried to constant weight to yield the title compound <b>22</b> (31.3 g). HPLC <i>t</i><sub>R</sub> (min, Method C) = 2.53, Chiral HPLC <i>t</i><sub>R</sub> (min, Method D) = 14.96</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> (<i>S</i>)-<i>N</i>-(2-(4-Chlorophenyl)-2-morpholinoethyl)-2-(pyrimidin-2-yl)-4-(trifluoromethyl)thiazole-5-carboxamide (<b>1</b>)</h4><div class="NLM_p last">(<i>S</i>)-2-(4-Chlorophenyl)-2-morpholinoethylamine <b>22</b> (31.3 g, 130 mmol) was dissolved in dry THF (700 mL) at RT. 2-(Pyrimidin-2-yl)-4-(trifluoromethyl)thiazole-5-carboxylic acid <b>23</b> (39.4 g, 143 mmol, preparation described in supplemental materials) was added followed by triethylamine (54.4 mL, 390 mmol). 2,4,6-Tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide (T3P) (122 mL, 50% solution in ethyl acetate, dissolved in THF 100 mL) was added slowly and resulted quickly in a clear solution. The reaction was stirred at RT for 3 h. To the reaction was added iPrOAc (500 mL), and the organic phase was washed with 0.5 M NaOH (200 mL) and 0.1 M NaOH (200 mL), followed by washing with water (2 × 200 mL). The product was then extracted with 1 M aqueous H<sub>2</sub>SO<sub>4</sub> (4 × 200 mL), and the combined water phases were washed with iPrOAc (2 × 200 mL) and was again made basic with 24% aqueous ammonia (strong exotherm, cooled with ice) and extracted with iPrOAc (2 × 400 mL). The combined organic phases were washed with water (1 × 300 mL) and brine (2 × 200 mL), dried over MgSO<sub>4</sub>, and the solvent was partly removed in vacuo (volume, ca. 400 mL) and heptane (600 mL) was added. The mixture was stirred on a rotary evaporator for 16 h while slowly cooling to room temperature. The reaction was cooled on ice for 30 min, and the product was isolated by filtration, washed with heptane (2 × 50 mL), and dried under vacuum to constant weight to yield the title compound (<b>1</b>) (40 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> 600 MHz): δ ppm 9.02 (d, 2H), 8.94 (t, 1H), 7.71 (t, 1H), 7.44 (d, 2H), 7.33 (d, 2H), 3.92–3.86 (m, 1H), 3.67–3.64 (m, 1H), 3.60–3.48 (m, 5H), 2.40–2.30 (m, 4H). LCMS (MH<sup>+</sup>): <i>m</i>/<i>z</i> = 498.3, <i>t</i><sub>R</sub> (min, Method B) = 0.49. HPLC <i>t</i><sub>R</sub> (min, Method C) = 5.16. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −34.89 (<i>c</i> = 1% in MeOH). Elemental Analysis (CHN) and KF H<sub>2</sub>O: Found C 50.67%, H 3.90%, N 13.76%, KF H<sub>2</sub>O < 0.1%. Expected C 50.66%, H 3.85%, N 14.07%.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Stereochemistry Determination of (<i>S</i>)-2-(4-Chlorophenyl)-2-morpholinoethylamine (<b>22</b>)</h4><div class="NLM_p last">The absolute stereochemistry of chiral amine <b>22</b> was determined by XRPD analysis of the corresponding Mosher’s amide,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> which confirmed the <i>S</i>-stereochemistry. Stereochemistry assignment of (2<i>R</i>)-N-[(2<i>S</i>)-2-(4-chlorophenyl)-2-morpholino-ethyl]-3,3,3-trifluoro-2-methoxy-2-phenyl-propanamide was determined from a combination of <i>R</i>-factor tests [<i>R</i><sub>1</sub><sup>+</sup> = 0.0414, <i>R</i><sub>1</sub><sup>–</sup> = 0.0561], Flack parameter [<i>x</i><sup>+</sup> = −0.02(2), <i>x</i><sup>–</sup> = 1.01(2)], and Bayesian statistics on Bijvoet differences, <i>p</i>3(ok), <i>p</i>3(twin), and <i>p</i>3(wrong) 1.000, 0.000, and 0.000, respectively. Calculation based on 6994 Bijvoet pairs. XRPD was measured on a sample of the batch and gave the same pattern as the one used for the structure determination. This means that the crystal selected for the structure determination is representative of the batch.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> P2X7 Inhibition Measured by FLIPR Assays</h3><div class="NLM_p last">Human (<b>NM_002562.5</b>), mouse (<b>NM_002562.5</b>), and rat (<b>NM_002562.5</b>) P2X7 receptors were cloned into a pCDNA3.1 vector and stably expressed in HEK 293s cells (passage number <25, ATCC Manassas, VA). The stable cells (15 000/well) were plated in 384-well poly-<span class="smallcaps smallerCapital">d</span>-lysine (PDL)-coated black FLIPR plates (Greiner Bio One, Monroe, NC) using 1.5% fetal bovine serum (FBS) (Atlanta Biologicals, Lawrenceville, GA), in Dulbecco’s modified Eagle’s medium (DMEM) (Gibco—Thermo Fischer Scientific, Waltham MA) 24 h before the assay. The plates were washed 2× with the assay buffer. For the human P2X7R assay, sucrose buffer was used to improve the signal-to-noise ratio (sucrose assay buffer, pH 7.4, 5 mM potassium chloride, 9.6 mM NaH<sub>2</sub>PO<sub>4</sub>·2H<sub>2</sub>O, 25 mM 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid buffer (HEPES), 0.5 mM CaCl<sub>2</sub>, 5 mM glucose, 280 mM sucrose, and 1.0 mM probenecid (Sigma, St. Louis, MO)), whereas for rat and mouse P2X7R, regular FLIPR buffer was used [Hank’s balanced salt solution buffer (HBSS), pH 7.4 1× buffer supplemented with 20 mM HEPES plus 2.5 mM probenecid (Sigma) and 0.05% bovine serum albumin (Sigma)]. After washing, the plates were loaded with 30 μL of Fluo-4 NW in Fluo-4 NW Calcium Assay Kit buffer (Molecular Probes, Eugene, OR) and were incubated at 37 °C for 30 min in a humidified chamber (5% CO<sub>2</sub>/95% air) and for 30 min at RT. Mobilization of intracellular Ca<sup>+2</sup> in response to the various P2X7 antagonists was measured online using the FLIPR Tetra reader. In the assay, baseline fluorescence was measured for 15 s, and then 15 μL of compounds (40 μM) was added and fluorescence was monitored for 3 min for agonist activity. Subsequently, 15 μL of BzATP (hP2X7 1 × 8 μM, rP2X7 1 × 15 μM) was added, and after a 30 min incubation at room temperature, the fluorescence was read for 3 min for IC<sub>50</sub> determination. Data were analyzed using Lundbeck’s LSP curve-fit software, which is similar to Prism nonlinear regression curve-fit analysis.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> P2X7R Binding Assays</h3><div class="NLM_p last"><i>In vitro</i> binding was performed in membranes prepared from HEK293 cells stably transfected with mouse, rat, or human P2X7 using [<sup>3</sup>H]-A-804598 as the radio-ligand. Binding was performed in assay buffer (50 mM Tris-HCL, 0.1% BSA, pH 7.4) at 4 °C for 1 h in a total volume of 250 μL using either 10 μg of rat P2X7R, 40 μg of human P2X7R, or 60 μg of mouse P2X7R membranes per well. The membranes were prepared using 25 mM Tris-HCl, pH 7.4, 250 mM sucrose, 2.5 mM ethylenediaminetetraacetic acid (EDTA), 2 μg/mL aprotinin, 0.5 μg/mL leupeptin, and 200 nM phenylmethanesulfonyl fluoride (PMSF). Nonspecific binding was defined using 10 μM cold A-804598. <i>K</i><sub>d</sub> was determined by concentration-dependent saturation binding using 10 concentrations of [<sup>3</sup>H]-A-804598 (0.5–50 nM).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> THP-1 Cell IL-1β Assay</h3><div class="NLM_p last">THP-1 cells (passage number <15, ATCC, Manassas, VA) were maintained in growth media (RPMI1640, 10% FBS (Atlanta Biologicals), 100 units/mL penicillin and 100 μg/mL streptomycin (P/S), and 0.05 mM β-mercaptoethanol) (all except FBS from Gibco)) and differentiated with 10 ng/mL of interferon γ (IFN-γ) (R&D Systems, Minneapolis, MN) over 48 h at 37 °C and 5% CO<sub>2</sub>. The differentiated cells were removed from the T150 flasks and resuspended in CTL test media (Cellular Technology Limited, OH) containing 1% Glutamax. Cells were primed by adding lipopolysaccharide (LPS) (Sigma) to a final concentration of 100 ng/mL, and then plated into PDL-coated 96-well plates at a density of 10k cells/well. The plates were covered with Breathe-Easier microplate sealing tape and incubated at 37 °C and 5% CO<sub>2</sub> for 3.5 h. Test compounds diluted in CTL test media were added to the cells and incubated for 20 min at 37 °C and 5% CO<sub>2</sub>. BzATP was then added to the cells at a final concentration of 1 mM and incubated for an additional 30 min at 37 °C and 5% CO<sub>2</sub>. The supernatant from the wells was transferred into a 384-well polypropylene plate. The IL-1β levels in the supernatants were measured using human AlphaLISA IL-1β immunoassay (PerkinElmer) and an Envision microplate reader (PerkinElmer, Waltham, MA).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Rat Primary Microglia Cultures</h3><div class="NLM_p">Female Sprague–Dawley rats (Crl:SD, Charles River, Kingston, NY; E14 timed pregnant at delivery) were singly housed at 20–22 °C on a 12 h dark/light cycle with food and water ad libitum. Primary microglia cultures were prepared from postnatal day 3 (P3).</div><div class="NLM_p">Microglia were cultured as described.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Briefly, the animals were euthanized by CO<sub>2</sub> anesthesia followed by decapitation. The brains were removed, and cortices were dissected out and chopped in ice-cold HBSS (Gibco). The tissue was mechanically triturated by pipette to obtain a single-cell suspension. Cortical suspension from one rat or two mice were plated into a single T150 flask (BD Falcon, Corning, NY) in DMEM-GlutaMax (Gibco) containing 4.5 g/L of <span class="smallcaps smallerCapital">d</span>-glucose and supplemented with 10% low endotoxin (0.06 EU/mL) FBS (Atlanta Biologicals) and 1% P/S (Gibco).</div><div class="NLM_p last">Cultures were grown in a humidified incubator at 37 °C under 5% CO<sub>2</sub> for 10–14 days, during which time microglia were harvested by tapping the flasks and collecting microglia floating in the medium. Microglia were pelleted by centrifugation at 1100 rpm (276<i>g</i>) on a Beckman Coulter (Brea, CA) Allegra 6 series with a GH-3.8 swing bucket rotor for 5 min, resuspended in DMEM/10%FBS/P/S medium, and plated at an assay-specific density in poly-<span class="smallcaps smallerCapital">d</span>-lysine (PDL)-coated plates (BD Falcon). Purity was assessed by labeling with the microglial maker CD11b, which routinely identified >95% of cells as microglia.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Electrophysiology</h3><div id="sec4_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Compound Preparation</h4><div class="NLM_p last">A 10 mM stock solution of Lu AF27139 in dimethyl sulfoxide (DMSO) was prepared immediately before use and diluted with extracellular solution buffer to the desired concentrations. Glass vial inserts were filled with 350–400 μL of compound solution and placed into the glass insert base plate for use in the QPatch assay, or in a capillary tube for recording in rat primary microglia.</div></div><div id="sec4_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> QPatch DRC in HEK293 Cells Expressing the Rat P2X7R</h4><div class="NLM_p">HEK293 cells stably expressing rat P2X7 were grown in T75 tissue culture flasks to 70–80% confluence. On the day of the experiment, the cells were washed with D-PBS, lifted with 2 mL of Detachin, and centrifuged (250<i>g</i>, 2 min). The supernatant was removed, and the cells were washed and resuspended in extracellular solution to achieve a final cell density of ∼3 × 10<sup>6</sup> cells/mL.</div><div id="sec4_8_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> QPatch Electrophysiology</h5><div class="NLM_p last">Whole-cell patch-clamp experiments were carried out on a QPatch-16 automated electrophysiology platform (Sophion Biosciences, Paramus, NJ). Following establishment of the whole-cell configuration, the cells were held at −60 mV. The extracellular solution contained 140 mM NaCl, 4 mM KCl, 0.1 mM MgCl<sub>2</sub>, 0.3 mM CaCl<sub>2</sub>, 10 mM HEPES, and 10 mM glucose at pH 7.4. The intracellular solution contained 140 mM CsCl<sub>2</sub>, 11 mM EGTA, 2 mM MgCl<sub>2</sub>, and 10 mM HEPES at pH 7.2. P2X7 currents were elicited with 100 μM BzATP (Sigma). Currents were analyzed using the Sophion QPatch software and exported to Microsoft Excel and GraphPad Prism 6 software (GraphPad Software, Inc) for further analysis.</div></div></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Electrophysiology Recordings from Rat Primary Microglia</h3><div class="NLM_p last">Primary rat microglia were seeded at a density of 300 000/35 mm dish for 24 h. Whole-cell patch-clamp recordings were performed using an EPC9 patch-clamp amplifier and PatchMaster software (HEKA Instruments, Inc., Holliston, MA). The cell’s membrane potential was held at −60 mV. External solution contained 140 mM NaCl, 4 mM KCl, 1 mM MgCl<sub>2</sub>, 1.8 mM CaCl<sub>2</sub>, 10 mM HEPES, and 10 mM glucose at pH 7.4. The patch solution contained 140 mM CsCl<sub>2</sub>, 11 mM EGTA, 2 mM MgCl<sub>2</sub>, and 10 mM HEPES, pH 7.2. Compound <b>1</b> was applied by gravity via a capillary tube placed in close proximity to the recording dish. P2X7R currents were elicited by application of 300 μM BzATP for 10 s.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> IL-1β Measurements in Mouse and Rat Microglia</h3><div class="NLM_p last">The IL-1β assay was conducted 1 day after rat microglia (100 000 cells/well/48 well plate) or mouse microglia (50 000 cells/well/96-well plate) were plated on PDL-coated plates (BD Falcon). The cells were primed with 3 EU/mL LPS (Control Standard Endotoxin, Associates of Cape Cod) for 3.5 h. Vehicle or <b>1</b> was added and incubated for an additional 30 min. BzATP was then added to the cells at a final concentration of 1 mM and incubated for an additional 30 min at 37 °C and 5% CO<sub>2</sub>. All treatments were added to wells sequentially without any media being removed or changed. Post incubation, the supernatant was collected and analyzed for IL-1β as per the manufacturer’s protocol (mouse: N45ZA-1, rat: N45IA-1; MesoScale Discovery, Rockville, MD). IL-1β levels were normalized to total protein as determined using the BCA protein assay kit (Thermo Scientific, Rockford, IL). IC<sub>50</sub> values were generated using GraphPad Prism 6 software (GraphPad Software, Inc., San Diego, CA). The data were expressed as mean ± standard deviation (SD).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Mouse and Rat Microdialysis</h3><div class="NLM_p last">Male Sprague–Dawley rats (Crl:SD, Charles River) (280–350 g) were implanted with a guide cannulas (BrainLink, Groningen, The Netherlands) into the frontal cortex (FC), and an additional cannula for intracerebroventricular (icv) injections was implanted into the lateral cerebral ventricle. Male C57BL (C57BL/6NCrl, Charles River, Kingston, NY) mice (18–25 g) were implanted with guide cannulas (BrainLink, Groningen, The Netherlands) into the frontal cortex (FC) and an additional cannula for intracerebroventricular (icv) injections into the lateral cerebral ventricle (<i>N</i> = 6–7). Both implantations were completed in one surgery. Seven days after surgery, microdialysis probes (2 mm polyethylene membrane), 3000 kDa molecular weight cutoff (BrainLink, Groningen, The Netherlands), were inserted via the guide cannula into the FC. The animals were then placed in plastic observation cages and connected to a two-channel swivel. The input of the dialysis probe was connected to a syringe pump, which delivered artificial cerebrospinal fluid (CSF, perfusion fluid CNS, M Dialysis AB, Stockholm, Sweden) with 0.15% human serum albumin to the probe at a rate of 0.7 μL/min overnight. The output from the swivel was attached to a peristaltic pump (EICOM USA, San Diego, CA) and a refrigerated fraction collector using a “push–pull” microdialysis method. After overnight perfusion, samples were collected every 60 min. LPS (rat: 3 μg/5 μL; mouse: 0.1 μg/3 μL) was injected icv 1 h prior to oral administration of Lu AF27139 or vehicle (20% 2-hydroxypropyl-β-cyclodextrin). BzATP (rat: 50 μg/5 μL; mouse: 5 μg/3 μL) was given icv 1 h after administration of <b>1</b> or vehicle. During microdialysis sampling, the conscious, unrestrained animals were housed in the animal containment system with free access to food and water. Microdialysis samples were kept at −80 °C until IL-1β analyses. IL-1β in the microdialysate samples was analyzed using custom and standard V-PLEX assays from MesoScale Discovery (Rockville, MD). The lower limit of detection was 2 pg/mL for IL-1β. Graphical and statistical analysis was done using GraphPad Prism software (version 5.01). An area under the curve (AUC) value was calculated from the baseline for each animal from time 0 to 5 h. A one-way analysis of variance (ANOVA) with Dunnett’s multiple comparison test was used to determine significance between treatment groups.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Ethical Statement</h3><div class="NLM_p last">All animal procedures were conducted in accordance with the Guide for Care and Use of Laboratory Animals<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> and with the approval of the Institutional Animal Care and Use Committees at Lundbeck Research USA.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Experimental Animals</h3><div class="NLM_p last">Unless noted otherwise, all <i>in vivo</i> experiments were conducted with male Sprague–Dawley (Crl:SD, Charles River) rats weighing 150–200 g. The animals were subjected to an acclimation period of 7 days prior to using for experiments and were maintained under standard husbandry conditions (22 °C, 35–50% relative humidity, 12 h light/dark cycle), with unrestricted access to standard rat chow and drinking water.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Formulation and Dosing Compound <b>1</b></h3><div class="NLM_p last">Unless mentioned otherwise, for <i>in vivo</i> experiments, <b>1</b> was formulated as a solution or fine suspension in 20% hydroxypropyl-β-cyclodextrin and administered via oral gavage at a volume of 5 or 10 mL/kg.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34"><a href="/doi/suppl/10.1021/acs.jmedchem.0c02249" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62874" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62874" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c02249?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02249</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Scheme S1; synthesis of intermediate <b>20</b> and associated detailed synthetic methods; liver microsomal stability assay; hepatocyte stability assay; MDCK-MDR1 permeability assay; compound <b>1</b> exposure and fraction unbound in plasma, brain, and spinal cord; LC–MS/MS method for analysis of compound <b>1</b> from exposure studies; Rat PK methods; <i>in vivo</i> exploratory toxicology study methods; and Tables S1a and S1b with rat and mouse toxicokinetic exposure data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02249/suppl_file/jm0c02249_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Structure smiles (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02249/suppl_file/jm0c02249_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02249/suppl_file/jm0c02249_si_001.pdf">jm0c02249_si_001.pdf (168.31 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02249/suppl_file/jm0c02249_si_002.csv">jm0c02249_si_002.csv (1.21 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c02249" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51747" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51747" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allen T. Hopper</span> - <span class="hlFld-Affiliation affiliation">Neuroinflammation
Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8797-7882" title="Orcid link">http://orcid.org/0000-0001-8797-7882</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c3a2b7abacb3b3a6b183a2acafeda0acae"><span class="__cf_email__" data-cfemail="8beaffe3e4fbfbeef9cbeae4e7a5e8e4e6">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Juhl</span> - <span class="hlFld-Affiliation affiliation">Process
Research Lundbeck A/S, Ottiliavej 9, 2500 Valby, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jorrit Hornberg</span> - <span class="hlFld-Affiliation affiliation">Toxicology
Research Lundbeck A/S, Ottiliavej 9, 2500 Valby, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lassina Badolo</span> - <span class="hlFld-Affiliation affiliation">Chemistry
and DMPK Lundbeck A/S, Ottiliavej 9, 2500 Valby, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Paul Kilburn</span> - <span class="hlFld-Affiliation affiliation">Chemistry
and DMPK Lundbeck A/S, Ottiliavej 9, 2500 Valby, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Annemette Thougaard</span> - <span class="hlFld-Affiliation affiliation">Toxicology
Research Lundbeck A/S, Ottiliavej 9, 2500 Valby, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gennady Smagin</span> - <span class="hlFld-Affiliation affiliation">Neuroinflammation
Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dekun Song</span> - <span class="hlFld-Affiliation affiliation">Neuroinflammation
Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Londye Calice</span> - <span class="hlFld-Affiliation affiliation">Neuroinflammation
Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Veena Menon</span> - <span class="hlFld-Affiliation affiliation">Neuroinflammation
Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elena Dale</span> - <span class="hlFld-Affiliation affiliation">Neuroinflammation
Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Zhang</span> - <span class="hlFld-Affiliation affiliation">Neuroinflammation
Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manuel Cajina</span> - <span class="hlFld-Affiliation affiliation">Neuroinflammation
Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Megan E. Nattini</span> - <span class="hlFld-Affiliation affiliation">Neuroinflammation
Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adarsh Gandhi</span> - <span class="hlFld-Affiliation affiliation">Neuroinflammation
Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michel Grenon</span> - <span class="hlFld-Affiliation affiliation">Neuroinflammation
Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ken Jones</span> - <span class="hlFld-Affiliation affiliation">Neuroinflammation
Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tanzilya Khayrullina</span> - <span class="hlFld-Affiliation affiliation">Neuroinflammation
Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gamini Chandrasena</span> - <span class="hlFld-Affiliation affiliation">Neuroinflammation
Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian Thomsen</span> - <span class="hlFld-Affiliation affiliation">Neuroinflammation
Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stevin H. Zorn</span> - <span class="hlFld-Affiliation affiliation">Neuroinflammation
Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robb Brodbeck</span> - <span class="hlFld-Affiliation affiliation">Neuroinflammation
Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suresh Babu Poda</span> - <span class="hlFld-Affiliation affiliation">Neuroinflammation
Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roland Staal</span> - <span class="hlFld-Affiliation affiliation">Neuroinflammation
Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Möller</span> - <span class="hlFld-Affiliation affiliation">Neuroinflammation
Disease Biology Unit Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>A.T.H., M.J., M.G., and P.K. supported Lu AF27139 identification, synthesis, and project leadership. G.S. and D.S. supported microdialysis studies. J.H., A.T., M.C., and G.C. supported safety evaluation and toxicokinetics. L.B., M.C., A.G., M.E.N., and G.C. supported ADME/PK. R.S., L.D., V.M., E.D., H.Z., C.T., S.H.Z., K.J., T.K., R.M.B., S.B.P., and T.M. supported in vitro molecular pharmacological characterization. These authors contributed equally.</p></li><li><span class="author-information-subsection-header">Funding</span><p>This research was completely funded by Lundbeck Research USA or H. Lundbeck A/S.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e3037-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85210" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85210" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors kindly acknowledge and thank the Lundbeck organization for their complete support, including financial support, for this project. They also acknowledge Dario Dollar and Benny Bang-Anderson for their input, challenge, and feedback in support of this work.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">BzATP</td><td class="NLM_def"><p class="first last">2′(3′)-<i>O</i>-(benzoylbenzoyl)adenosine-5′-triphosphate</p></td></tr><tr><td class="NLM_term">Clint</td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>u</sub></td><td class="NLM_def"><p class="first last">concentration unbound</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s modified Eagle’s medium</p></td></tr><tr><td class="NLM_term">D-PBS</td><td class="NLM_def"><p class="first last">Dulbecco’s phosphate-buffered saline</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">FC</td><td class="NLM_def"><p class="first last">frontal cortex</p></td></tr><tr><td class="NLM_term">FLIPR</td><td class="NLM_def"><p class="first last">fluorescent imaging plate reader</p></td></tr><tr><td class="NLM_term"><i>f</i><sub>u</sub></td><td class="NLM_def"><p class="first last">fraction unbound</p></td></tr><tr><td class="NLM_term">HBSS</td><td class="NLM_def"><p class="first last">Hank’s balanced salt solution buffer</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid buffer</p></td></tr><tr><td class="NLM_term">ICV</td><td class="NLM_def"><p class="first last">intracerebroventricular</p></td></tr><tr><td class="NLM_term">LBF</td><td class="NLM_def"><p class="first last">liver blood flow</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">MDD</td><td class="NLM_def"><p class="first last">major depressive disorder</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">multiple sclerosis</p></td></tr><tr><td class="NLM_term">NPP</td><td class="NLM_def"><p class="first last">neuropathic pain</p></td></tr><tr><td class="NLM_term">PMSF</td><td class="NLM_def"><p class="first last">phenylmethanesulfonyl fluoride</p></td></tr><tr><td class="NLM_term">P2X7R</td><td class="NLM_def"><p class="first last">P2X purinoceptor 7</p></td></tr><tr><td class="NLM_term">P/S</td><td class="NLM_def"><p class="first last">penicillin–streptomycin</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28570" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28570" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 45 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bartlett, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sluyter, R.</span></span> <span> </span><span class="NLM_article-title">The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">638</span>– <span class="NLM_lpage">675</span>, <span class="refDoi"> DOI: 10.1124/pr.113.008003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1124%2Fpr.113.008003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=24928329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12qtL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2014&pages=638-675&author=R.+Bartlettauthor=L.+Stokesauthor=R.+Sluyter&title=The+P2X7+receptor+channel%3A+recent+developments+and+the+use+of+P2X7+antagonists+in+models+of+disease&doi=10.1124%2Fpr.113.008003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease</span></div><div class="casAuthors">Bartlett, Rachael; Stokes, Leanne; Sluyter, Ronald</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">638-675</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The P2X7 receptor is a trimeric ATP-gated cation channel found predominantly, but not exclusively, on immune cells.  P2X7 activation results in a no. of downstream events, including the release of proinflammatory mediators and cell death and proliferation.  As such, P2X7 plays important roles in various inflammatory, immune, neurol. and musculoskeletal disorders.  This review focuses on the use of P2X7 antagonists in rodent models of neurol. disease and injury, inflammation, andmusculoskeletal and other disorders.  The cloning and characterization of human, rat, mouse, guinea pig, dog, and Rhesus macaque P2X7, as well as recent observations regarding the gating and permeability of P2X7, are discussed.  Furthermore, this review discusses polymorphic and splice variants of P2X7, as well as the generation and use of P2X7 knockout mice.  Recent evidence for emerging signaling pathways downstream of P2X7 activation and the growing list of neg. and pos. modulators of P2X7 activation and expression are also described.  In addn., the use of P2X7 antagonists in numerous rodent models of disease is extensively summarized.  Finally, theuseof P2X7 antagonists in clin. trials in humans and future directions exploring P2X7 as a therapeutic target are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsce8HhOp0XrVg90H21EOLACvtfcHk0lhIvIzQLT2o5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12qtL7L&md5=4452cb0593e70f15736686b9c2702ef7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1124%2Fpr.113.008003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.113.008003%26sid%3Dliteratum%253Aachs%26aulast%3DBartlett%26aufirst%3DR.%26aulast%3DStokes%26aufirst%3DL.%26aulast%3DSluyter%26aufirst%3DR.%26atitle%3DThe%2520P2X7%2520receptor%2520channel%253A%2520recent%2520developments%2520and%2520the%2520use%2520of%2520P2X7%2520antagonists%2520in%2520models%2520of%2520disease%26jtitle%3DPharmacol.%2520Rev.%26date%3D2014%26volume%3D66%26spage%3D638%26epage%3D675%26doi%3D10.1124%2Fpr.113.008003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sperlágh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vizi, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirkner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illes, P.</span></span> <span> </span><span class="NLM_article-title">P2X7 receptors in the nervous system</span>. <i>Prog. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">346</span>, <span class="refDoi"> DOI: 10.1016/j.pneurobio.2006.03.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.pneurobio.2006.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=16697102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFOhsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2006&pages=327-346&author=B.+Sperl%C3%A1ghauthor=E.+S.+Viziauthor=K.+Wirknerauthor=P.+Illes&title=P2X7+receptors+in+the+nervous+system&doi=10.1016%2Fj.pneurobio.2006.03.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">P2X7 receptors in the nervous system</span></div><div class="casAuthors">Sperlagh, Beata; Vizi, E. Sylvester; Wirkner, Kerstin; Illes, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">327-346</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  P2X7 receptors are ligand-gated ion channels, expressed as homo-oligomeric assemblies of individual subunits.  They are widely distributed at immunocompetent cells of the central and peripheral nervous system and are believed to be primarily involved in host-defense reaction.  However, a growing amt. of evidence indicates that their signaling role in the brain is more widespread than previously anticipated.  In this paper, we review the present knowledge on the structural and pharmacol. features of the P2X7 receptor, as well as its cell-type specific localization in the nervous system.  Subsequently, the participation of P2X7 receptors in distinct neuronal, astroglial and microglial functions are described.  Finally, since they may play a prominent role in certain neurol. disorders, such as ischemia-reperfusion injury, Alzheimer's disease, spinal cord injury and sensory neuropathies, the pathol. role and potential therapeutic exploitation of P2X7 receptors are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4uY7TwvgO9LVg90H21EOLACvtfcHk0lhIvIzQLT2o5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFOhsrc%253D&md5=c6ccc6eaffb8985e257c4a52c9443f59</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2006.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2006.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DSperl%25C3%25A1gh%26aufirst%3DB.%26aulast%3DVizi%26aufirst%3DE.%2BS.%26aulast%3DWirkner%26aufirst%3DK.%26aulast%3DIlles%26aufirst%3DP.%26atitle%3DP2X7%2520receptors%2520in%2520the%2520nervous%2520system%26jtitle%3DProg.%2520Neurobiol.%26date%3D2006%26volume%3D78%26spage%3D327%26epage%3D346%26doi%3D10.1016%2Fj.pneurobio.2006.03.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labasi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perregaux, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stam, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrushova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koller, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabel, C. A.</span></span> <span> </span><span class="NLM_article-title">Altered cytokine production in mice lacking P2X7 receptors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1074/jbc.M006781200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1074%2Fjbc.M006781200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=11016935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtFSjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=125-132&author=M.+Solleauthor=J.+Labasiauthor=D.+G.+Perregauxauthor=E.+Stamauthor=N.+Petrushovaauthor=B.+H.+Kollerauthor=R.+J.+Griffithsauthor=C.+A.+Gabel&title=Altered+cytokine+production+in+mice+lacking+P2X7+receptors&doi=10.1074%2Fjbc.M006781200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Altered cytokine production in mice lacking P2X7 receptors</span></div><div class="casAuthors">Solle, Mike; Labasi, Jeff; Perregaux, David G.; Stam, Ethan; Petrushova, Nina; Koller, Beverly H.; Griffiths, Richard J.; Gabel, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The P2X7 receptor (P2X7R) is an ATP-gated ion channel expressed by monocytes and macrophages.  To directly address the role of this receptor in interleukin (IL)-1β post-translational processing, the authors have generated a P2X7R-deficient mouse line.  P2X7R-/- macrophages respond to lipopolysaccharide and produce levels of cyclooxygenase-2 and pro-IL-1β comparable with those generated by wild-type cells.  In response to ATP, however, pro-IL-1β produced by the P2X7R-/- cells is not externalized or activated by caspase-1.  Nigericin, an alternate secretion stimulus, promotes release of 17-kDa IL-1β from P2X7R-/- macrophages.  In response to in vivo lipopolysaccharide injection, both wild-type and P2X7R-/- animals display increases in peritoneal lavage IL-6 levels but no detectable IL-1.  Subsequent ATP injection to wild-type animals promotes an increase in IL-1, which in turn leads to addnl. IL-6 prodn.; similar increases did not occur in ATP-treated, LPS-primed P2X7R-/- animals.  Absence of the P2X7R thus leads to an inability of peritoneal macrophages to release IL-1 in response to ATP.  As a result of the IL-1 deficiency, in vivo cytokine signaling cascades are impaired in P2X7R-deficient animals.  Together these results demonstrate that P2X7R activation can provide a signal that leads to maturation and release of IL-1β and initiation of a cytokine cascade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplWJDl5YjMEbVg90H21EOLACvtfcHk0lhIvIzQLT2o5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtFSjug%253D%253D&md5=cbbd35688998cce33e72e3b835d0f9c3</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M006781200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M006781200%26sid%3Dliteratum%253Aachs%26aulast%3DSolle%26aufirst%3DM.%26aulast%3DLabasi%26aufirst%3DJ.%26aulast%3DPerregaux%26aufirst%3DD.%2BG.%26aulast%3DStam%26aufirst%3DE.%26aulast%3DPetrushova%26aufirst%3DN.%26aulast%3DKoller%26aufirst%3DB.%2BH.%26aulast%3DGriffiths%26aufirst%3DR.%2BJ.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26atitle%3DAltered%2520cytokine%2520production%2520in%2520mice%2520lacking%2520P2X7%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D125%26epage%3D132%26doi%3D10.1074%2Fjbc.M006781200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burnstock, G.</span></span> <span> </span><span class="NLM_article-title">P2X ion channel receptors and inflammation</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1007/s11302-015-9493-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1007%2Fs11302-015-9493-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=26739702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC28XjslGmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=59-67&author=G.+Burnstock&title=P2X+ion+channel+receptors+and+inflammation&doi=10.1007%2Fs11302-015-9493-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">P2X ion channel receptors and inflammation</span></div><div class="casAuthors">Burnstock, Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-67</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Neuroinflammation limits tissue damage in response to pathogens or injury and promotes repair.  There are two stages of inflammation, initiation and resoln.  P2X receptors are gaining attention in relation to immunol. and inflammation.  The P2X7 receptor in particular appears to be an essential immunomodulatory receptor, although P2X1 and P2X4 receptors also appear to be involved.  ATP released from damaged or infected cells causes inflammation by release of inflammatory cytokines via P2X7 receptors and acts as a danger signal by occupying upregulated P2X receptors on immune cells to increase immune responses.  The purinergic involvement in inflammation is being explored for the development of novel therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSRKcDsxubzrVg90H21EOLACvtfcHk0lh89ds5z9aSeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjslGmug%253D%253D&md5=c8ce49c3caa010bb73e33ec75b931abd</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs11302-015-9493-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-015-9493-0%26sid%3Dliteratum%253Aachs%26aulast%3DBurnstock%26aufirst%3DG.%26atitle%3DP2X%2520ion%2520channel%2520receptors%2520and%2520inflammation%26jtitle%3DPurinergic%2520Signalling%26date%3D2016%26volume%3D12%26spage%3D59%26epage%3D67%26doi%3D10.1007%2Fs11302-015-9493-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sperlágh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illes, P.</span></span> <span> </span><span class="NLM_article-title">P2X7 receptor: an emerging target in central nervous system diseases</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">547</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2014.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.tips.2014.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=25223574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVOhsLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=537-547&author=B.+Sperl%C3%A1ghauthor=P.+Illes&title=P2X7+receptor%3A+an+emerging+target+in+central+nervous+system+diseases&doi=10.1016%2Fj.tips.2014.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">P2X7 receptor: an emerging target in central nervous system diseases</span></div><div class="casAuthors">Sperlagh, Beata; Illes, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">537-547</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The ATP-sensitive homomeric P2X7 receptor (P2X7R) has received particular attention as a potential drug target because of its widespread involvement in inflammatory diseases as a key regulatory element of the inflammasome complex.  However, it has only recently become evident that P2X7Rs also play a pivotal role in central nervous system (CNS) pathol.  There is an explosion of data indicating that genetic deletion and pharmacol. blockade of P2X7Rs alter responsiveness in animal models of neurol. disorders, such as stroke, neurotrauma, epilepsy, neuropathic pain, multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, and Huntington's disease.  Moreover, recent studies suggest that P2X7Rs regulate the pathophysiol. of psychiatric disorders, including mood disorders, implicating P2X7Rs as drug targets in a variety of CNS pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLksNvXWN1iLVg90H21EOLACvtfcHk0lh89ds5z9aSeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVOhsLnP&md5=b8f94c09430e82877eb6194f863924c4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2014.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2014.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DSperl%25C3%25A1gh%26aufirst%3DB.%26aulast%3DIlles%26aufirst%3DP.%26atitle%3DP2X7%2520receptor%253A%2520an%2520emerging%2520target%2520in%2520central%2520nervous%2520system%2520diseases%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2014%26volume%3D35%26spage%3D537%26epage%3D547%26doi%3D10.1016%2Fj.tips.2014.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrejew, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira-Giacomelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaser, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnaud-Sampaio, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lameu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, H.</span></span> <span> </span><span class="NLM_article-title">The P2X7 receptor: central hub of brain diseases</span>. <i>Front. Mol. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>13</i></span>, <span class="NLM_elocation-id">124</span> <span class="refDoi"> DOI: 10.3389/fnmol.2020.00124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.3389%2Ffnmol.2020.00124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=32848594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFyisL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2020&author=R.+Andrejewauthor=A.+Oliveira-Giacomelliauthor=D.+E.+Ribeiroauthor=T.+Glaserauthor=V.+F.+Arnaud-Sampaioauthor=C.+Lameuauthor=H.+Ulrich&title=The+P2X7+receptor%3A+central+hub+of+brain+diseases&doi=10.3389%2Ffnmol.2020.00124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The P2X7 receptor: central hub of brain diseases</span></div><div class="casAuthors">Andrejew, Roberta; Oliveira-Giacomelli, Agatha; Ribeiro, Deidiane Elisa; Glaser, Talita; Arnaud-Sampaio, Vanessa Fernandes; Lameu, Claudiana; Ulrich, Henning</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">124</span>CODEN:
                <span class="NLM_cas:coden">FMNRAJ</span>;
        ISSN:<span class="NLM_cas:issn">1662-5099</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The P2X7 receptor is a cation channel activated by high concns. of ATP (ATP).  Upon long-term activation, it complexes with membrane proteins forming a wide pore that leads to cell death and increased release of ATP into the extracellular milieu.  The P2X7 receptor is widely expressed in the CNS, such as frontal cortex, hippocampus, amygdala and striatum, regions involved in neurodegenerative diseases and psychiatric disorders.  Despite P2X7 receptor functions in glial cells have been extensively studied, the existence and roles of this receptor in neurons are still controversially discussed.  Regardless, P2X7 receptors mediate several processes obsd. in neuropsychiatric disorders and brain tumors, such as activation of neuroinflammatory response, stimulation of glutamate release and neuroplasticity impairment.  Moreover, P2X7 receptor gene polymorphisms have been assocd. to depression, and isoforms of P2X7 receptors are implicated in neuropsychiatric diseases.  In view of that, the P2X7 receptor has been proposed to be a potential target for therapeutic intervention in brain diseases.  This review discusses the mol. mechanisms underlying P2X7 receptor-mediated signaling in neurodegenerative diseases, psychiatric disorders, and brain tumors.  In addn., it highlights the recent advances in the development of P2X7 receptor antagonists that are able of penetrating the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk3bSo6D37f7Vg90H21EOLACvtfcHk0lh89ds5z9aSeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFyisL7E&md5=565648d0ecb4e7adefb366ad24affd77</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2020.00124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2020.00124%26sid%3Dliteratum%253Aachs%26aulast%3DAndrejew%26aufirst%3DR.%26aulast%3DOliveira-Giacomelli%26aufirst%3DA.%26aulast%3DRibeiro%26aufirst%3DD.%2BE.%26aulast%3DGlaser%26aufirst%3DT.%26aulast%3DArnaud-Sampaio%26aufirst%3DV.%2BF.%26aulast%3DLameu%26aufirst%3DC.%26aulast%3DUlrich%26aufirst%3DH.%26atitle%3DThe%2520P2X7%2520receptor%253A%2520central%2520hub%2520of%2520brain%2520diseases%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2020%26volume%3D13%26doi%3D10.3389%2Ffnmol.2020.00124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span> <span> </span><span class="NLM_article-title">Recent advances in CNS P2x7 physiology and pharmacology: focus on neuropsychiatric disorders</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">30</span> <span class="refDoi"> DOI: 10.3389/fphar.2018.00030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.3389%2Ffphar.2018.00030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=29449810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Skt7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&author=A.+Bhattacharya&title=Recent+advances+in+CNS+P2x7+physiology+and+pharmacology%3A+focus+on+neuropsychiatric+disorders&doi=10.3389%2Ffphar.2018.00030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in CNS P2x7 physiology and pharmacology: focus on neuropsychiatric disorders</span></div><div class="casAuthors">Bhattacharya, Anindya</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">30/1-30/7</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  The ATP-gated P2X7 ion channel is an abundant microglial protein in the CNS that plays an important pathol. role in executing ATP-driven danger signal transduction.  Emerging data has generated scientific interest and excitement around targeting the P2X7 ion channel as a potential drug target for CNS disorders.  Over the past years, a wealth of data has been published on CNS P2X7 biol., in particular the role of P2X7 in microglial cells, and in vivo effects of brain-penetrant P2X7 antagonists.  Likewise, significant progress has been made around the medicinal chem. of CNS P2X7 ligands, as antagonists for I target validation in models of CNS diseases, to identification of two clin. compds. (JNJ-54175446 and JNJ-55308942) and finally, discovery of P2X7 PET ligands.  This review is an attempt to bring together the current understanding of P2X7 in the CNS with a focus on P2X7 as a drug target in neuropsychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDXBpgvW1cqbVg90H21EOLACvtfcHk0lh89ds5z9aSeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Skt7vF&md5=303be8cadeaf840559a0192f673cff0b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2018.00030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2018.00030%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DA.%26atitle%3DRecent%2520advances%2520in%2520CNS%2520P2x7%2520physiology%2520and%2520pharmacology%253A%2520focus%2520on%2520neuropsychiatric%2520disorders%26jtitle%3DFront.%2520Pharmacol.%26date%3D2018%26volume%3D9%26doi%3D10.3389%2Ffphar.2018.00030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calzaferri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Ruiz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Diego, A. M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de
Pascual, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendez-Lopez, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cano-Abad, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maneu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de los Rios, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, A. G.</span></span> <span> </span><span class="NLM_article-title">The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">2427</span>– <span class="NLM_lpage">2465</span>, <span class="refDoi"> DOI: 10.1002/med.21710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1002%2Fmed.21710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=32677086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVKlurbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2020&pages=2427-2465&author=F.+Calzaferriauthor=C.+Ruiz-Ruizauthor=A.+M.+G.+de+Diegoauthor=R.+de%0APascualauthor=I.+Mendez-Lopezauthor=M.+F.+Cano-Abadauthor=V.+Maneuauthor=C.+de+los+Riosauthor=L.+Gandiaauthor=A.+G.+Garcia&title=The+purinergic+P2X7+receptor+as+a+potential+drug+target+to+combat+neuroinflammation+in+neurodegenerative+diseases&doi=10.1002%2Fmed.21710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases</span></div><div class="casAuthors">Calzaferri, Francesco; Ruiz-Ruiz, Cristina; de Diego, Antonio M. G.; de Pascual, Ricardo; Mendez-Lopez, Iago; Cano-Abad, Maria F.; Maneu, Victoria; de los Rios, Cristobal; Gandia, Luis; Garcia, Antonio G.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2427-2465</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review of the purinergic P2X7 receptors (P2X7Rs)are gatekeepers of inflammation, they could be developed as drug targets for NDDs.  Herein, we review this challenging hypothesis and comment on the numerous studies that have investigated P2X7Rs, emphasizing their mol. structure and functions, as well as their role in inflammation.  Then, we elaborate on research undertaken in the field of medicinal chem. to det. potential P2X7R antagonists.  Subsequently, we review the state of neuroinflammation and P2X7R expression in the brain, in animal models and patients suffering from AD, Parkinson's disease, amyotrophic lateral sclerosis, Huntington disease, multiple sclerosis, and retinal degeneration.  Next, we summarize the in vivo studies testing the hypothesis that by mitigating neuroinflammation, P2X7R blockers afford neuroprotection, increasing neuroplasticity and neuronal repair in animal models of NDDs.  Finally, we reviewed previous and ongoing CTs investigating compds. directed toward targets assocd. with NDDs; we propose that CTs with P2X7R antagonists should be initiated.  Despite the high expectations for putative P2X7Rs antagonists in various central nervous system diseases, the field is moving forward at a relatively slow pace, presumably due to the complexity of P2X7Rs.  A better pharmacol. approach to combat NDDs would be a dual strategy, combining P2X7R antagonism with drugs targeting a selective pathway in a given NDD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6K9cEDPmFNLVg90H21EOLACvtfcHk0lhL5h6iQiztWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVKlurbM&md5=61c929af816b30378efcdb9a89e8b56a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fmed.21710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21710%26sid%3Dliteratum%253Aachs%26aulast%3DCalzaferri%26aufirst%3DF.%26aulast%3DRuiz-Ruiz%26aufirst%3DC.%26aulast%3Dde%2BDiego%26aufirst%3DA.%2BM.%2BG.%26aulast%3Dde%2BPascual%26aufirst%3DR.%26aulast%3DMendez-Lopez%26aufirst%3DI.%26aulast%3DCano-Abad%26aufirst%3DM.%2BF.%26aulast%3DManeu%26aufirst%3DV.%26aulast%3Dde%2Blos%2BRios%26aufirst%3DC.%26aulast%3DGandia%26aufirst%3DL.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26atitle%3DThe%2520purinergic%2520P2X7%2520receptor%2520as%2520a%2520potential%2520drug%2520target%2520to%2520combat%2520neuroinflammation%2520in%2520neurodegenerative%2520diseases%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2020%26volume%3D40%26spage%3D2427%26epage%3D2465%26doi%3D10.1002%2Fmed.21710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chessell, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatcher, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bountra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michel, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egerton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murfin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peck, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grahames, C. B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casula, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yiangou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anand, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buell, G. N.</span></span> <span> </span><span class="NLM_article-title">Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">386</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2005.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.pain.2005.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=15777864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitlCiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2005&pages=386-396&author=I.+P.+Chessellauthor=J.+P.+Hatcherauthor=C.+Bountraauthor=A.+D.+Michelauthor=J.+P.+Hughesauthor=P.+Greenauthor=J.+Egertonauthor=M.+Murfinauthor=J.+Richardsonauthor=W.+L.+Peckauthor=C.+B.+A.+Grahamesauthor=M.+A.+Casulaauthor=Y.+Yiangouauthor=R.+Birchauthor=P.+Anandauthor=G.+N.+Buell&title=Disruption+of+the+P2X7+purinoceptor+gene+abolishes+chronic+inflammatory+and+neuropathic+pain&doi=10.1016%2Fj.pain.2005.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain</span></div><div class="casAuthors">Chessell, Iain P.; Hatcher, Jonathan P.; Bountra, Chas; Michel, Anton D.; Hughes, Jane P.; Green, Paula; Egerton, Julie; Murfin, Melanie; Richardson, Jill; Peck, Wendy L.; Grahames, Caroline B. A.; Casula, Maria Anna; Yiangou, Yiangos; Birch, Rolfe; Anand, Praveen; Buell, Gary N.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">386-396</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The P2X7 purinoceptor is a ligand-gated cation channel, expressed predominantly by cells of immune origin, with a unique phenotype which includes release of biol. active inflammatory cytokine, interleukin (IL)-1β following activation, and unique ion channel biophysics obsd. only in this receptor family.  In mice lacking this receptor, inflammatory (in an adjuvant-induced model) and neuropathic (in a partial nerve ligation model) hypersensitivity is completely absent to both mech. and thermal stimuli, while normal nociceptive processing is preserved.  The knockout animals were unimpaired in their ability to produce mRNA for pro-IL-1β, and cytometric anal. of paw and systemic cytokines from knockout and wild-type animals following adjuvant insult suggests a selective effect of the gene deletion on release of IL-1β and IL-10, with systemic redns. in adjuvant-induced increases in IL-6 and MCP-1.  In addn., the authors show that this receptor is upregulated in human dorsal root ganglia and injured nerves obtained from chronic neuropathic pain patients.  The authors hypothesize that the P2X7 receptor, via regulation of mature IL-1β prodn., plays a common upstream transductional role in the development of pain of neuropathic and inflammatory origin.  Drugs which block this target may have the potential to deliver broad-spectrum analgesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-BHrUu6ak17Vg90H21EOLACvtfcHk0lhL5h6iQiztWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitlCiu78%253D&md5=883f5bdb9b8950fa97d5a69a7325b026</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2005.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2005.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DChessell%26aufirst%3DI.%2BP.%26aulast%3DHatcher%26aufirst%3DJ.%2BP.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DMichel%26aufirst%3DA.%2BD.%26aulast%3DHughes%26aufirst%3DJ.%2BP.%26aulast%3DGreen%26aufirst%3DP.%26aulast%3DEgerton%26aufirst%3DJ.%26aulast%3DMurfin%26aufirst%3DM.%26aulast%3DRichardson%26aufirst%3DJ.%26aulast%3DPeck%26aufirst%3DW.%2BL.%26aulast%3DGrahames%26aufirst%3DC.%2BB.%2BA.%26aulast%3DCasula%26aufirst%3DM.%2BA.%26aulast%3DYiangou%26aufirst%3DY.%26aulast%3DBirch%26aufirst%3DR.%26aulast%3DAnand%26aufirst%3DP.%26aulast%3DBuell%26aufirst%3DG.%2BN.%26atitle%3DDisruption%2520of%2520the%2520P2X7%2520purinoceptor%2520gene%2520abolishes%2520chronic%2520inflammatory%2520and%2520neuropathic%2520pain%26jtitle%3DPain%26date%3D2005%26volume%3D114%26spage%3D386%26epage%3D396%26doi%3D10.1016%2Fj.pain.2005.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derecki, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovenberg, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drevets, W. C.</span></span> <span> </span><span class="NLM_article-title">Role of neuro-immunological factors in the pathophysiology of mood disorders</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>233</i></span>,  <span class="NLM_fpage">1623</span>– <span class="NLM_lpage">1636</span>, <span class="refDoi"> DOI: 10.1007/s00213-016-4214-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1007%2Fs00213-016-4214-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=26803500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=2016&pages=1623-1636&author=A.+Bhattacharyaauthor=N.+C.+Dereckiauthor=T.+W.+Lovenbergauthor=W.+C.+Drevets&title=Role+of+neuro-immunological+factors+in+the+pathophysiology+of+mood+disorders&doi=10.1007%2Fs00213-016-4214-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Role of neuro-immunological factors in the pathophysiology of mood disorders</span></div><div class="casAuthors">Bhattacharya, Anindya; Derecki, Noel C.; Lovenberg, Timothy W.; Drevets, Wayne C.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">233</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1623-1636</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Mood disorders, despite the widespread availability of monoamine-based antidepressant treatments, are assocd. with persistently high rates of disability, together with elevated rates of mortality due to suicide, cardiovascular disease, and other causes.  The development of more effective treatments has been hindered by the lack of knowledge about the etiol. and pathogenesis of mood disorders.  An emerging area of science that promises novel pathways to antidepressant and mood stabilizing therapies surrounds evidence that immune cells and their signaling play a major role in the pathophysiol. of major depressive disorder (MDD) and bipolar disorder (BD).  Here, we review evidence that the release of neuroactive cytokines, particularly interleukins such as IL-1β, IL-6, and TNF-α, is altered in these disorders and discuss mechanisms such as the ATP-gated ion channel P2X7, through which cytokine signaling can influence neuro-glial interactions.  Brain P2X7, an emerging target and antagonism of P2X7 holds promise as a novel mechanism for targeting treatment-resistant depression.  We further discuss the role of microglia and astroglia in central neuroinflammation and their interaction with the peripheral immune system.  We present extant clin. evidence that bolsters the role of neuroinflammation and neuroactive cytokines in mood disorders.  To that end, the role of clin. imaging by probing neuroinflammatory markers is also discussed briefly.  Finally, we present data using preclin. neuroinflammation models that produce depression-like behaviors in exptl. animals to identify neuroinflammatory mechanisms which may aid in novel neuroimmune target identification for the development of exciting pharmacol. interventions in mood disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3LHj0rffjabVg90H21EOLACvtfcHk0lhL5h6iQiztWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKgs7c%253D&md5=94cfc55223e0c7c21dad372c00e502cb</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs00213-016-4214-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-016-4214-0%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DDerecki%26aufirst%3DN.%2BC.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DDrevets%26aufirst%3DW.%2BC.%26atitle%3DRole%2520of%2520neuro-immunological%2520factors%2520in%2520the%2520pathophysiology%2520of%2520mood%2520disorders%26jtitle%3DPsychopharmacology%26date%3D2016%26volume%3D233%26spage%3D1623%26epage%3D1636%26doi%3D10.1007%2Fs00213-016-4214-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grigoleit, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aluisio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O′Connor, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrovian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carruthers, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovenberg, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span> <span> </span><span class="NLM_article-title">Neuropsychopharmacology of JNJ-55308942: evaluation of a clinical candidate targeting P2X7 ion channels in animal models of neuroinflammation and anhedonia</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2586</span>– <span class="NLM_lpage">2596</span>, <span class="refDoi"> DOI: 10.1038/s41386-018-0141-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1038%2Fs41386-018-0141-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=30026598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlyrsLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2018&pages=2586-2596&author=A.+Bhattacharyaauthor=B.+Lordauthor=J.-S.+Grigoleitauthor=Y.+Heauthor=I.+Fraserauthor=S.+N.+Campbellauthor=N.+Taylorauthor=L.+Aluisioauthor=J.+C.+O%E2%80%B2Connorauthor=M.+Pappauthor=C.+Chrovianauthor=N.+Carruthersauthor=T.+W.+Lovenbergauthor=M.+A.+Letavic&title=Neuropsychopharmacology+of+JNJ-55308942%3A+evaluation+of+a+clinical+candidate+targeting+P2X7+ion+channels+in+animal+models+of+neuroinflammation+and+anhedonia&doi=10.1038%2Fs41386-018-0141-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropsychopharmacology of JNJ-55308942: evaluation of a clinical candidate targeting P2X7 ion channels in animal models of neuroinflammation and anhedonia</span></div><div class="casAuthors">Bhattacharya, Anindya; Lord, Brian; Grigoleit, Jan-Sebastian; He, Yingbo; Fraser, Ian; Campbell, Shannon N.; Taylor, Natalie; Aluisio, Leah; O'Connor, Jason C.; Papp, Mariusz; Chrovian, Christa; Carruthers, Nicholas; Lovenberg, Timothy W.; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2586-2596</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">This study describes the in-vitro and in-vivo neuropharmacol. of a novel brain-penetrant P2X7 antagonist, JNJ-55308942, currently in clin. development.  In human blood and in mouse blood and microglia, JNJ-55308942 attenuated IL-1β release in a potent and concn.-dependent manner.  After oral dosing, the compd. exhibited both dose and concn.-dependent occupancy of rat brain P2X7 with an ED50 of 0.07 mg/kg.  The P2X7 antagonist (3 mg/kg, oral) blocked Bz-ATP-induced brain IL-1β release in conscious rats, demonstrating functional effects of target engagement in the brain.  JNJ-55308942 (30 mg/kg, oral) attenuated LPS-induced microglial activation in mice, assessed at day 2 after a single systemic LPS injection (0.8 mg/kg, i.p.), suggesting a role for P2X7 in microglial activation.  In a model of BCG-induced depression, JNJ-55308942 dosed orally, reversed the BCG-induced deficits of sucrose preference and social interaction, indicating for the first time a role of P2X7 in the BCG model of depression, probably due to the neuroinflammatory component induced by BCG inoculation.  Finally, in a rat model of chronic stress induced sucrose intake deficit, JNJ-55308942 reversed the deficit with concurrent high P2X7 brain occupancy as measured by autoradiog.  This body of data demonstrates that JNJ-55308942 is a potent P2X7 antagonist, engages the target in brain, modulates IL-1β release and microglial activation leading to efficacy in two models of anhedonia in rodents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGZTSe0OICSLVg90H21EOLACvtfcHk0ljlxe8th2ZScA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlyrsLrM&md5=55178bf0da9e58ef818367d78f1d6b50</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fs41386-018-0141-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41386-018-0141-6%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DGrigoleit%26aufirst%3DJ.-S.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DFraser%26aufirst%3DI.%26aulast%3DCampbell%26aufirst%3DS.%2BN.%26aulast%3DTaylor%26aufirst%3DN.%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DO%25E2%2580%25B2Connor%26aufirst%3DJ.%2BC.%26aulast%3DPapp%26aufirst%3DM.%26aulast%3DChrovian%26aufirst%3DC.%26aulast%3DCarruthers%26aufirst%3DN.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DNeuropsychopharmacology%2520of%2520JNJ-55308942%253A%2520evaluation%2520of%2520a%2520clinical%2520candidate%2520targeting%2520P2X7%2520ion%2520channels%2520in%2520animal%2520models%2520of%2520neuroinflammation%2520and%2520anhedonia%26jtitle%3DNeuropsychopharmacology%26date%3D2018%26volume%3D43%26spage%3D2586%26epage%3D2596%26doi%3D10.1038%2Fs41386-018-0141-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chrovian, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rech, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span> <span> </span><span class="NLM_article-title">P2X7 antagonists as potential therapeutic agents for the treatment of CNS disorders</span>. <i>Prog. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1016/B978-0-444-63380-4.00002-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2FB978-0-444-63380-4.00002-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=24418608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVWnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=65-100&author=C.+C.+Chrovianauthor=J.+C.+Rechauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=P2X7+antagonists+as+potential+therapeutic+agents+for+the+treatment+of+CNS+disorders&doi=10.1016%2FB978-0-444-63380-4.00002-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">P2X7 antagonists as potential therapeutic agents for the treatment of CNS disorders</span></div><div class="casAuthors">Chrovian, Christa C.; Rech, Jason C.; Bhattacharya, Anindya; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">65-100</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  This paper discusses the P2X7 antagonists as potential therapeutic agents for treatment of CNS disorders.  No. of recent patent applications and medicinal chem. pub-applications have described novel compds. and their activity as P2X7 antagonists; many of these reports highlight the compds.' efficacy in pre-clin. in vivo models of pain, inflammation and arthritis were discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqALhHJWaw5D7Vg90H21EOLACvtfcHk0ljlxe8th2ZScA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVWnt7k%253D&md5=1fe5fd0796848db27e67aee05602f3e6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FB978-0-444-63380-4.00002-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-444-63380-4.00002-0%26sid%3Dliteratum%253Aachs%26aulast%3DChrovian%26aufirst%3DC.%2BC.%26aulast%3DRech%26aufirst%3DJ.%2BC.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DP2X7%2520antagonists%2520as%2520potential%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520CNS%2520disorders%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D53%26spage%3D65%26epage%3D100%26doi%3D10.1016%2FB978-0-444-63380-4.00002-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savall, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoetens, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koudriakova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaptason, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rech, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Angelis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepassi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovenberg, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carruthers, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span> <span> </span><span class="NLM_article-title">Identification of (R)-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-dihydro-1H-imidazo[4,5-c]pyridin-5(4H)-yl)methanone (JNJ 54166060), a Small Molecule Antagonist of the P2X7 receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8535</span>– <span class="NLM_lpage">8548</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00989</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00989" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlyqsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8535-8548&author=D.+M.+Swansonauthor=B.+M.+Savallauthor=K.+J.+Coeauthor=F.+Schoetensauthor=T.+Koudriakovaauthor=J.+Skaptasonauthor=J.+Wallauthor=J.+Rechauthor=X.+Dengauthor=M.+De+Angelisauthor=A.+Eversonauthor=B.+Lordauthor=Q.+Wangauthor=H.+Aoauthor=B.+Scottauthor=K.+Sepassiauthor=T.+W.+Lovenbergauthor=N.+I.+Carruthersauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=Identification+of+%28R%29-%282-Chloro-3-%28trifluoromethyl%29phenyl%29%281-%285-fluoropyridin-2-yl%29-4-methyl-6%2C7-dihydro-1H-imidazo%5B4%2C5-c%5Dpyridin-5%284H%29-yl%29methanone+%28JNJ+54166060%29%2C+a+Small+Molecule+Antagonist+of+the+P2X7+receptor&doi=10.1021%2Facs.jmedchem.6b00989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of (R)-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-dihydro-1H-imidazo[4,5-c]pyridin-5(4H)-yl)methanone (JNJ 54166060), a Small Molecule Antagonist of the P2X7 receptor</span></div><div class="casAuthors">Swanson, Devin M.; Savall, Brad M.; Coe, Kevin J.; Schoetens, Freddy; Koudriakova, Tatiana; Skaptason, Judith; Wall, Jessica; Rech, Jason; Deng, Xiahou; De Angelis, Meri; Everson, Anita; Lord, Brian; Wang, Qi; Ao, Hong; Scott, Brian; Sepassi, Kia; Lovenberg, Timothy W.; Carruthers, Nicholas I.; Bhattacharya, Anindya; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8535-8548</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and SAR of a series of 4,5,6,7-tetrahydro-imidazo[4,5-c]pyridine P2X7 antagonists are described.  Addressing P2X7 affinity and liver microsomal stability issues encountered with this template afforded Me substituted 4,5,6,7-tetrahydro-imidazo[4,5-c]pyridines ultimately leading to the identification of JNJ 54166060.  JNJ 54166060 is a potent P2X7 antagonist with an ED50=2.3 mg/kg in rat, high oral bioavailability and low-moderate clearance in pre-clin. species, acceptable safety margins in rat, and a predicted human dose of 120 mg QD.  Addnl., JNJ 54166060 possesses a unique CYP profile and was found to be a regioselective inhibitor of midazolam CYP3A metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQfT4dUZEP6bVg90H21EOLACvtfcHk0lj6v3Aehusxxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlyqsr%252FO&md5=a48451477fca4bec1fd13df7d5a22ea8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00989%26sid%3Dliteratum%253Aachs%26aulast%3DSwanson%26aufirst%3DD.%2BM.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DCoe%26aufirst%3DK.%2BJ.%26aulast%3DSchoetens%26aufirst%3DF.%26aulast%3DKoudriakova%26aufirst%3DT.%26aulast%3DSkaptason%26aufirst%3DJ.%26aulast%3DWall%26aufirst%3DJ.%26aulast%3DRech%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DEverson%26aufirst%3DA.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DScott%26aufirst%3DB.%26aulast%3DSepassi%26aufirst%3DK.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DIdentification%2520of%2520%2528R%2529-%25282-Chloro-3-%2528trifluoromethyl%2529phenyl%2529%25281-%25285-fluoropyridin-2-yl%2529-4-methyl-6%252C7-dihydro-1H-imidazo%255B4%252C5-c%255Dpyridin-5%25284H%2529-yl%2529methanone%2520%2528JNJ%252054166060%2529%252C%2520a%2520Small%2520Molecule%2520Antagonist%2520of%2520the%2520P2X7%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8535%26epage%3D8548%26doi%3D10.1021%2Facs.jmedchem.6b00989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span>; <span class="NLM_string-name">Yuan, J.</span>; <span class="NLM_string-name">Bakthavatchalam, R.</span>; <span class="NLM_string-name">Hodgetts, K. J.</span>; <span class="NLM_string-name">Capitosti, S. M.</span>; <span class="NLM_string-name">Mao, J.</span>; <span class="NLM_string-name">Wustrow, D. J.</span>; <span class="NLM_string-name">Guo, Q.</span></span> <span> </span><span class="NLM_article-title">Preparation of 5-membered Heterocyclic Amides and Related Compounds as Specific Receptor Activity Modulators</span>. WO Patent <span class="NLM_patent">WO2009012482</span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=H.+Li&author=J.+Yuan&author=R.+Bakthavatchalam&author=K.+J.+Hodgetts&author=S.+M.+Capitosti&author=J.+Mao&author=D.+J.+Wustrow&author=Q.+Guo&title=Preparation+of+5-membered+Heterocyclic+Amides+and+Related+Compounds+as+Specific+Receptor+Activity+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26atitle%3DPreparation%2520of%25205-membered%2520Heterocyclic%2520Amides%2520and%2520Related%2520Compounds%2520as%2520Specific%2520Receptor%2520Activity%2520Modulators%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kilburn, J. P.</span>; <span class="NLM_string-name">Hopper, A. T.</span>; <span class="NLM_string-name">Juhl, M.</span></span> <span> </span><span class="NLM_article-title">Enantiomeric Synthesis of (S)-N-[2-(4-Chlorophenyl)-2-morpholinoethyl]-2-(pyrimidin-2-yl)-4-(trifluoromethyl)thiazole-5-carboxamide as a Potent P2X7 Purinergic Receptor Inhibitor</span>. WO Patent <span class="NLM_patent">WO2017076825</span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+P.+Kilburn&author=A.+T.+Hopper&author=M.+Juhl&title=Enantiomeric+Synthesis+of+%28S%29-N-%5B2-%284-Chlorophenyl%29-2-morpholinoethyl%5D-2-%28pyrimidin-2-yl%29-4-%28trifluoromethyl%29thiazole-5-carboxamide+as+a+Potent+P2X7+Purinergic+Receptor+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKilburn%26aufirst%3DJ.%2BP.%26atitle%3DEnantiomeric%2520Synthesis%2520of%2520%2528S%2529-N-%255B2-%25284-Chlorophenyl%2529-2-morpholinoethyl%255D-2-%2528pyrimidin-2-yl%2529-4-%2528trifluoromethyl%2529thiazole-5-carboxamide%2520as%2520a%2520Potent%2520P2X7%2520Purinergic%2520Receptor%2520Inhibitor%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rech, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savall, B. M.</span></span> <span> </span><span class="NLM_article-title">The evolution of P2X7 antagonists with a focus on CNS indications</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3838</span>– <span class="NLM_lpage">3845</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.06.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.bmcl.2016.06.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=27426304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOitL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3838-3845&author=J.+C.+Rechauthor=A.+Bhattacharyaauthor=M.+A.+Letavicauthor=B.+M.+Savall&title=The+evolution+of+P2X7+antagonists+with+a+focus+on+CNS+indications&doi=10.1016%2Fj.bmcl.2016.06.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of P2X7 antagonists with a focus on CNS indications</span></div><div class="casAuthors">Rech, Jason C.; Bhattacharya, Anindya; Letavic, Michael A.; Savall, Brad M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3838-3845</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The P2X7 receptor is an ATP-gated nonselective cation channel that has been linked to a no. of inflammatory diseases.  Activation of the P2X7 receptor by elevated levels of ATP results in the release of proinflammatory cytokines and elevated levels of these cytokines has been assocd. with a variety of disease states.  A no. of research groups in both industry and academia have explored the identification of P2X7R antagonists as therapeutic agents.  Much of this early effort focused on the treatment of diseases related to peripheral inflammation and resulted in several clin. candidates, none of which were advanced to market.  The emerging role of the P2X7 receptor in neuroinflammation and related diseases has resulted in a shift in medicinal chem. efforts toward the development of centrally penetrant antagonists.  This review will highlight the biol. supporting the role of P2X7 in diseases related to neuroinflammation and review the recent medicinal chem. efforts to identify centrally penetrant antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdaLGUAKgul7Vg90H21EOLACvtfcHk0lj6v3Aehusxxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOitL3L&md5=04046ec16457c856c96dd50632b96efe</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.06.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.06.048%26sid%3Dliteratum%253Aachs%26aulast%3DRech%26aufirst%3DJ.%2BC.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26atitle%3DThe%2520evolution%2520of%2520P2X7%2520antagonists%2520with%2520a%2520focus%2520on%2520CNS%2520indications%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3838%26epage%3D3845%26doi%3D10.1016%2Fj.bmcl.2016.06.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savall, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aluisio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andres, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Angelis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonaventure, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carruthers, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceusters, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvorak, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelin, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koudriakova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovenberg, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otieno, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoetens, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickenden, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span> <span> </span><span class="NLM_article-title">4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical Candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4559</span>– <span class="NLM_lpage">4572</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00408</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00408" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1Wms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4559-4572&author=M.+A.+Letavicauthor=B.+M.+Savallauthor=B.+D.+Allisonauthor=L.+Aluisioauthor=J.+I.+Andresauthor=M.+De+Angelisauthor=H.+Aoauthor=D.+A.+Beauchampauthor=P.+Bonaventureauthor=S.+Bryantauthor=N.+I.+Carruthersauthor=M.+Ceustersauthor=K.+J.+Coeauthor=C.+A.+Dvorakauthor=I.+C.+Fraserauthor=C.+F.+Gelinauthor=T.+Koudriakovaauthor=J.+Liangauthor=B.+Lordauthor=T.+W.+Lovenbergauthor=M.+A.+Otienoauthor=F.+Schoetensauthor=D.+M.+Swansonauthor=Q.+Wangauthor=A.+D.+Wickendenauthor=A.+Bhattacharya&title=4-Methyl-6%2C7-dihydro-4H-triazolo%5B4%2C5-c%5Dpyridine-Based+P2X7+Receptor+Antagonists%3A+Optimization+of+Pharmacokinetic+Properties+Leading+to+the+Identification+of+a+Clinical+Candidate&doi=10.1021%2Facs.jmedchem.7b00408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical Candidate</span></div><div class="casAuthors">Letavic, Michael A.; Savall, Brad M.; Allison, Brett D.; Aluisio, Leah; Andres, Jose Ignacio; De Angelis, Meri; Ao, Hong; Beauchamp, Derek A.; Bonaventure, Pascal; Bryant, Stewart; Carruthers, Nicholas I.; Ceusters, Marc; Coe, Kevin J.; Dvorak, Curt A.; Fraser, Ian C.; Gelin, Christine F.; Koudriakova, Tatiana; Liang, Jimmy; Lord, Brian; Lovenberg, Timothy W.; Otieno, Monicah A.; Schoetens, Freddy; Swanson, Devin M.; Wang, Qi; Wickenden, Alan D.; Bhattacharya, Anindya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4559-4572</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and preclin. characterization of novel 4-(R)-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridines that are potent and selective brain penetrant P2X7 antagonists are described.  Optimization efforts based on previously disclosed unsubstituted 6,7-dihydro-4H-triazolo[4,5-c]pyridines, Me substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrazines, and several other series lead to the identification of a series of 4-(R)-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridines that are selective P2X7 antagonists with potency at the rodent and human P2X7 ion channels.  These novel P2X7 antagonists have suitable physicochem. properties, and several analogs have an excellent pharmacokinetic profile, good partitioning into the CNS and show robust in vivo target engagement after oral dosing.  Improvements in metabolic stability led to the identification of JNJ-54175446 (I) as a candidate for clin. development.  The drug discovery efforts and strategies that resulted in the identification of the clin. candidate are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkx8e5Sq5aYbVg90H21EOLACvtfcHk0lj6v3Aehusxxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1Wms7Y%253D&md5=5b5465d8f64d527da6647997efe34aee</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00408%26sid%3Dliteratum%253Aachs%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DAllison%26aufirst%3DB.%2BD.%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DBeauchamp%26aufirst%3DD.%2BA.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DBryant%26aufirst%3DS.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DCeusters%26aufirst%3DM.%26aulast%3DCoe%26aufirst%3DK.%2BJ.%26aulast%3DDvorak%26aufirst%3DC.%2BA.%26aulast%3DFraser%26aufirst%3DI.%2BC.%26aulast%3DGelin%26aufirst%3DC.%2BF.%26aulast%3DKoudriakova%26aufirst%3DT.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DOtieno%26aufirst%3DM.%2BA.%26aulast%3DSchoetens%26aufirst%3DF.%26aulast%3DSwanson%26aufirst%3DD.%2BM.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWickenden%26aufirst%3DA.%2BD.%26aulast%3DBhattacharya%26aufirst%3DA.%26atitle%3D4-Methyl-6%252C7-dihydro-4H-triazolo%255B4%252C5-c%255Dpyridine-Based%2520P2X7%2520Receptor%2520Antagonists%253A%2520Optimization%2520of%2520Pharmacokinetic%2520Properties%2520Leading%2520to%2520the%2520Identification%2520of%2520a%2520Clinical%2520Candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4559%26epage%3D4572%26doi%3D10.1021%2Facs.jmedchem.7b00408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ameriks, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carruthers, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravula, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rech, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savall, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span> <span> </span><span class="NLM_article-title">Preclinical characterization of substituted 6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one P2X7 receptor antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.12.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.bmcl.2015.12.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=26707399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVKrtbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=257-261&author=M.+K.+Ameriksauthor=H.+Aoauthor=N.+I.+Carruthersauthor=B.+Lordauthor=S.+Ravulaauthor=J.+C.+Rechauthor=B.+M.+Savallauthor=J.+L.+Wallauthor=Q.+Wangauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=Preclinical+characterization+of+substituted+6%2C7-dihydro-%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazin-8%285H%29-one+P2X7+receptor+antagonists&doi=10.1016%2Fj.bmcl.2015.12.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical characterization of substituted 6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one P2X7 receptor antagonists</span></div><div class="casAuthors">Ameriks, Michael K.; Ao, Hong; Carruthers, Nicholas I.; Lord, Brian; Ravula, Suchitra; Rech, Jason C.; Savall, Brad M.; Wall, Jessica L.; Wang, Qi; Bhattacharya, Anindya; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">257-261</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis, SAR, and preclin. characterization of a series of substituted 6,7-dihydro[1,2,4]triazolo[4,3]pyrazin-8(5H)-one P2X7 receptor antagonists are described.  Optimized leads from this series comprise some of the most potent human P2X7R antagonists reported to date (IC50s < 1 nM).  They also exhibit sufficient potency and oral bioavailability in rat to enable extensive in vivo profiling.  Although many of the disclosed compds. are peripherally restricted, compd. I is brain penetrant and upon oral administration demonstrated dose-dependent target engagement in rat hippocampus as detd. by ex vivo receptor occupancy with radiotracer II (ED50 = 0.8 mg/kg).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre9WCgWhiM_rVg90H21EOLACvtfcHk0lh3bfsqi_8P0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVKrtbjL&md5=d1a36bd7f088f4533308ad49fee7fa5b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.12.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.12.052%26sid%3Dliteratum%253Aachs%26aulast%3DAmeriks%26aufirst%3DM.%2BK.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DRavula%26aufirst%3DS.%26aulast%3DRech%26aufirst%3DJ.%2BC.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DWall%26aufirst%3DJ.%2BL.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DPreclinical%2520characterization%2520of%2520substituted%25206%252C7-dihydro-%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazin-8%25285H%2529-one%2520P2X7%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D257%26epage%3D261%26doi%3D10.1016%2Fj.bmcl.2015.12.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly-Roberts, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namovic, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surber, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaidyanathan, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Medrano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarvis, M. F.</span></span> <span> </span><span class="NLM_article-title">[3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2008.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.neuropharm.2008.06.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=18602931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2008&pages=223-229&author=D.+L.+Donnelly-Robertsauthor=M.+T.+Namovicauthor=B.+Surberauthor=S.+X.+Vaidyanathanauthor=A.+Perez-Medranoauthor=Y.+Wangauthor=W.+A.+Carrollauthor=M.+F.+Jarvis&title=%5B3H%5DA-804598+%28%5B3H%5D2-cyano-1-%5B%281S%29-1-phenylethyl%5D-3-quinolin-5-ylguanidine%29+is+a+novel%2C+potent%2C+and+selective+antagonist+radioligand+for+P2X7+receptors&doi=10.1016%2Fj.neuropharm.2008.06.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors</span></div><div class="casAuthors">Donnelly-Roberts, Diana L.; Namovic, Marian T.; Surber, Bruce; Vaidyanathan, Srirajan X.; Perez-Medrano, Arturo; Wang, Ying; Carroll, William A.; Jarvis, Michael F.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">223-229</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">ATP-sensitive P2X7 receptors are localized on cells of immunol. origin including peripheral macrophages and glial cells in the CNS.  Activation of P2X7 receptors leads to rapid changes in intracellular calcium concns., release of the pro-inflammatory cytokine IL-1β, and following prolonged agonist exposure, the formation of cytolytic pores in plasma membranes.  Data from gene knockout studies and recently described selective antagonists indicate a role for P2X7 receptor activation in inflammation and pain.  While several species selective P2X7 antagonists exist, A-804598 represents a structurally novel, competitive, and selective antagonist that has equiv. high affinity at rat (IC50 = 10 nM), mouse (IC50 = 9 nM) and human (IC50 = 11 nM) P2X7 receptors.  A-804598 also potently blocked agonist stimulated release of IL-1β and Yo-Pro uptake from differentiated THP-1 cells that natively express human P2X7 receptors.  A-804598 was tritiated ([3H]A-804598; 8.1 Ci/mmol) and utilized to study recombinant rat P2X7 receptors expressed in 1321N1 cells.  [3H]A-804598 labeled a single class of high affinity binding sites (Kd = 2.4 nM and apparent Bmax = 0.56 pmol/mg).  No specific binding was obsd. in untransfected 1321N1 cells.  The pharmacol. profile for P2X antagonists to inhibit [3H]A-804598 binding correlated with their ability to block functional activation of P2X7 receptors (r = 0.95).  These data demonstrate that A-804598 is one of the most potent and selective antagonists for mammalian P2X7 receptors described to date and [3H]A-804598 is a high affinity antagonist radioligand that specifically labels rat P2X7 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKvMcp2KKTbrVg90H21EOLACvtfcHk0lh3bfsqi_8P0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGlsg%253D%253D&md5=c69eddd94289bbb2f8161dfa69d09fa0</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2008.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2008.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DDonnelly-Roberts%26aufirst%3DD.%2BL.%26aulast%3DNamovic%26aufirst%3DM.%2BT.%26aulast%3DSurber%26aufirst%3DB.%26aulast%3DVaidyanathan%26aufirst%3DS.%2BX.%26aulast%3DPerez-Medrano%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCarroll%26aufirst%3DW.%2BA.%26aulast%3DJarvis%26aufirst%3DM.%2BF.%26atitle%3D%255B3H%255DA-804598%2520%2528%255B3H%255D2-cyano-1-%255B%25281S%2529-1-phenylethyl%255D-3-quinolin-5-ylguanidine%2529%2520is%2520a%2520novel%252C%2520potent%252C%2520and%2520selective%2520antagonist%2520radioligand%2520for%2520P2X7%2520receptors%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D56%26spage%3D223%26epage%3D229%26doi%3D10.1016%2Fj.neuropharm.2008.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duplantier, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dombroski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabel, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labasi, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mussari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perregaux, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shepard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevena, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney-Pickett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, K.</span></span> <span> </span><span class="NLM_article-title">Optimization of the physicochemical and pharmacokinetic attributes in a 6-azauracil series of P2X7 receptor antagonists leading to the discovery of the clinical candidate CE-224,535</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3708</span>– <span class="NLM_lpage">3711</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.04.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.bmcl.2011.04.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=21565499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntFKhsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3708-3711&author=A.+J.+Duplantierauthor=M.+A.+Dombroskiauthor=C.+Subramanyamauthor=A.+M.+Beaulieuauthor=S.-P.+Changauthor=C.+A.+Gabelauthor=C.+Jordanauthor=A.+S.+Kalgutkarauthor=K.+G.+Krausauthor=J.+M.+Labasiauthor=C.+Mussariauthor=D.+G.+Perregauxauthor=R.+Shepardauthor=T.+J.+Taylorauthor=K.+A.+Trevenaauthor=C.+Whitney-Pickettauthor=K.+Yoon&title=Optimization+of+the+physicochemical+and+pharmacokinetic+attributes+in+a+6-azauracil+series+of+P2X7+receptor+antagonists+leading+to+the+discovery+of+the+clinical+candidate+CE-224%2C535&doi=10.1016%2Fj.bmcl.2011.04.077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of the physicochemical and pharmacokinetic attributes in a 6-azauracil series of P2X7 receptor antagonists leading to the discovery of the clinical candidate CE-224,535</span></div><div class="casAuthors">Duplantier, Allen J.; Dombroski, Mark A.; Subramanyam, Chakrapani; Beaulieu, Aimee M.; Chang, Shang-Poa; Gabel, Christopher A.; Jordan, Crystal; Kalgutkar, Amit S.; Kraus, Kenneth G.; Labasi, Jeff M.; Mussari, Christopher; Perregaux, David G.; Shepard, Rick; Taylor, Timothy J.; Trevena, Kristen A.; Whitney-Pickett, Carrie; Yoon, Kwansik</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3708-3711</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">High throughput screening (HTS) of our compd. file provided an attractive lead compd. with modest P2X7 receptor antagonist potency and high selectivity against a panel of receptors and channels, but also with high human plasma protein binding and a predicted short half-life in humans.  Multi-parameter optimization was used to address the potency, physicochem. and pharmacokinetic properties which led to potent P2X7R antagonists with good disposition properties.  Compd. 33 (CE-224,535, I) was advanced to clin. studies for the treatment of rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKwcSH1ohcU7Vg90H21EOLACvtfcHk0ljx3c0-AuEQPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntFKhsLc%253D&md5=8833590dff93be295f4604891eae853b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.077%26sid%3Dliteratum%253Aachs%26aulast%3DDuplantier%26aufirst%3DA.%2BJ.%26aulast%3DDombroski%26aufirst%3DM.%2BA.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DBeaulieu%26aufirst%3DA.%2BM.%26aulast%3DChang%26aufirst%3DS.-P.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26aulast%3DJordan%26aufirst%3DC.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKraus%26aufirst%3DK.%2BG.%26aulast%3DLabasi%26aufirst%3DJ.%2BM.%26aulast%3DMussari%26aufirst%3DC.%26aulast%3DPerregaux%26aufirst%3DD.%2BG.%26aulast%3DShepard%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DT.%2BJ.%26aulast%3DTrevena%26aufirst%3DK.%2BA.%26aulast%3DWhitney-Pickett%26aufirst%3DC.%26aulast%3DYoon%26aufirst%3DK.%26atitle%3DOptimization%2520of%2520the%2520physicochemical%2520and%2520pharmacokinetic%2520attributes%2520in%2520a%25206-azauracil%2520series%2520of%2520P2X7%2520receptor%2520antagonists%2520leading%2520to%2520the%2520discovery%2520of%2520the%2520clinical%2520candidate%2520CE-224%252C535%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3708%26epage%3D3711%26doi%3D10.1016%2Fj.bmcl.2011.04.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keystone, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McInnes, I. B.</span></span> <span> </span><span class="NLM_article-title">Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine</span>. <i>Ann. Rheum. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1630</span>– <span class="NLM_lpage">1635</span>, <span class="refDoi"> DOI: 10.1136/annrheumdis-2011-143578</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1136%2Fannrheumdis-2011-143578" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=22966146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1SqurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2012&pages=1630-1635&author=E.+C.+Keystoneauthor=M.+M.+Wangauthor=M.+Laytonauthor=S.+Hollisauthor=I.+B.+McInnes&title=Clinical+evaluation+of+the+efficacy+of+the+P2X7+purinergic+receptor+antagonist+AZD9056+on+the+signs+and+symptoms+of+rheumatoid+arthritis+in+patients+with+active+disease+despite+treatment+with+methotrexate+or+sulphasalazine&doi=10.1136%2Fannrheumdis-2011-143578"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine</span></div><div class="casAuthors">Keystone, Edward C.; Wang, Millie M.; Layton, Mark; Hollis, Sally; McInnes, Iain B.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1630-1635</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Objectives: The P2X7 purinergic receptor antagonist AZD9056 was evaluated in a phase IIa study and subsequently in a phase IIb study to assess the effects of orally administered AZD9056 on the signs/symptoms of rheumatoid arthritis (RA), with American College of Rheumatol. 20% response criteria (ACR20) as the primary outcome.  Methods: Both studies were randomized, double-blind, placebo-controlled, parallel-group studies in patients with RA receiving methotrexate or sulphasalazine.  Phase IIa was an ascending-dose trial in two cohorts (n=75) using AZD9056 administered daily over 4 wk.  Phase IIb included an open-label etanercept treatment group.  Patients were randomized to receive treatment for 6 mo with 50, 100, 200 or 400 mg AZD9056 (oral, once a day) or matching placebo (oral, once a day), or s.c. etanercept (50 mg once a week).  Results: In phase IIa, 65% of AZD9056 recipients at 400 mg/day responded at the ACR20 level compared with 27% of placebo-treated patients.  A significant redn. in swollen and tender joint count was obsd. in the actively treated group compared with placebo, whereas no effect on acute-phase response was obsd.  Of 385 randomized patients in the phase IIb study, 383 received treatment.  AZD9056 (all doses) had no clin. or statistically significant effect on RA relative to placebo as measured by the proportion of patients meeting the ACR20 criteria at 6 mo and further supported by secondary end points.  In both studies AZD9056 was well tolerated up to 400 mg/day.  Conclusions: AZD9056 does not have significant efficacy in the treatment of RA, and the P2X7 receptor does not appear to be a therapeutically useful target in RA.  Trial registration no. ClinicalTrials.gov NCT00520572.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzCebkc5d0gLVg90H21EOLACvtfcHk0ljx3c0-AuEQPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1SqurzL&md5=97ca48663327aa8578f11001fa96d8c0</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1136%2Fannrheumdis-2011-143578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fannrheumdis-2011-143578%26sid%3Dliteratum%253Aachs%26aulast%3DKeystone%26aufirst%3DE.%2BC.%26aulast%3DWang%26aufirst%3DM.%2BM.%26aulast%3DLayton%26aufirst%3DM.%26aulast%3DHollis%26aufirst%3DS.%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26atitle%3DClinical%2520evaluation%2520of%2520the%2520efficacy%2520of%2520the%2520P2X7%2520purinergic%2520receptor%2520antagonist%2520AZD9056%2520on%2520the%2520signs%2520and%2520symptoms%2520of%2520rheumatoid%2520arthritis%2520in%2520patients%2520with%2520active%2520disease%2520despite%2520treatment%2520with%2520methotrexate%2520or%2520sulphasalazine%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2012%26volume%3D71%26spage%3D1630%26epage%3D1635%26doi%3D10.1136%2Fannrheumdis-2011-143578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ali, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurijssens, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostenfeld, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHugh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stylianou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott-Stevens, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosking, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewit, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2125.2012.04320.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1111%2Fj.1365-2125.2012.04320.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=22568863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVGmsbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2013&pages=197-207&author=Z.+Aliauthor=B.+Laurijssensauthor=T.+Ostenfeldauthor=S.+McHughauthor=A.+Stylianouauthor=P.+Scott-Stevensauthor=L.+Hoskingauthor=O.+Dewitauthor=J.+C.+Richardsonauthor=C.+Chen&title=Pharmacokinetic+and+pharmacodynamic+profiling+of+a+P2X7+receptor+allosteric+modulator+GSK1482160+in+healthy+human+subjects&doi=10.1111%2Fj.1365-2125.2012.04320.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects</span></div><div class="casAuthors">Ali, Zahid; Laurijssens, Bart; Ostenfeld, Thor; McHugh, Simon; Stylianou, Anastasia; Scott-Stevens, Paul; Hosking, Louise; Dewit, Odile; Richardson, Jill C.; Chen, Chao</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">197-207</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • P2X7 receptors are involved in the prodn. of pro-inflammatory cytokines, such as Il-1β, by central and peripheral immune cells.  Il-1β has been implicated as an important mediator of inflammation.  Therefore, the P2X7 receptor is an attractive therapeutic target for inflammatory diseases.  WHAT THIS STUDY ADDS • Findings in pharmacokinetics, pharmacodynamics, safety and tolerability of a P2X7 receptor modulator, GSK1482160, from the first human study for the mol. are described.  A pharmacokinetic/pharmacodynamic model for LPS-stimulated ATP-induced Il-1β prodn. in blood allowed the integration of all relevant data and provided in vivo evidence of the nature of the drug-receptor interaction.  The model has the potential to be used to simulate future trials.  AIMS This paper describes findings from the first-in-human study for GSK1482160, an orally available allosteric P2X7 receptor modulator.  The study aimed to assess the pharmacokinetics (PK), pharmacodynamics (PD), safety and tolerability of the compd. in healthy subjects.  METHODS Escalating single doses of up to 1 g were administered to healthy subjects in a single-blind and placebo-controlled fashion.  Safety, tolerability, blood drug concns. and ex vivo Il-1β prodn. in blood were evaluated.  RESULTS. Drug concn. peaked within 3.5 h of dosing under fasting conditions and declined thereafter with a relatively short half-life of less than 4.5 h.  Exposure was proportional to dose with between subject variability of less than 60%.  A PK/PD model quantified Il-1β as a function of drug exposure.  The model allowed simulation of in vivo pharmacol. for various untested dose levels and regimens.  Furthermore, the mechanistic model supported the hypothesis that the compd. reduces the efficacy of ATP at the P2X7 receptor without affecting its affinity.  No major safety or tolerability concerns were identified in this small study (n= 29), except for one case of asymptomatic accelerated idioventricular rhythm at the top dose.  CONCLUSION. The model-based approach maximized anal. power by integrating all biomarker data and revealed mechanistic insight into the pharmacol. of P2X7 modulation by GSK1482160.  Simulations by this model ultimately led to the discontinuation of the development of this compd.  The therapeutic relevance of the P2X7 receptor remains to be tested in patients.  The mechanistic-model-based approach can be applied widely to drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr41Bz54gV-qLVg90H21EOLACvtfcHk0ljx3c0-AuEQPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVGmsbnF&md5=835023636e0c5b039245344c2a9a207a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2012.04320.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2012.04320.x%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DZ.%26aulast%3DLaurijssens%26aufirst%3DB.%26aulast%3DOstenfeld%26aufirst%3DT.%26aulast%3DMcHugh%26aufirst%3DS.%26aulast%3DStylianou%26aufirst%3DA.%26aulast%3DScott-Stevens%26aufirst%3DP.%26aulast%3DHosking%26aufirst%3DL.%26aulast%3DDewit%26aufirst%3DO.%26aulast%3DRichardson%26aufirst%3DJ.%2BC.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DPharmacokinetic%2520and%2520pharmacodynamic%2520profiling%2520of%2520a%2520P2X7%2520receptor%2520allosteric%2520modulator%2520GSK1482160%2520in%2520healthy%2520human%2520subjects%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2013%26volume%3D75%26spage%3D197%26epage%3D207%26doi%3D10.1111%2Fj.1365-2125.2012.04320.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdi, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beswick, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billinton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collis, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonfria, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleave, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lejeune, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livermore, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medhurst, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michel, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moses, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slingsby, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steadman, J. G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, D. S.</span></span> <span> </span><span class="NLM_article-title">Discovery and structure-activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5080</span>– <span class="NLM_lpage">5084</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.07.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.bmcl.2010.07.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=20673717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVehsbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=5080-5084&author=M.+H.+Abdiauthor=P.+J.+Beswickauthor=A.+Billintonauthor=L.+J.+Chambersauthor=A.+Charltonauthor=S.+D.+Collinsauthor=K.+L.+Collisauthor=D.+K.+Deanauthor=E.+Fonfriaauthor=R.+J.+Gleaveauthor=C.+L.+Lejeuneauthor=D.+G.+Livermoreauthor=S.+J.+Medhurstauthor=A.+D.+Michelauthor=A.+P.+Mosesauthor=L.+Pageauthor=S.+Patelauthor=S.+A.+Romanauthor=S.+Sengerauthor=B.+Slingsbyauthor=J.+G.+A.+Steadmanauthor=A.+J.+Stevensauthor=D.+S.+Walter&title=Discovery+and+structure-activity+relationships+of+a+series+of+pyroglutamic+acid+amide+antagonists+of+the+P2X7+receptor&doi=10.1016%2Fj.bmcl.2010.07.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and structure-activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor</span></div><div class="casAuthors">Abdi, Muna H.; Beswick, Paul J.; Billinton, Andy; Chambers, Laura J.; Charlton, Andrew; Collins, Sue D.; Collis, Katharine L.; Dean, David K.; Fonfria, Elena; Gleave, Robert J.; Lejeune, Clarisse L.; Livermore, David G.; Medhurst, Stephen J.; Michel, Anton D.; Moses, Andrew P.; Page, Lee; Patel, Sadhana; Roman, Shilina A.; Senger, Stefan; Slingsby, Brian; Steadman, Jon G. A.; Stevens, Alexander J.; Walter, Daryl S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5080-5084</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A computational lead-hopping exercise identified compd. 4 (I) as a structurally distinct P2X7 receptor antagonist.  Structure-activity relationships (SAR) of a series of pyroglutamic acid amide analogs of 4 were investigated and compd. 31 was identified as a potent P2X7 antagonist with excellent in vivo activity in animal models of pain, and a profile suitable for progression to clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDVRhpk7pAFrVg90H21EOLACvtfcHk0lhSxBXCEGOsNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVehsbbE&md5=7ffef75090b4baf3bba946701ec9dd8f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.07.033%26sid%3Dliteratum%253Aachs%26aulast%3DAbdi%26aufirst%3DM.%2BH.%26aulast%3DBeswick%26aufirst%3DP.%2BJ.%26aulast%3DBillinton%26aufirst%3DA.%26aulast%3DChambers%26aufirst%3DL.%2BJ.%26aulast%3DCharlton%26aufirst%3DA.%26aulast%3DCollins%26aufirst%3DS.%2BD.%26aulast%3DCollis%26aufirst%3DK.%2BL.%26aulast%3DDean%26aufirst%3DD.%2BK.%26aulast%3DFonfria%26aufirst%3DE.%26aulast%3DGleave%26aufirst%3DR.%2BJ.%26aulast%3DLejeune%26aufirst%3DC.%2BL.%26aulast%3DLivermore%26aufirst%3DD.%2BG.%26aulast%3DMedhurst%26aufirst%3DS.%2BJ.%26aulast%3DMichel%26aufirst%3DA.%2BD.%26aulast%3DMoses%26aufirst%3DA.%2BP.%26aulast%3DPage%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DRoman%26aufirst%3DS.%2BA.%26aulast%3DSenger%26aufirst%3DS.%26aulast%3DSlingsby%26aufirst%3DB.%26aulast%3DSteadman%26aufirst%3DJ.%2BG.%2BA.%26aulast%3DStevens%26aufirst%3DA.%2BJ.%26aulast%3DWalter%26aufirst%3DD.%2BS.%26atitle%3DDiscovery%2520and%2520structure-activity%2520relationships%2520of%2520a%2520series%2520of%2520pyroglutamic%2520acid%2520amide%2520antagonists%2520of%2520the%2520P2X7%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D5080%26epage%3D5084%26doi%3D10.1016%2Fj.bmcl.2010.07.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boes, M.</span></span> <span> </span><span class="NLM_article-title">Preparation of Indole-3-Carboxamide or Azaindole-3-Carboxamide Compounds as P2x7R Antagonists for Treating Multiple Sclerosis</span>. U.S. Patent <span class="NLM_patent">US20130197046</span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=M.+Boes&title=Preparation+of+Indole-3-Carboxamide+or+Azaindole-3-Carboxamide+Compounds+as+P2x7R+Antagonists+for+Treating+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoes%26aufirst%3DM.%26atitle%3DPreparation%2520of%2520Indole-3-Carboxamide%2520or%2520Azaindole-3-Carboxamide%2520Compounds%2520as%2520P2x7R%2520Antagonists%2520for%2520Treating%2520Multiple%2520Sclerosis%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, K.</span>; <span class="NLM_string-name">Hubler, F.</span>; <span class="NLM_string-name">Kimmerlin, T.</span>; <span class="NLM_string-name">Murphy, M.</span>; <span class="NLM_string-name">Renneberg, D.</span>; <span class="NLM_string-name">Stamm, S.</span></span> <span> </span><span class="NLM_article-title">Preparation of Heterocyclic Amide Derivatives as P2X7 Receptor Antagonists</span>. WO Patent <span class="NLM_patent">WO2013014587</span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=K.+Hilpert&author=F.+Hubler&author=T.+Kimmerlin&author=M.+Murphy&author=D.+Renneberg&author=S.+Stamm&title=Preparation+of+Heterocyclic+Amide+Derivatives+as+P2X7+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHilpert%26aufirst%3DK.%26atitle%3DPreparation%2520of%2520Heterocyclic%2520Amide%2520Derivatives%2520as%2520P2X7%2520Receptor%2520Antagonists%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Honore, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly-Roberts, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namovic, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikusa, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauvin, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandran, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medrano, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faltynek, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarvis, M. F.</span></span> <span> </span><span class="NLM_article-title">A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>319</i></span>,  <span class="NLM_fpage">1376</span>– <span class="NLM_lpage">1385</span>, <span class="refDoi"> DOI: 10.1124/jpet.106.111559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1124%2Fjpet.106.111559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=16982702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yltLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2006&pages=1376-1385&author=P.+Honoreauthor=D.+Donnelly-Robertsauthor=M.+T.+Namovicauthor=G.+Hsiehauthor=C.+Z.+Zhuauthor=J.+P.+Mikusaauthor=G.+Hernandezauthor=C.+Zhongauthor=D.+M.+Gauvinauthor=P.+Chandranauthor=R.+Harrisauthor=A.+P.+Medranoauthor=W.+Carrollauthor=K.+Marshauthor=J.+P.+Sullivanauthor=C.+R.+Faltynekauthor=M.+F.+Jarvis&title=A-740003+%5BN-%281-%7B%5B%28cyanoimino%29%285-quinolinylamino%29+methyl%5Damino%7D-2%2C2-dimethylpropyl%29-2-%283%2C4-dimethoxyphenyl%29acetamide%5D%2C+a+novel+and+selective+P2X7+receptor+antagonist%2C+dose-dependently+reduces+neuropathic+pain+in+the+rat&doi=10.1124%2Fjpet.106.111559"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat</span></div><div class="casAuthors">Honore, Prisca; Donnelly-Roberts, Diana; Namovic, Marian T.; Hsieh, Gin; Zhu, Chang Z.; Mikusa, Joe P.; Hernandez, Gricelda; Zhong, Chengmin; Gauvin, Donna M.; Chandran, Prasant; Harris, Richard; Medrano, Arturo Perez; Carroll, William; Marsh, Kennan; Sullivan, James P.; Faltynek, Connie R.; Jarvis, Michael F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1376-1385</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">ATP-sensitive P2X7 receptors are localized on cells of immunol. origin including glial cells in the central nervous system.  Activation of P2X7 receptors leads to rapid changes in intracellular calcium concns., release of the proinflammatory cytokine interleukin-1β (IL-1β), and following prolonged agonist exposure, cytolytic plasma membrane pore formation.  P2X7 knockout mice show reduced inflammation as well as decreased nociceptive sensitivity following peripheral nerve injury.  A-740003 (N-(1-{[(cyanoimino)(5-quinolinylamino) methyl] amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide) is a novel competitive antagonist of P2X7 receptors (IC50 values = 40 nM for human and 18 nM for rat) as measured by agonist-stimulated changes in intracellular calcium concns.  A-740003 showed weak or no activity (IC50 > 10 μM) at other P2 receptors and an array of other neurotransmitter and peptide receptors, ion channels, reuptake sites, and enzymes.  A-740003 potently blocked agonist-evoked IL-1β release (IC50 = 156 nM) and pore formation (IC50 = 92 nM) in differentiated human THP-1 cells.  Systemic administration of A-740003 produced dose-dependent antinociception in a spinal nerve ligation model (ED50 = 19 mg/kg i.p.) in the rat.  A-740003 also attenuated tactile allodynia in two other models of neuropathic pain, chronic constriction injury of the sciatic nerve and vincristine-induced neuropathy.  In addn., A-740003 effectively reduced thermal hyperalgesia obsd. following intraplantar administration of carrageenan or complete Freund's adjuvant (ED50 = 38-54 mg/kg i.p.).  A-740003 was ineffective in attenuating acute thermal nociception in normal rats and did not alter motor performance at analgesic doses.  These data demonstrate that selective blockade of P2X7 receptors in vivo produces significant antinociception in animal models of neuropathic and inflammatory pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKvrIcS3OJT7Vg90H21EOLACvtfcHk0lhSxBXCEGOsNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yltLrP&md5=a7d3bfa9cfc728ab7730ec7b351ecb1d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.111559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.111559%26sid%3Dliteratum%253Aachs%26aulast%3DHonore%26aufirst%3DP.%26aulast%3DDonnelly-Roberts%26aufirst%3DD.%26aulast%3DNamovic%26aufirst%3DM.%2BT.%26aulast%3DHsieh%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DC.%2BZ.%26aulast%3DMikusa%26aufirst%3DJ.%2BP.%26aulast%3DHernandez%26aufirst%3DG.%26aulast%3DZhong%26aufirst%3DC.%26aulast%3DGauvin%26aufirst%3DD.%2BM.%26aulast%3DChandran%26aufirst%3DP.%26aulast%3DHarris%26aufirst%3DR.%26aulast%3DMedrano%26aufirst%3DA.%2BP.%26aulast%3DCarroll%26aufirst%3DW.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26aulast%3DFaltynek%26aufirst%3DC.%2BR.%26aulast%3DJarvis%26aufirst%3DM.%2BF.%26atitle%3DA-740003%2520%255BN-%25281-%257B%255B%2528cyanoimino%2529%25285-quinolinylamino%2529%2520methyl%255Damino%257D-2%252C2-dimethylpropyl%2529-2-%25283%252C4-dimethoxyphenyl%2529acetamide%255D%252C%2520a%2520novel%2520and%2520selective%2520P2X7%2520receptor%2520antagonist%252C%2520dose-dependently%2520reduces%2520neuropathic%2520pain%2520in%2520the%2520rat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D319%26spage%3D1376%26epage%3D1385%26doi%3D10.1124%2Fjpet.106.111559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregg, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kort, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Medrano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voight, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grayson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namovic, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly-Roberts, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niforatos, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honore, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarvis, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faltynek, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, W. A.</span></span> <span> </span><span class="NLM_article-title">Structure-Activity Relationship Studies on a Series of Novel, Substituted 1-Benzyl-5-phenyltetrazole P2X7 Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3659</span>– <span class="NLM_lpage">3666</span>, <span class="refDoi"> DOI: 10.1021/jm051202e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051202e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BD28XkvVehtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3659-3666&author=D.+W.+Nelsonauthor=R.+J.+Greggauthor=M.+E.+Kortauthor=A.+Perez-Medranoauthor=E.+A.+Voightauthor=Y.+Wangauthor=G.+Graysonauthor=M.+T.+Namovicauthor=D.+L.+Donnelly-Robertsauthor=W.+Niforatosauthor=P.+Honoreauthor=M.+F.+Jarvisauthor=C.+R.+Faltynekauthor=W.+A.+Carroll&title=Structure-Activity+Relationship+Studies+on+a+Series+of+Novel%2C+Substituted+1-Benzyl-5-phenyltetrazole+P2X7+Antagonists&doi=10.1021%2Fjm051202e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship Studies on a Series of Novel, Substituted 1-Benzyl-5-phenyltetrazole P2X7 Antagonists</span></div><div class="casAuthors">Nelson, Derek W.; Gregg, Robert J.; Kort, Michael E.; Perez-Medrano, Arturo; Voight, Eric A.; Wang, Ying; Grayson, George; Namovic, Marian T.; Donnelly-Roberts, Diana L.; Niforatos, Wende; Honore, Prisca; Jarvis, Michael F.; Faltynek, Connie R.; Carroll, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3659-3666</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1-Benzyl-5-aryltetrazoles were discovered to be novel antagonists for the P2X7 receptor.  Structure-activity relationship (SAR) studies were conducted around both the benzyl and Ph moieties.  In addn., the importance of the regiochem. substitution on the tetrazole was examd.  Compds. were evaluated for activity to inhibit calcium flux in both human and rat recombinant P2X7 cell lines using fluorometric imaging plate reader technol.  Analogs were also assayed for their ability to inhibit IL-1β release and to inhibit P2X7-mediated pore formation in human THP-1 cells.  Compd. 15d was advanced to efficacy studies in a model of neuropathic pain where significant reversal of mech. allodynia was obsd. at doses that did not affect motor coordination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHB1Jk_r-cm7Vg90H21EOLACvtfcHk0lg8u2Ox1zEPmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkvVehtrc%253D&md5=1a5db08795350fdd48d35d4efc954cc7</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm051202e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051202e%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DD.%2BW.%26aulast%3DGregg%26aufirst%3DR.%2BJ.%26aulast%3DKort%26aufirst%3DM.%2BE.%26aulast%3DPerez-Medrano%26aufirst%3DA.%26aulast%3DVoight%26aufirst%3DE.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DGrayson%26aufirst%3DG.%26aulast%3DNamovic%26aufirst%3DM.%2BT.%26aulast%3DDonnelly-Roberts%26aufirst%3DD.%2BL.%26aulast%3DNiforatos%26aufirst%3DW.%26aulast%3DHonore%26aufirst%3DP.%26aulast%3DJarvis%26aufirst%3DM.%2BF.%26aulast%3DFaltynek%26aufirst%3DC.%2BR.%26aulast%3DCarroll%26aufirst%3DW.%2BA.%26atitle%3DStructure-Activity%2520Relationship%2520Studies%2520on%2520a%2520Series%2520of%2520Novel%252C%2520Substituted%25201-Benzyl-5-phenyltetrazole%2520P2X7%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3659%26epage%3D3666%26doi%3D10.1021%2Fjm051202e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Able, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fish, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bye, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booth, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathaniel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katugampola, S. D.</span></span> <span> </span><span class="NLM_article-title">Receptor localization, native tissue binding and ex vivo occupancy for centrally penetrant P2X7 antagonists in the rat</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">414</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.01025.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1111%2Fj.1476-5381.2010.01025.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=20840537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FivFylsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2011&pages=405-414&author=S.+L.+Ableauthor=R.+L.+Fishauthor=H.+Byeauthor=L.+Boothauthor=Y.+R.+Loganauthor=C.+Nathanielauthor=P.+Hayterauthor=S.+D.+Katugampola&title=Receptor+localization%2C+native+tissue+binding+and+ex+vivo+occupancy+for+centrally+penetrant+P2X7+antagonists+in+the+rat&doi=10.1111%2Fj.1476-5381.2010.01025.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor localization, native tissue binding and ex vivo occupancy for centrally penetrant P2X7 antagonists in the rat</span></div><div class="casAuthors">Able S L; Fish R L; Bye H; Booth L; Logan Y R; Nathaniel C; Hayter P; Katugampola S D</div><div class="citationInfo"><span class="NLM_cas:title">British journal of pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">405-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  The P2X7 receptor is implicated in inflammation and pain and is therefore a potential target for therapeutic intervention.  Here, the development of a native tissue radioligand binding, localization and ex vivo occupancy assay for centrally penetrant P2X7 receptor antagonists is described.  EXPERIMENTAL APPROACH:  Autoradiography studies using the P2X7 antagonist radioligand [3H]-A-804598 were carried out in rat brain and spinal cord.  Subsequent in vitro binding and ex vivo occupancy assays were performed using rat cortex homogenate.  KEY RESULTS:  P2X7 expression was shown to be widespread throughout the rat brain, and in the grey matter of the spinal cord.  In binding assays in rat cortex homogenate, ∼60% specific binding was achieved at equilibrium.  In kinetic binding assays, k(on) and k(off) values of 0.0021·min-1·nM-1 and 0.0070·min-1 were determined, and the K(d) derived from kinetic measurements was consistent with that derived from saturation analysis.  Novel P2X7 antagonists inhibited the binding of [3H]-A-804598 to rat cortex P2X7 receptors with K(i) values of <40 nM.  In an ex vivo occupancy assay, a P2X7 antagonist dosed orally to rats caused a concentration-dependent inhibition of the specific binding of [3H]-A-804598 to rat cortex.  CONCLUSIONS AND IMPLICATIONS:  The present study describes the development of an assay that allows localization of P2X7 receptors, the measurement of the binding affinity of P2X7 receptor antagonists in native tissue, and provides a means of determining central P2X7 receptor occupancy.  These assays could form an important part of a P2X7 drug discovery programme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXlc9eyWdycmZyxfu64m4ffW6udTcc2eboK-ean42MMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FivFylsQ%253D%253D&md5=bd39cdac52c8abe07b76a9a165bbe199</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.01025.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.01025.x%26sid%3Dliteratum%253Aachs%26aulast%3DAble%26aufirst%3DS.%2BL.%26aulast%3DFish%26aufirst%3DR.%2BL.%26aulast%3DBye%26aufirst%3DH.%26aulast%3DBooth%26aufirst%3DL.%26aulast%3DLogan%26aufirst%3DY.%2BR.%26aulast%3DNathaniel%26aufirst%3DC.%26aulast%3DHayter%26aufirst%3DP.%26aulast%3DKatugampola%26aufirst%3DS.%2BD.%26atitle%3DReceptor%2520localization%252C%2520native%2520tissue%2520binding%2520and%2520ex%2520vivo%2520occupancy%2520for%2520centrally%2520penetrant%2520P2X7%2520antagonists%2520in%2520the%2520rat%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D162%26spage%3D405%26epage%3D414%26doi%3D10.1111%2Fj.1476-5381.2010.01025.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naing, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grapperhaus, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillion, D. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of 2-chloro-N-((4,4-difluoro-1-hydroxycyclohexyl)methyl)-5-(5-fluoropyrimidin-2-yl)benzamide as a potent and CNS penetrable P2X7 receptor antagonist</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">3107</span>– <span class="NLM_lpage">3111</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.03.094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.bmcl.2010.03.094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=20392639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFGns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3107-3111&author=X.+Chenauthor=B.+Pierceauthor=W.+Naingauthor=M.+L.+Grapperhausauthor=D.+P.+Phillion&title=Discovery+of+2-chloro-N-%28%284%2C4-difluoro-1-hydroxycyclohexyl%29methyl%29-5-%285-fluoropyrimidin-2-yl%29benzamide+as+a+potent+and+CNS+penetrable+P2X7+receptor+antagonist&doi=10.1016%2Fj.bmcl.2010.03.094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-chloro-N-((4,4-difluoro-1-hydroxycyclohexyl)methyl)-5-(5-fluoropyrimidin-2-yl)benzamide as a potent and CNS penetrable P2X7 receptor antagonist</span></div><div class="casAuthors">Chen, Xiangyang; Pierce, Betsy; Naing, Win; Grapperhaus, Margaret L.; Phillion, Dennis P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3107-3111</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Focused SAR studies were carried out around 5-heteroaryl and 1-amide portions of the 2-chlorobenzamide scaffold, resulting in the discovery of a potent, metabolically stable and centrally penetrable antagonist against P2X7 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUL1qmvwKLI7Vg90H21EOLACvtfcHk0lg8u2Ox1zEPmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFGns7k%253D&md5=b610d050a8857453c636084ddc6a96e8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.03.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.03.094%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DPierce%26aufirst%3DB.%26aulast%3DNaing%26aufirst%3DW.%26aulast%3DGrapperhaus%26aufirst%3DM.%2BL.%26aulast%3DPhillion%26aufirst%3DD.%2BP.%26atitle%3DDiscovery%2520of%25202-chloro-N-%2528%25284%252C4-difluoro-1-hydroxycyclohexyl%2529methyl%2529-5-%25285-fluoropyrimidin-2-yl%2529benzamide%2520as%2520a%2520potent%2520and%2520CNS%2520penetrable%2520P2X7%2520receptor%2520antagonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3107%26epage%3D3111%26doi%3D10.1016%2Fj.bmcl.2010.03.094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoblock, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aluisio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nepomuceno, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neff, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welty, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovenberg, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonaventure, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickenden, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span> <span> </span><span class="NLM_article-title">Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>170</i></span>,  <span class="NLM_fpage">624</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1111/bph.12314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1111%2Fbph.12314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=23889535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsV2ntrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2013&pages=624-640&author=A.+Bhattacharyaauthor=Q.+Wangauthor=H.+Aoauthor=J.+R.+Shoblockauthor=B.+Lordauthor=L.+Aluisioauthor=I.+Fraserauthor=D.+Nepomucenoauthor=R.+A.+Neffauthor=N.+Weltyauthor=T.+W.+Lovenbergauthor=P.+Bonaventureauthor=A.+D.+Wickendenauthor=M.+A.+Letavic&title=Pharmacological+characterization+of+a+novel+centrally+permeable+P2X7+receptor+antagonist%3A+JNJ-47965567&doi=10.1111%2Fbph.12314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567</span></div><div class="casAuthors">Bhattacharya, Anindya; Wang, Qi; Ao, Hong; Shoblock, James R.; Lord, Brian; Aluisio, Leah; Fraser, Ian; Nepomuceno, Diane; Neff, Robert A.; Welty, Natalie; Lovenberg, Timothy W.; Bonaventure, Pascal; Wickenden, Alan D.; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">624-640</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : An increasing body of evidence suggests that the purinergic receptor P2X, ligand-gated ion channel, 7 (P2X7) in the CNS may play a key role in neuropsychiatry, neurodegeneration and chronic pain.  In this study, we characterized JNJ-47965567, a centrally permeable, high-affinity, selective P2X7 antagonist.  Exptl. Approach : We have used a combination of in vitro assays (calcium flux, radioligand binding, electrophysiol., IL-1β release) in both recombinant and native systems.  Target engagement of JNJ-47965567 was demonstrated by ex vivo receptor binding autoradiog. and in vivo blockade of Bz-ATP induced IL-1β release in the rat brain.  Finally, the efficacy of JNJ-47965567 was tested in std. models of depression, mania and neuropathic pain.  Key Results : JNJ-47965567 is potent high affinity (pKi 7.9 ± 0.07), selective human P2X7 antagonist, with no significant obsd. speciation.  In native systems, the potency of the compd. to attenuate IL-1β release was 6.7 ± 0.07 (human blood), 7.5 ± 0.07 (human monocytes) and 7.1 ± 0.1 (rat microglia).  JNJ-47965567 exhibited target engagement in rat brain, with a brain EC50 of 78 ± 19 ng·mL-1 (P2X7 receptor autoradiog.) and functional block of Bz-ATP induced IL-1β release.  JNJ-47965567 (30 mg·kg-1) attenuated amphetamine-induced hyperactivity and exhibited modest, yet significant efficacy in the rat model of neuropathic pain.  No efficacy was obsd. in forced swim test.  Conclusion and Implications : JNJ-47965567 is centrally permeable, high affinity P2X7 antagonist that can be used to probe the role of central P2X7 in rodent models of CNS pathophysiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS_bU7fI8KzLVg90H21EOLACvtfcHk0lg5qmMRmRjXYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsV2ntrnI&md5=29d3bc1d3ecedda01f3d33b53d96c289</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fbph.12314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12314%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DShoblock%26aufirst%3DJ.%2BR.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DFraser%26aufirst%3DI.%26aulast%3DNepomuceno%26aufirst%3DD.%26aulast%3DNeff%26aufirst%3DR.%2BA.%26aulast%3DWelty%26aufirst%3DN.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DWickenden%26aufirst%3DA.%2BD.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DPharmacological%2520characterization%2520of%2520a%2520novel%2520centrally%2520permeable%2520P2X7%2520receptor%2520antagonist%253A%2520JNJ-47965567%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D170%26spage%3D624%26epage%3D640%26doi%3D10.1111%2Fbph.12314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lord, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aluisio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoblock, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neff, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varlinskaya, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceusters, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovenberg, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carruthers, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonaventure, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drinkenburg, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span> <span> </span><span class="NLM_article-title">Pharmacology of a novel central nervous system-penetrant P2X7 antagonist JNJ-42253432</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>351</i></span>,  <span class="NLM_fpage">628</span>– <span class="NLM_lpage">641</span>, <span class="refDoi"> DOI: 10.1124/jpet.114.218487</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1124%2Fjpet.114.218487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=25271258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFWhu7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2014&pages=628-641&author=B.+Lordauthor=L.+Aluisioauthor=J.+R.+Shoblockauthor=R.+A.+Neffauthor=E.+I.+Varlinskayaauthor=M.+Ceustersauthor=T.+W.+Lovenbergauthor=N.+Carruthersauthor=P.+Bonaventureauthor=M.+A.+Letavicauthor=T.+Deakauthor=W.+Drinkenburgauthor=A.+Bhattacharya&title=Pharmacology+of+a+novel+central+nervous+system-penetrant+P2X7+antagonist+JNJ-42253432&doi=10.1124%2Fjpet.114.218487"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of a novel central nervous system-penetrant P2X7 antagonist JNJ-42253432</span></div><div class="casAuthors">Lord, Brian; Aluisio, Leah; Shoblock, James R.; Neff, Robert A.; Varlinskaya, Elena I.; Ceusters, Marc; Lovenberg, Timothy W.; Carruthers, Nicholas; Bonaventure, Pascal; Letavic, Michael A.; Deak, Terrence; Drinkenburg, Wilhelmus; Bhattacharya, Anindya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">628-641, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">In the central nervous system, the ATP-gated Purinergic receptor P2X ligand-gated ion channel 7 (P2X7) is expressed in glial cells and modulates neurophysiol. via release of gliotransmitters, including the proinflammatory cytokine interleukin (IL)-1β.  In this study, we characterized JNJ-42253432 [2-methyl-N-([1-(4-phenylpiperazin-1-yl)cyclohexyl]methyl)-1,2,3,4-tetrahydroisoquinoline-5-carboxamide] as a centrally permeable (brain-to-plasma ratio of 1), high-affinity P2X7 antagonist with desirable pharmacokinetic and pharmacodynamic properties for in vivo testing in rodents.  JNJ-42253432 is a high-affinity antagonist for the rat (pKi 9.1 ± 0.07) and human (pKi 7.9 ± 0.08) P2X7 channel.  The compd. blocked the ATP-induced current and Bz-ATP [2'(3')-O-(4-benzoylbenzoyl)adenosine-5'-triphosphate tri(triethylammonium)]-induced release of IL-1β in a concn.-dependent manner.  When dosed in rats, JNJ-42253432 occupied the brain P2X7 channel with an ED50 of 0.3 mg/kg, corresponding to a mean plasma concn. of 42 ng/mL.  The compd. blocked the release of IL-1β induced by Bz-ATP in freely moving rat brain.  At higher doses/exposure, JNJ-42253432 also increased serotonin levels in the rat brain, which is due to antagonism of the serotonin transporter (SERT) resulting in an ED50 of 10 mg/kg for SERT occupancy.  JNJ-42253432 reduced electroencephalog. spectral power in the α-1 band in a dose-dependent manner; the compd. also attenuated amphetamine-induced hyperactivity.  JNJ-42253432 significantly increased both overall social interaction and social preference, an effect that was independent of stress induced by foot-shock.  Surprisingly, there was no effect of the compd. on either neuropathic pain or inflammatory pain behaviors.  In summary, in this study, we characterize JNJ-42253432 as a novel brain-penetrant P2X7 antagonist with high affinity and selectivity for the P2X7 channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU5MO_PDXIeLVg90H21EOLACvtfcHk0lg5qmMRmRjXYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFWhu7fN&md5=1ab23844891e251b37713c5cd80162a7</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.218487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.218487%26sid%3Dliteratum%253Aachs%26aulast%3DLord%26aufirst%3DB.%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DShoblock%26aufirst%3DJ.%2BR.%26aulast%3DNeff%26aufirst%3DR.%2BA.%26aulast%3DVarlinskaya%26aufirst%3DE.%2BI.%26aulast%3DCeusters%26aufirst%3DM.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DCarruthers%26aufirst%3DN.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DDeak%26aufirst%3DT.%26aulast%3DDrinkenburg%26aufirst%3DW.%26aulast%3DBhattacharya%26aufirst%3DA.%26atitle%3DPharmacology%2520of%2520a%2520novel%2520central%2520nervous%2520system-penetrant%2520P2X7%2520antagonist%2520JNJ-42253432%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D351%26spage%3D628%26epage%3D641%26doi%3D10.1124%2Fjpet.114.218487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackenzie, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">North, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surprenant, A.</span></span> <span> </span><span class="NLM_article-title">Brilliant blue G selectively blocks ATP-gated rat P2X7 receptors</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1124/mol.58.1.82</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1124%2Fmol.58.1.82" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10860929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1Kru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2000&pages=82-88&author=L.-H.+Jiangauthor=A.+B.+Mackenzieauthor=R.+A.+Northauthor=A.+Surprenant&title=Brilliant+blue+G+selectively+blocks+ATP-gated+rat+P2X7+receptors&doi=10.1124%2Fmol.58.1.82"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Brilliant blue G selectively blocks ATP-gated rat P2X7 receptors</span></div><div class="casAuthors">Jiang, Lin-Hua; Mackenzie, Amanda B.; North, R. Alan; Surprenant, Annmarie</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">82-88</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">There are few antagonists selective for subtypes of the several P2X receptors, but these are needed to identify the receptors expressed on native cells and tissues.  In particular, P2X4 and P2X7 receptor subunits are colocalized on immune, epithelial, and exocrine gland cells, but both are relatively insensitive to suramin and pyridoxal-5-phosphate-6-azo-2',4'-disulfonic acid deriv.  In this article, we show that Coomassie Brilliant Blue G selectively inhibits P2X7 receptors with nanomolar affinity.  We measured currents in response to P2X receptor activation in HEK293 cells heterologously expressing human or rat P2X1, P2X2, P2X3, P2X2/3, P2X4, P2X1/5, and P2X7 receptors.  Brilliant Blue G produced a noncompetitive inhibition of rat and human P2X7 receptors with IC50 values of 10 and 200 nM, resp.  IC50 values for inhibition of the other receptors ranged from 2 to >30 μM; the rat and human P2X4 receptors showed IC50 values of >10 and 3.2 μM.  Coomassie Blue G also blocked YO-PRO1 uptake and membrane blebbing, which are uniquely assocd. with activation of P2X7 receptors.  Thus, Brilliant Blue G is at least 1000-fold more potent at rat P2X7 receptors than at rat P2X4 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRFsnEAvo6AbVg90H21EOLACvtfcHk0lg5qmMRmRjXYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1Kru74%253D&md5=0ee3dd2e29ec0a128b834ed71580f92c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fmol.58.1.82&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.58.1.82%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DL.-H.%26aulast%3DMackenzie%26aufirst%3DA.%2BB.%26aulast%3DNorth%26aufirst%3DR.%2BA.%26aulast%3DSurprenant%26aufirst%3DA.%26atitle%3DBrilliant%2520blue%2520G%2520selectively%2520blocks%2520ATP-gated%2520rat%2520P2X7%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D58%26spage%3D82%26epage%3D88%26doi%3D10.1124%2Fmol.58.1.82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelegrin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surprenant, A.</span></span> <span> </span><span class="NLM_article-title">Amino acid residues in the P2X7 receptor that mediate differential sensitivity to ATP and BzATP</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">92</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1124/mol.106.030163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1124%2Fmol.106.030163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=17032903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1GrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=92-100&author=M.+T.+Youngauthor=P.+Pelegrinauthor=A.+Surprenant&title=Amino+acid+residues+in+the+P2X7+receptor+that+mediate+differential+sensitivity+to+ATP+and+BzATP&doi=10.1124%2Fmol.106.030163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Amino acid residues in the P2X7 receptor that mediate differential sensitivity to ATP and BzATP</span></div><div class="casAuthors">Young, Mark T.; Pelegrin, Pablo; Surprenant, Annmarie</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">92-100</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Agonist properties of the P2X7 receptor (P2X7R) differ strikingly from other P2X receptors in two main ways: high concns. of ATP (> 100 μM) are required to activate the receptor, and the ATP analog 2',3'-O-(4-benzoyl-benzoyl)ATP (BzATP) is both more potent than ATP and evokes a higher max. current.  However, there are striking species differences in these properties.  We sought to exploit the large differences in ATP and BzATP responses between rat and mouse P2X7R to delineate regions or specific residues that may be responsible for the unique actions of these agonists at the P2X7R.  We measured membrane currents in response to ATP and BzATP at wild-type rat and mouse P2X7R, at chimeric P2X7Rs, and at mouse P2X7Rs bearing point mutations.  Wild-type rat P2X7R was 10 times more sensitive to ATP and 100 times more sensitive to BzATP than wild-type mouse P2X7R.  We found that agonist EC50 values were detd. solely by the ectodomain of the P2X7R.  Two segments (residues 115-136 and 282-288), when transposed together, converted mouse sensitivities to those of rat.  Point mutations through these regions revealed a single residue, asparagine284, in the rat P2X7R that fully accounted for the 10-fold difference in ATP sensitivity, whereas the 100-fold difference in BzATP sensitivity required the transfer of both Lys127 and Asn284 from rat to mouse.  Thus, single amino acid differences between species can account for large changes in agonist effectiveness and differentiate between the two widely used agonists at P2X7 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-29lKBv4UU7Vg90H21EOLACvtfcHk0lh7Tysr1kDaZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1GrsA%253D%253D&md5=b7ceab86f26250ace786baf4640c891b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fmol.106.030163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.106.030163%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DM.%2BT.%26aulast%3DPelegrin%26aufirst%3DP.%26aulast%3DSurprenant%26aufirst%3DA.%26atitle%3DAmino%2520acid%2520residues%2520in%2520the%2520P2X7%2520receptor%2520that%2520mediate%2520differential%2520sensitivity%2520to%2520ATP%2520and%2520BzATP%26jtitle%3DMol.%2520Pharmacol.%26date%3D2007%26volume%3D71%26spage%3D92%26epage%3D100%26doi%3D10.1124%2Fmol.106.030163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pelegrin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surprenant, A.</span></span> <span> </span><span class="NLM_article-title">Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptor</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">5071</span>– <span class="NLM_lpage">5082</span>, <span class="refDoi"> DOI: 10.1038/sj.emboj.7601378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1038%2Fsj.emboj.7601378" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=17036048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFChsrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=5071-5082&author=P.+Pelegrinauthor=A.+Surprenant&title=Pannexin-1+mediates+large+pore+formation+and+interleukin-1%CE%B2+release+by+the+ATP-gated+P2X7+receptor&doi=10.1038%2Fsj.emboj.7601378"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptor</span></div><div class="casAuthors">Pelegrin, Pablo; Surprenant, Annmarie</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5071-5082</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">P2X7 receptors are ATP-gated cation channels; their activation in macrophage also leads to rapid opening of a membrane pore permeable to dyes such as ethidium, and to release of the pro-inflammatory cytokine, interleukin-1β (IL-1β).  It has not been known what this dye-uptake path is, or whether it is involved in downstream signaling to IL-1β release.  Here, we identify pannexin-1, a recently described mammalian protein that functions as a hemichannel when ectopically expressed, as this dye-uptake pathway and show that signaling through pannexin-1 is required for processing of caspase-1 and release of mature IL-1β induced by P2X7 receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgKvoL27FfqbVg90H21EOLACvtfcHk0lh7Tysr1kDaZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFChsrzM&md5=9b4bb218bde9ee4145bd3f70d900012c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601378%26sid%3Dliteratum%253Aachs%26aulast%3DPelegrin%26aufirst%3DP.%26aulast%3DSurprenant%26aufirst%3DA.%26atitle%3DPannexin-1%2520mediates%2520large%2520pore%2520formation%2520and%2520interleukin-1%25CE%25B2%2520release%2520by%2520the%2520ATP-gated%2520P2X7%2520receptor%26jtitle%3DEMBO%2520J.%26date%3D2006%26volume%3D25%26spage%3D5071%26epage%3D5082%26doi%3D10.1038%2Fsj.emboj.7601378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilenski, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apparsundaram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weikert, R.</span></span> <span> </span><span class="NLM_article-title">Unbound brain concentration determines receptor occupancy: a correlation of drug concentration and brain serotonin and dopamine reuptake transporter occupancy for eighteen compounds in rats</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1548</span>– <span class="NLM_lpage">1556</span>, <span class="refDoi"> DOI: 10.1124/dmd.109.026674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1124%2Fdmd.109.026674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=19389861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosFems7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1548-1556&author=X.+Liuauthor=O.+Vilenskiauthor=J.+Kwanauthor=S.+Apparsundaramauthor=R.+Weikert&title=Unbound+brain+concentration+determines+receptor+occupancy%3A+a+correlation+of+drug+concentration+and+brain+serotonin+and+dopamine+reuptake+transporter+occupancy+for+eighteen+compounds+in+rats&doi=10.1124%2Fdmd.109.026674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Unbound brain concentration determines receptor occupancy: a correlation of drug concentration and brain serotonin and dopamine reuptake transporter occupancy for eighteen compounds in rats</span></div><div class="casAuthors">Liu, Xingrong; Vilenski, Olga; Kwan, Joyce; Apparsundaram, Subbu; Weikert, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1548-1556</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">It is a commonly accepted hypothesis that central nervous system (CNS) activity is detd. by the unbound brain drug concn.  However, limited exptl. data are available in the literature to support this hypothesis.  The objective of this study was to test this hypothesis by examg. the relationship between in vitro binding affinity (KI) and in vivo activity quantified as the drug concn. occupying 50% of the transporters (OC50) for 18 serotonin (SERT) and dopamine transporter (DAT) inhibitors.  In vivo rat OC50 was detd. by autoradiog. using [3H]N,N-dimethyl-2,2-amino-4-cyanophenylthiobenzylamine and [3H](-)-2-β-carbomethoxy-3-β-(4-fluorophenyl)tropane-1,5-naphthalenedisulfonate (WIN35,428) as the ligands to assess SERT and DAT occupancy, resp.  The unbound brain concns. were calcd. from total brain concns. and the unbound brain fraction, which was detd. by the brain homogenate method.  The in vivo total brain SERT and DAT OC50 values (mean ± S.D.) were 408 ± 368- and 410 ± 395-fold greater than the KI values, resp.  In contrast, the in vivo unbound brain SERT and DAT OC50 values were only 3.3 ± 2.1- and 4.1 ± 4.0-fold different from the KI values.  Therefore, prediction of the biophase drug concn. by using the unbound brain concn. rather than the total brain concn. results in an approx. 100-fold improvement for the accuracy.  In the present study, a 10-fold improvement was also obsd. by using the unbound plasma concn. rather than the total plasma concn. to predict the biophase concn. in the brain.  This study supports the hypothesis that CNS activity is more accurately detd. by the unbound brain drug concn. and not by the total brain drug concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwATPXsf2CK7Vg90H21EOLACvtfcHk0lh7Tysr1kDaZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosFems7k%253D&md5=d80077b28035f6e2c9e2e9df4b483b10</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.026674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.026674%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DVilenski%26aufirst%3DO.%26aulast%3DKwan%26aufirst%3DJ.%26aulast%3DApparsundaram%26aufirst%3DS.%26aulast%3DWeikert%26aufirst%3DR.%26atitle%3DUnbound%2520brain%2520concentration%2520determines%2520receptor%2520occupancy%253A%2520a%2520correlation%2520of%2520drug%2520concentration%2520and%2520brain%2520serotonin%2520and%2520dopamine%2520reuptake%2520transporter%2520occupancy%2520for%2520eighteen%2520compounds%2520in%2520rats%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1548%26epage%3D1556%26doi%3D10.1124%2Fdmd.109.026674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swarts, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanisch, U.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möller, T.</span></span> <span> </span><span class="NLM_article-title">Lipopolysaccharide is a frequent and significant contaminant in microglia-activating factors</span>. <i>Glia</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">16</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1002/glia.20585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1002%2Fglia.20585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=17910052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A280%3ADC%252BD2snkvVSguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2008&pages=16-26&author=J.+R.+Weinsteinauthor=S.+Swartsauthor=C.+Bishopauthor=U.-K.+Hanischauthor=T.+M%C3%B6ller&title=Lipopolysaccharide+is+a+frequent+and+significant+contaminant+in+microglia-activating+factors&doi=10.1002%2Fglia.20585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Lipopolysaccharide is a frequent and significant contaminant in microglia-activating factors</span></div><div class="casAuthors">Weinstein Jonathan R; Swarts Sarah; Bishop Caroline; Hanisch Uwe-Karsten; Moller Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Glia</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-26</span>
        ISSN:<span class="NLM_cas:issn">0894-1491</span>.
    </div><div class="casAbstract">Lipopolysaccharide (LPS/endotoxin) is a potent immunologic stimulant.  Many commercial-grade reagents used in research are not screened for LPS contamination.  LPS induces a wide spectrum of proinflammatory responses in microglia, the immune cells of the brain.  Recent studies have demonstrated that a broad range of endogenous factors including plasma-derived proteins and bioactive phospholipids can also activate microglia.  However, few of these studies have reported either the LPS levels found in the preparations used or the effect of LPS inhibitors such as polymyxin B (PMX) on factor-induced responses.  Here, we used the Limulus amoebocyte lysate assay to screen a broad range of commercial- and pharmaceutical-grade proteins, peptides, lipids, and inhibitors commonly used in microglia research for contamination with LPS.  We then characterized the ability of PMX to alter a representative set of factor-induced microglial activation parameters including surface antigen expression, metabolic activity/proliferation, and NO/cytokine/chemokine release in both the N9 microglial cell line and primary microglia.  Significant levels of LPS contamination were detected in a number of commercial-grade plasma/serum- and nonplasma/serum-derived proteins, phospholipids, and synthetic peptide preparations, but not in pharmaceutical-grade recombinant proteins or pharmacological inhibitors.  PMX had a significant inhibitory effect on the microglia-activating potential of a number of commercial-, but not pharmaceutical-grade, protein preparations.  Novel PMX-resistant responses to alpha(2)-macroglobulin and albumin were incidentally observed.  Our results indicate that LPS is a frequent and significant contaminant in commercial-grade preparations of previously reported microglia-activating factors.  Careful attention to LPS levels and appropriate controls are necessary for future studies in the neuroinflammation field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTpXqaVjdOqgYxhnOQkIHOxfW6udTcc2eYSuf8fNUuPirntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snkvVSguw%253D%253D&md5=df9cd5fe2be7eb0f617a2f4be588106f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fglia.20585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.20585%26sid%3Dliteratum%253Aachs%26aulast%3DWeinstein%26aufirst%3DJ.%2BR.%26aulast%3DSwarts%26aufirst%3DS.%26aulast%3DBishop%26aufirst%3DC.%26aulast%3DHanisch%26aufirst%3DU.-K.%26aulast%3DM%25C3%25B6ller%26aufirst%3DT.%26atitle%3DLipopolysaccharide%2520is%2520a%2520frequent%2520and%2520significant%2520contaminant%2520in%2520microglia-activating%2520factors%26jtitle%3DGlia%26date%3D2008%26volume%3D56%26spage%3D16%26epage%3D26%26doi%3D10.1002%2Fglia.20585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hornberg, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laursen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenden, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thougaard, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toft, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mow, T.</span></span> <span> </span><span class="NLM_article-title">Exploratory toxicology as an integrated part of drug discovery. Part I: Why and how</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1131</span>– <span class="NLM_lpage">1136</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2013.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.drudis.2013.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=24368175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFyrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1131-1136&author=J.+J.+Hornbergauthor=M.+Laursenauthor=N.+Brendenauthor=M.+Perssonauthor=A.+V.+Thougaardauthor=D.+B.+Toftauthor=T.+Mow&title=Exploratory+toxicology+as+an+integrated+part+of+drug+discovery.+Part+I%3A+Why+and+how&doi=10.1016%2Fj.drudis.2013.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Exploratory toxicology as an integrated part of drug discovery. Part I: Why and how</span></div><div class="casAuthors">Hornberg, Jorrit J.; Laursen, Morten; Brenden, Nina; Persson, Mikael; Thougaard, Annemette V.; Toft, Dorthe B.; Mow, Tomas</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1131-1136</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Toxicity and clin. safety have major impact on drug development success.  Moving toxicol. studies into earlier phases of the R&D chain prevents drug candidates with a safety risk from entering clin. development.  However, to identify candidates without such risk, safety has to be designed actively.  Therefore, we argue that toxicol. should be fully integrated into the discovery process.  We describe our strategy, including safety assessment of novel targets, selection of chem. series without inherent liabilities, designing out risk factors and profiling of candidates, and we discuss considerations regarding what to screen for.  We aim to provide timely go/no-go decisions (fail early) and direction to the discovery teams, by steering away from safety risk (showing what will not fail).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqa0a8DdfgYIbVg90H21EOLACvtfcHk0liPXBtd_Ezc-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFyrsbY%253D&md5=fcfa691b512dad747ef6fe55eeda8873</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2013.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2013.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DHornberg%26aufirst%3DJ.%2BJ.%26aulast%3DLaursen%26aufirst%3DM.%26aulast%3DBrenden%26aufirst%3DN.%26aulast%3DPersson%26aufirst%3DM.%26aulast%3DThougaard%26aufirst%3DA.%2BV.%26aulast%3DToft%26aufirst%3DD.%2BB.%26aulast%3DMow%26aufirst%3DT.%26atitle%3DExploratory%2520toxicology%2520as%2520an%2520integrated%2520part%2520of%2520drug%2520discovery.%2520Part%2520I%253A%2520Why%2520and%2520how%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D1131%26epage%3D1136%26doi%3D10.1016%2Fj.drudis.2013.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hornberg, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laursen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenden, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thougaard, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toft, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mow, T.</span></span> <span> </span><span class="NLM_article-title">Exploratory toxicology as an integrated part of drug discovery. Part II: Screening strategies</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1137</span>– <span class="NLM_lpage">1144</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2013.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.drudis.2013.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=24374152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlOrtLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1137-1144&author=J.+J.+Hornbergauthor=M.+Laursenauthor=N.+Brendenauthor=M.+Perssonauthor=A.+V.+Thougaardauthor=D.+B.+Toftauthor=T.+Mow&title=Exploratory+toxicology+as+an+integrated+part+of+drug+discovery.+Part+II%3A+Screening+strategies&doi=10.1016%2Fj.drudis.2013.12.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Exploratory toxicology as an integrated part of drug discovery. Part II: Screening strategies</span></div><div class="casAuthors">Hornberg, Jorrit J.; Laursen, Morten; Brenden, Nina; Persson, Mikael; Thougaard, Annemette V.; Toft, Dorthe B.; Mow, Tomas</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1137-1144</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In an effort to reduce toxicity-related attrition, different strategies have been implemented throughout the pharmaceutical industry.  Previously (in Part I), we have outlined our 'integrated toxicol.' strategy, which aims to provide timely go/no-go decisions (fail early) but also to show a direction to the drug discovery teams (showing what will not fail).  In this review (Part II of the series) we describe our compd. testing strategies with respect to cardiovascular safety, hepatotoxicity, genotoxicity, immunotoxicity and exploratory in vivo toxicity.  We discuss the in vitro, ex vivo and in vivo assays and models we employ to assess safety risks and optimize compd. series during the drug discovery process, including their predictivity and the decisions they generate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYRCY7sDSqWbVg90H21EOLACvtfcHk0liPXBtd_Ezc-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlOrtLnE&md5=7261ea8fdeac799ea63f1269091b8d34</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2013.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2013.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DHornberg%26aufirst%3DJ.%2BJ.%26aulast%3DLaursen%26aufirst%3DM.%26aulast%3DBrenden%26aufirst%3DN.%26aulast%3DPersson%26aufirst%3DM.%26aulast%3DThougaard%26aufirst%3DA.%2BV.%26aulast%3DToft%26aufirst%3DD.%2BB.%26aulast%3DMow%26aufirst%3DT.%26atitle%3DExploratory%2520toxicology%2520as%2520an%2520integrated%2520part%2520of%2520drug%2520discovery.%2520Part%2520II%253A%2520Screening%2520strategies%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D1137%26epage%3D1144%26doi%3D10.1016%2Fj.drudis.2013.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flückiger-Isler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamber, M.</span></span> <span> </span><span class="NLM_article-title">Direct comparison of the Ames microplate format (MPF) test in liquid medium with the standard Ames pre-incubation assay on agar plates by use of equivocal to weakly positive test compounds</span>. <i>Mutat. Res., Genet. Toxicol. Environ. Mutagen.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>747</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1016/j.mrgentox.2012.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.mrgentox.2012.03.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=747&publication_year=2012&pages=36-45&author=S.+Fl%C3%BCckiger-Islerauthor=M.+Kamber&title=Direct+comparison+of+the+Ames+microplate+format+%28MPF%29+test+in+liquid+medium+with+the+standard+Ames+pre-incubation+assay+on+agar+plates+by+use+of+equivocal+to+weakly+positive+test+compounds&doi=10.1016%2Fj.mrgentox.2012.03.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.mrgentox.2012.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mrgentox.2012.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DFl%25C3%25BCckiger-Isler%26aufirst%3DS.%26aulast%3DKamber%26aufirst%3DM.%26atitle%3DDirect%2520comparison%2520of%2520the%2520Ames%2520microplate%2520format%2520%2528MPF%2529%2520test%2520in%2520liquid%2520medium%2520with%2520the%2520standard%2520Ames%2520pre-incubation%2520assay%2520on%2520agar%2520plates%2520by%2520use%2520of%2520equivocal%2520to%2520weakly%2520positive%2520test%2520compounds%26jtitle%3DMutat.%2520Res.%252C%2520Genet.%2520Toxicol.%2520Environ.%2520Mutagen.%26date%3D2012%26volume%3D747%26spage%3D36%26epage%3D45%26doi%3D10.1016%2Fj.mrgentox.2012.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thougaard, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christiansen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mow, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornberg, J. J.</span></span> <span> </span><span class="NLM_article-title">Validation of a high throughput flow cytometric <i>in vitro</i> micronucleus assay including assessment of metabolic activation in TK6 cells</span>. <i>Environ. Mol. Mutagen.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">704</span>– <span class="NLM_lpage">718</span>, <span class="refDoi"> DOI: 10.1002/em.21891</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1002%2Fem.21891" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=25111698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlahtLvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=704-718&author=A.+V.+Thougaardauthor=J.+Christiansenauthor=T.+Mowauthor=J.+J.+Hornberg&title=Validation+of+a+high+throughput+flow+cytometric+in+vitro+micronucleus+assay+including+assessment+of+metabolic+activation+in+TK6+cells&doi=10.1002%2Fem.21891"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of a high throughput flow cytometric in vitro micronucleus assay including assessment of metabolic activation in TK6 cells</span></div><div class="casAuthors">Thougaard, Annemette V.; Christiansen, Joan; Mow, Tomas; Hornberg, Jorrit J.</div><div class="citationInfo"><span class="NLM_cas:title">Environmental and Molecular Mutagenesis</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">704-718</span>CODEN:
                <span class="NLM_cas:coden">EMMUEG</span>;
        ISSN:<span class="NLM_cas:issn">0893-6692</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Genotoxicity is an unacceptable property for new drug candidates and we employ three screening assays during the drug discovery process to identify genotoxicity early and optimize chem. series.  One of these methods is the flow cytometric in vitro micronucleus assay for which protocol optimizations have been described recently.  Here, we report further validation of the assay in TK6 cells including assessment of metabolic activation.  We first optimized assay conditions to allow for testing with and without metabolic activation in parallel in a 96-well plate format.  Then, we tested a set of 48 compds. carefully selected to contain known in vivo genotoxins, nongenotoxins and drugs.  Avoidance of irrelevant positives, a known issue with mammalian cell-based genotoxicity assays, is important to prevent early deselection of potentially promising compds.  Therefore, we enriched the validation set with compds. that were previously reported to produce irrelevant pos. results in mammalian cell-based genotoxicity assays.  The resulting dataset was used to set the relevant cut-off values for scoring a compd. pos. or neg., such that we obtained an optimal balance of high sensitivity (88%) and high specificity (87%).  Finally, we tested an addnl. set of 16 drugs to further probe assay performance and 14 of them were classified correctly.  To our knowledge, the present study is the most comprehensive validation of the in vitro flow cytometric micronucleus assay and the first to report parallel assessment with metabolic activation in reasonable throughput.  The assay allows for rapidly screening novel compds. for genotoxicity and is therefore well-suited for use in early drug discovery projects.  Environ.  Mol.  Mutagen., 2014. © 2014 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXWaiDTjKjW7Vg90H21EOLACvtfcHk0ljdMx5wLI-iIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlahtLvJ&md5=b6d75d5d4d62c36ffb5ccb15ab30b51f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fem.21891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fem.21891%26sid%3Dliteratum%253Aachs%26aulast%3DThougaard%26aufirst%3DA.%2BV.%26aulast%3DChristiansen%26aufirst%3DJ.%26aulast%3DMow%26aufirst%3DT.%26aulast%3DHornberg%26aufirst%3DJ.%2BJ.%26atitle%3DValidation%2520of%2520a%2520high%2520throughput%2520flow%2520cytometric%2520in%2520vitro%2520micronucleus%2520assay%2520including%2520assessment%2520of%2520metabolic%2520activation%2520in%2520TK6%2520cells%26jtitle%3DEnviron.%2520Mol.%2520Mutagen.%26date%3D2014%26volume%3D55%26spage%3D704%26epage%3D718%26doi%3D10.1002%2Fem.21891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walmsley, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, M.</span></span> <span> </span><span class="NLM_article-title">The GADD45a-GFP GreenScreen HC assay</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>817</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1007%2F978-1-61779-421-6_12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=22147576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OnsrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=817&publication_year=2012&pages=231-250&author=R.+M.+Walmsleyauthor=M.+Tate&title=The+GADD45a-GFP+GreenScreen+HC+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The GADD45a-GFP GreenScreen HC assay</span></div><div class="casAuthors">Walmsley, Richard M.; Tate, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">817</span>
        (<span class="NLM_cas:issue">Genetic Toxicology</span>),
    <span class="NLM_cas:pages">231-250</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Mutagens, clastogens, and aneugens cause increased expression of the human GADD45a gene.  This has been exploited in the GreenScreen HC genotoxicity assay in which the gene's expression is linked to the expression of green fluorescent protein (GFP).  The host for the reporter construct is the human lymphoblastoid cell line TK6.  It was chosen for its growth as a cell suspension, which allows simple pipet transfers, and for its wild-type p53 competent status.  P53 is required for proper GADD45a expression, and more generally for genome stability.  TK6 is a karyotypically stable cell line.  The GreenScreen assays were designed to facilitate screening, and this is reflected in its microplate format and low compd. requirement.  Protocols are available for testing with and without S9 as a source of exogenous metabolic activation.  Data is collected either spectrophotometrically or by flow cytometry, and a simple spreadsheet converts raw data into dose-response curves, and provides a statistically significant pos. or neg. result.  Extensive validation has demonstrated that in contrast to other in vitro mammalian genotoxicity assays, the GADD45a assays have both high sensitivity and specificity - they very rarely produce misleading pos. results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD0EqM59A-NbVg90H21EOLACvtfcHk0ljdMx5wLI-iIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OnsrrO&md5=5d7e9eea24272b838150333970e51ef8</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1007%2F978-1-61779-421-6_12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-61779-421-6_12%26sid%3Dliteratum%253Aachs%26aulast%3DWalmsley%26aufirst%3DR.%2BM.%26aulast%3DTate%26aufirst%3DM.%26atitle%3DThe%2520GADD45a-GFP%2520GreenScreen%2520HC%2520assay%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2012%26volume%3D817%26spage%3D231%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nadziejka, D. E.</span></span> <i>The ACS Style Guide: A Manual for Authors and Editors</i>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">ACS Publications</span>, <span class="NLM_year">1997</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=D.+E.+Nadziejka&title=The+ACS+Style+Guide%3A+A+Manual+for+Authors+and+Editors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNadziejka%26aufirst%3DD.%2BE.%26btitle%3DThe%2520ACS%2520Style%2520Guide%253A%2520A%2520Manual%2520for%2520Authors%2520and%2520Editors%26pub%3DACS%2520Publications%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roszkowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojtasiewicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leniewski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurin, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarnocki, Z.</span></span> <span> </span><span class="NLM_article-title">Enantioselective synthesis of 1-substituted tetrahydro-β-carboline derivatives via asymmetric transfer hydrogenation</span>. <i>J. Mol. Catal. A: Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>232</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">149</span>, <span class="refDoi"> DOI: 10.1016/j.molcata.2005.01.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.molcata.2005.01.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVSjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=2005&pages=143-149&author=P.+Roszkowskiauthor=K.+Wojtasiewiczauthor=A.+Leniewskiauthor=J.+K.+Maurinauthor=T.+Lisauthor=Z.+Czarnocki&title=Enantioselective+synthesis+of+1-substituted+tetrahydro-%CE%B2-carboline+derivatives+via+asymmetric+transfer+hydrogenation&doi=10.1016%2Fj.molcata.2005.01.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Enantioselective synthesis of 1-substituted tetrahydro-β-carboline derivatives via asymmetric transfer hydrogenation</span></div><div class="casAuthors">Roszkowski, Piotr; Wojtasiewicz, Krystyna; Leniewski, Andrzej; Maurin, Jan K.; Lis, Tadeusz; Czarnocki, Zbigniew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Catalysis A: Chemical</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">232</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">143-149</span>CODEN:
                <span class="NLM_cas:coden">JMCCF2</span>;
        ISSN:<span class="NLM_cas:issn">1381-1169</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Several 1-substituted 3,4-dihydro-β-carboline derivs. were subjected to asym. transfer hydrogenation catalyzed by chiral ruthenium complexes to give both enantiomers of 1,2,3,4-tetrahydro-β-carbolines of high optical purity and in good yields.  The abs. stereochem. of the 1-octyl deriv. was established on the basis of X-ray anal. of its Mosher amide (I).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1bBKGLMCF6rVg90H21EOLACvtfcHk0ljdMx5wLI-iIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVSjtbs%253D&md5=4026897949677ddeaf3af2adffe1d54c</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.molcata.2005.01.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcata.2005.01.044%26sid%3Dliteratum%253Aachs%26aulast%3DRoszkowski%26aufirst%3DP.%26aulast%3DWojtasiewicz%26aufirst%3DK.%26aulast%3DLeniewski%26aufirst%3DA.%26aulast%3DMaurin%26aufirst%3DJ.%2BK.%26aulast%3DLis%26aufirst%3DT.%26aulast%3DCzarnocki%26aufirst%3DZ.%26atitle%3DEnantioselective%2520synthesis%2520of%25201-substituted%2520tetrahydro-%25CE%25B2-carboline%2520derivatives%2520via%2520asymmetric%2520transfer%2520hydrogenation%26jtitle%3DJ.%2520Mol.%2520Catal.%2520A%253A%2520Chem.%26date%3D2005%26volume%3D232%26spage%3D143%26epage%3D149%26doi%3D10.1016%2Fj.molcata.2005.01.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Möller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanisch, U.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransom, B. R.</span></span> <span> </span><span class="NLM_article-title">Thrombin-induced activation of cultured rodent microglia</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">1539</span>– <span class="NLM_lpage">1547</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.2000.0751539.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1046%2Fj.1471-4159.2000.0751539.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10987834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmslGlt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2000&pages=1539-1547&author=T.+M%C3%B6llerauthor=U.-K.+Hanischauthor=B.+R.+Ransom&title=Thrombin-induced+activation+of+cultured+rodent+microglia&doi=10.1046%2Fj.1471-4159.2000.0751539.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Thrombin-induced activation of cultured rodent microglia</span></div><div class="casAuthors">Moller, Thomas; Hanisch, Uwe-Karsten; Ransom, Bruce R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1539-1547</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Microglia are the resident immune cells of the CNS.  Upon brain damage, these cells are rapidly activated and function as tissue macrophages.  The first steps in this activation still remain unclear, but it is widely believed that substances released from damaged brain tissue trigger this process.  In this article, the authors describe the effects of the blood coagulation factor thrombin on cultured rodent microglial cells.  Thrombin induced a transient Ca2+ increase in microglial cells, which persisted in Ca2+-free media.  It was blocked by thapsigargin, indicating that thrombin caused a Ca2+ release from internal stores.  Preincubation with pertussis toxin did not alter the thrombin-induced [Ca2+]i signal, whereas it was blocked by hirudin, a blocker of thrombin's proteolytic activity.  Incubation with thrombin led to the prodn. of nitric oxide and the release of the cytokines tumor necrosis factor-α, interleukin-6, interleukin-12, the chemokine KC, and the sol. tumor necrosis factor-α receptor II and had a significant proliferative effect.  Our findings indicate that thrombin, a mol. that enters the brain at sites of injury, rapidly triggered microglial activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHiYopP1DsVLVg90H21EOLACvtfcHk0lg9D4EwqMKjDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmslGlt78%253D&md5=d6675511cc6d2d34b77684b7d0ed65e8</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2000.0751539.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2000.0751539.x%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B6ller%26aufirst%3DT.%26aulast%3DHanisch%26aufirst%3DU.-K.%26aulast%3DRansom%26aufirst%3DB.%2BR.%26atitle%3DThrombin-induced%2520activation%2520of%2520cultured%2520rodent%2520microglia%26jtitle%3DJ.%2520Neurochem.%26date%3D2000%26volume%3D75%26spage%3D1539%26epage%3D1547%26doi%3D10.1046%2Fj.1471-4159.2000.0751539.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bayne, K.</span></span> <span> </span><span class="NLM_article-title">Revised Guide for the Care and Use of Laboratory Animals available. American Physiological Society</span>. <i>Physiologist</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">208</span>– <span class="NLM_lpage">211</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=208-211&author=K.+Bayne&title=Revised+Guide+for+the+Care+and+Use+of+Laboratory+Animals+available.+American+Physiological+Society"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBayne%26aufirst%3DK.%26atitle%3DRevised%2520Guide%2520for%2520the%2520Care%2520and%2520Use%2520of%2520Laboratory%2520Animals%2520available.%2520American%2520Physiological%2520Society%26jtitle%3DPhysiologist%26date%3D1996%26volume%3D39%26spage%3D208%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/medium/jm0c02249_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/large/jm0c02249_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02249&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/medium/jm0c02249_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/large/jm0c02249_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of Lu AF27139 (<b>1</b>), Lu AF27138 (<b>2</b>), and P2X7R comparator compounds JNJ-54175446 (<b>3</b>), JNJ-54166060 (<b>4</b>), JNJ analogue (<b>5</b>), A-804598 (<b>6</b>), CE224,535 (<b>7</b>), AZD9056 (<b>8</b>), GSK1482160 (<b>9</b>), AFC5128 (<b>10</b>), Actelion compound (<b>11</b>), A-740003 (<b>12</b>), A-438079 (<b>13</b>), Abbott compound (<b>14</b>), Pfizer compound (<b>15</b>), JNJ-47965567 (<b>16</b>), JNJ-42253432 (<b>17</b>), and BBG (<b>18</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/large/jm0c02249_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02249&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/medium/jm0c02249_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/large/jm0c02249_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>1</b> inhibits BzATP-induced currents in (A) HEK293 cells stably transfected with rat P2X7R and (B) rat primary microglia. Repeated administration of 300 μM BzATP demonstrates a slowly reversible effect of a single 60 s administration of 100 nM <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/large/jm0c02249_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02249&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/medium/jm0c02249_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/large/jm0c02249_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>1</b> concentration-dependently inhibits IL-1β release in rat and mouse primary cortical microglia primed with LPS and induced with 1 mM BzATP (A) rat microglia IL-1β release with an average IC<sub>50</sub> of 38 ± 19 nM (<i>n</i> = 4). The rat IC<sub>50</sub> of the example curve is 2.2 nM, and (B) mouse IL-1β release with an IC<sub>50</sub> of 26 ± 6 nM (<i>n</i> = 3). The mouse IC<sub>50</sub> for the example curve is 21.9 nM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/large/jm0c02249_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02249&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/medium/jm0c02249_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/large/jm0c02249_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Oral administration of <b>1</b> inhibits icv administered LPS-primed and icv BzATP-stimulated IL-1β production in (A) rat and (B) mouse cortex. LPS was administered at time 1 h, compound <b>1</b> at time 0, and BzATP at time 1 h. Microdialysis samples were collected every 60 min and IL-1β in the microdialysate samples analyzed using a V-PLEX assay from MesoScale Discovery (Rockville, MD), <i>n</i> = 6 or 7 per time-point. The lower limit of detection was 2 pg/mL for IL-1β. Graphical and statistical analyses performed using GraphPad Prism software (version 5.01). Area under the curve (AUC) was calculated from baseline for each animal between time 0 and 5 h. Analysis of variance (ANOVA) with Dunnett’s multiple comparison test was used to determine the significance between treatment groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/large/jm0c02249_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02249&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/medium/jm0c02249_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/large/jm0c02249_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Lu AF27139 (<b>1</b>); Reagents and Conditions: (a) (i) Morpholine, Tetrahydrofuran (THF); (ii) 2M HCl in Ether; (b) Zn, HCl, EtoH, 87% Crude Yield, Two Steps; (c) <i>N</i>-Acetyl-<span class="smallcaps smallerCapital">l</span>-leucine, MeCN/H<sub>2</sub>O (30:1), 30% Yield, 97% ee; (d) <b>20</b>, 2,4,6-Tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide (T3P), Triethanolamine (TEA), THF, Room Temperature (RT), 3 h, 62% Yield</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c02249/20210415/images/large/jm0c02249_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02249&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i38">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35541" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35541" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 45 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bartlett, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sluyter, R.</span></span> <span> </span><span class="NLM_article-title">The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">638</span>– <span class="NLM_lpage">675</span>, <span class="refDoi"> DOI: 10.1124/pr.113.008003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1124%2Fpr.113.008003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=24928329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12qtL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2014&pages=638-675&author=R.+Bartlettauthor=L.+Stokesauthor=R.+Sluyter&title=The+P2X7+receptor+channel%3A+recent+developments+and+the+use+of+P2X7+antagonists+in+models+of+disease&doi=10.1124%2Fpr.113.008003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease</span></div><div class="casAuthors">Bartlett, Rachael; Stokes, Leanne; Sluyter, Ronald</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">638-675</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The P2X7 receptor is a trimeric ATP-gated cation channel found predominantly, but not exclusively, on immune cells.  P2X7 activation results in a no. of downstream events, including the release of proinflammatory mediators and cell death and proliferation.  As such, P2X7 plays important roles in various inflammatory, immune, neurol. and musculoskeletal disorders.  This review focuses on the use of P2X7 antagonists in rodent models of neurol. disease and injury, inflammation, andmusculoskeletal and other disorders.  The cloning and characterization of human, rat, mouse, guinea pig, dog, and Rhesus macaque P2X7, as well as recent observations regarding the gating and permeability of P2X7, are discussed.  Furthermore, this review discusses polymorphic and splice variants of P2X7, as well as the generation and use of P2X7 knockout mice.  Recent evidence for emerging signaling pathways downstream of P2X7 activation and the growing list of neg. and pos. modulators of P2X7 activation and expression are also described.  In addn., the use of P2X7 antagonists in numerous rodent models of disease is extensively summarized.  Finally, theuseof P2X7 antagonists in clin. trials in humans and future directions exploring P2X7 as a therapeutic target are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsce8HhOp0XrVg90H21EOLACvtfcHk0liUFCYXvSajZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12qtL7L&md5=4452cb0593e70f15736686b9c2702ef7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1124%2Fpr.113.008003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.113.008003%26sid%3Dliteratum%253Aachs%26aulast%3DBartlett%26aufirst%3DR.%26aulast%3DStokes%26aufirst%3DL.%26aulast%3DSluyter%26aufirst%3DR.%26atitle%3DThe%2520P2X7%2520receptor%2520channel%253A%2520recent%2520developments%2520and%2520the%2520use%2520of%2520P2X7%2520antagonists%2520in%2520models%2520of%2520disease%26jtitle%3DPharmacol.%2520Rev.%26date%3D2014%26volume%3D66%26spage%3D638%26epage%3D675%26doi%3D10.1124%2Fpr.113.008003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sperlágh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vizi, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirkner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illes, P.</span></span> <span> </span><span class="NLM_article-title">P2X7 receptors in the nervous system</span>. <i>Prog. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">346</span>, <span class="refDoi"> DOI: 10.1016/j.pneurobio.2006.03.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.pneurobio.2006.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=16697102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFOhsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2006&pages=327-346&author=B.+Sperl%C3%A1ghauthor=E.+S.+Viziauthor=K.+Wirknerauthor=P.+Illes&title=P2X7+receptors+in+the+nervous+system&doi=10.1016%2Fj.pneurobio.2006.03.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">P2X7 receptors in the nervous system</span></div><div class="casAuthors">Sperlagh, Beata; Vizi, E. Sylvester; Wirkner, Kerstin; Illes, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">327-346</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  P2X7 receptors are ligand-gated ion channels, expressed as homo-oligomeric assemblies of individual subunits.  They are widely distributed at immunocompetent cells of the central and peripheral nervous system and are believed to be primarily involved in host-defense reaction.  However, a growing amt. of evidence indicates that their signaling role in the brain is more widespread than previously anticipated.  In this paper, we review the present knowledge on the structural and pharmacol. features of the P2X7 receptor, as well as its cell-type specific localization in the nervous system.  Subsequently, the participation of P2X7 receptors in distinct neuronal, astroglial and microglial functions are described.  Finally, since they may play a prominent role in certain neurol. disorders, such as ischemia-reperfusion injury, Alzheimer's disease, spinal cord injury and sensory neuropathies, the pathol. role and potential therapeutic exploitation of P2X7 receptors are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4uY7TwvgO9LVg90H21EOLACvtfcHk0liUFCYXvSajZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFOhsrc%253D&md5=c6ccc6eaffb8985e257c4a52c9443f59</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2006.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2006.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DSperl%25C3%25A1gh%26aufirst%3DB.%26aulast%3DVizi%26aufirst%3DE.%2BS.%26aulast%3DWirkner%26aufirst%3DK.%26aulast%3DIlles%26aufirst%3DP.%26atitle%3DP2X7%2520receptors%2520in%2520the%2520nervous%2520system%26jtitle%3DProg.%2520Neurobiol.%26date%3D2006%26volume%3D78%26spage%3D327%26epage%3D346%26doi%3D10.1016%2Fj.pneurobio.2006.03.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labasi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perregaux, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stam, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrushova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koller, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabel, C. A.</span></span> <span> </span><span class="NLM_article-title">Altered cytokine production in mice lacking P2X7 receptors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1074/jbc.M006781200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1074%2Fjbc.M006781200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=11016935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtFSjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=125-132&author=M.+Solleauthor=J.+Labasiauthor=D.+G.+Perregauxauthor=E.+Stamauthor=N.+Petrushovaauthor=B.+H.+Kollerauthor=R.+J.+Griffithsauthor=C.+A.+Gabel&title=Altered+cytokine+production+in+mice+lacking+P2X7+receptors&doi=10.1074%2Fjbc.M006781200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Altered cytokine production in mice lacking P2X7 receptors</span></div><div class="casAuthors">Solle, Mike; Labasi, Jeff; Perregaux, David G.; Stam, Ethan; Petrushova, Nina; Koller, Beverly H.; Griffiths, Richard J.; Gabel, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The P2X7 receptor (P2X7R) is an ATP-gated ion channel expressed by monocytes and macrophages.  To directly address the role of this receptor in interleukin (IL)-1β post-translational processing, the authors have generated a P2X7R-deficient mouse line.  P2X7R-/- macrophages respond to lipopolysaccharide and produce levels of cyclooxygenase-2 and pro-IL-1β comparable with those generated by wild-type cells.  In response to ATP, however, pro-IL-1β produced by the P2X7R-/- cells is not externalized or activated by caspase-1.  Nigericin, an alternate secretion stimulus, promotes release of 17-kDa IL-1β from P2X7R-/- macrophages.  In response to in vivo lipopolysaccharide injection, both wild-type and P2X7R-/- animals display increases in peritoneal lavage IL-6 levels but no detectable IL-1.  Subsequent ATP injection to wild-type animals promotes an increase in IL-1, which in turn leads to addnl. IL-6 prodn.; similar increases did not occur in ATP-treated, LPS-primed P2X7R-/- animals.  Absence of the P2X7R thus leads to an inability of peritoneal macrophages to release IL-1 in response to ATP.  As a result of the IL-1 deficiency, in vivo cytokine signaling cascades are impaired in P2X7R-deficient animals.  Together these results demonstrate that P2X7R activation can provide a signal that leads to maturation and release of IL-1β and initiation of a cytokine cascade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplWJDl5YjMEbVg90H21EOLACvtfcHk0lhqs2KPvzGgTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtFSjug%253D%253D&md5=cbbd35688998cce33e72e3b835d0f9c3</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M006781200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M006781200%26sid%3Dliteratum%253Aachs%26aulast%3DSolle%26aufirst%3DM.%26aulast%3DLabasi%26aufirst%3DJ.%26aulast%3DPerregaux%26aufirst%3DD.%2BG.%26aulast%3DStam%26aufirst%3DE.%26aulast%3DPetrushova%26aufirst%3DN.%26aulast%3DKoller%26aufirst%3DB.%2BH.%26aulast%3DGriffiths%26aufirst%3DR.%2BJ.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26atitle%3DAltered%2520cytokine%2520production%2520in%2520mice%2520lacking%2520P2X7%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D125%26epage%3D132%26doi%3D10.1074%2Fjbc.M006781200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burnstock, G.</span></span> <span> </span><span class="NLM_article-title">P2X ion channel receptors and inflammation</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1007/s11302-015-9493-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1007%2Fs11302-015-9493-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=26739702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC28XjslGmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=59-67&author=G.+Burnstock&title=P2X+ion+channel+receptors+and+inflammation&doi=10.1007%2Fs11302-015-9493-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">P2X ion channel receptors and inflammation</span></div><div class="casAuthors">Burnstock, Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-67</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Neuroinflammation limits tissue damage in response to pathogens or injury and promotes repair.  There are two stages of inflammation, initiation and resoln.  P2X receptors are gaining attention in relation to immunol. and inflammation.  The P2X7 receptor in particular appears to be an essential immunomodulatory receptor, although P2X1 and P2X4 receptors also appear to be involved.  ATP released from damaged or infected cells causes inflammation by release of inflammatory cytokines via P2X7 receptors and acts as a danger signal by occupying upregulated P2X receptors on immune cells to increase immune responses.  The purinergic involvement in inflammation is being explored for the development of novel therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSRKcDsxubzrVg90H21EOLACvtfcHk0lhqs2KPvzGgTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjslGmug%253D%253D&md5=c8ce49c3caa010bb73e33ec75b931abd</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs11302-015-9493-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-015-9493-0%26sid%3Dliteratum%253Aachs%26aulast%3DBurnstock%26aufirst%3DG.%26atitle%3DP2X%2520ion%2520channel%2520receptors%2520and%2520inflammation%26jtitle%3DPurinergic%2520Signalling%26date%3D2016%26volume%3D12%26spage%3D59%26epage%3D67%26doi%3D10.1007%2Fs11302-015-9493-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sperlágh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illes, P.</span></span> <span> </span><span class="NLM_article-title">P2X7 receptor: an emerging target in central nervous system diseases</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">547</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2014.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.tips.2014.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=25223574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVOhsLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=537-547&author=B.+Sperl%C3%A1ghauthor=P.+Illes&title=P2X7+receptor%3A+an+emerging+target+in+central+nervous+system+diseases&doi=10.1016%2Fj.tips.2014.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">P2X7 receptor: an emerging target in central nervous system diseases</span></div><div class="casAuthors">Sperlagh, Beata; Illes, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">537-547</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The ATP-sensitive homomeric P2X7 receptor (P2X7R) has received particular attention as a potential drug target because of its widespread involvement in inflammatory diseases as a key regulatory element of the inflammasome complex.  However, it has only recently become evident that P2X7Rs also play a pivotal role in central nervous system (CNS) pathol.  There is an explosion of data indicating that genetic deletion and pharmacol. blockade of P2X7Rs alter responsiveness in animal models of neurol. disorders, such as stroke, neurotrauma, epilepsy, neuropathic pain, multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, and Huntington's disease.  Moreover, recent studies suggest that P2X7Rs regulate the pathophysiol. of psychiatric disorders, including mood disorders, implicating P2X7Rs as drug targets in a variety of CNS pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLksNvXWN1iLVg90H21EOLACvtfcHk0ljgqIDvlgWTbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVOhsLnP&md5=b8f94c09430e82877eb6194f863924c4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2014.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2014.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DSperl%25C3%25A1gh%26aufirst%3DB.%26aulast%3DIlles%26aufirst%3DP.%26atitle%3DP2X7%2520receptor%253A%2520an%2520emerging%2520target%2520in%2520central%2520nervous%2520system%2520diseases%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2014%26volume%3D35%26spage%3D537%26epage%3D547%26doi%3D10.1016%2Fj.tips.2014.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrejew, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira-Giacomelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaser, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnaud-Sampaio, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lameu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, H.</span></span> <span> </span><span class="NLM_article-title">The P2X7 receptor: central hub of brain diseases</span>. <i>Front. Mol. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>13</i></span>, <span class="NLM_elocation-id">124</span> <span class="refDoi"> DOI: 10.3389/fnmol.2020.00124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.3389%2Ffnmol.2020.00124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=32848594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFyisL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2020&author=R.+Andrejewauthor=A.+Oliveira-Giacomelliauthor=D.+E.+Ribeiroauthor=T.+Glaserauthor=V.+F.+Arnaud-Sampaioauthor=C.+Lameuauthor=H.+Ulrich&title=The+P2X7+receptor%3A+central+hub+of+brain+diseases&doi=10.3389%2Ffnmol.2020.00124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The P2X7 receptor: central hub of brain diseases</span></div><div class="casAuthors">Andrejew, Roberta; Oliveira-Giacomelli, Agatha; Ribeiro, Deidiane Elisa; Glaser, Talita; Arnaud-Sampaio, Vanessa Fernandes; Lameu, Claudiana; Ulrich, Henning</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">124</span>CODEN:
                <span class="NLM_cas:coden">FMNRAJ</span>;
        ISSN:<span class="NLM_cas:issn">1662-5099</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The P2X7 receptor is a cation channel activated by high concns. of ATP (ATP).  Upon long-term activation, it complexes with membrane proteins forming a wide pore that leads to cell death and increased release of ATP into the extracellular milieu.  The P2X7 receptor is widely expressed in the CNS, such as frontal cortex, hippocampus, amygdala and striatum, regions involved in neurodegenerative diseases and psychiatric disorders.  Despite P2X7 receptor functions in glial cells have been extensively studied, the existence and roles of this receptor in neurons are still controversially discussed.  Regardless, P2X7 receptors mediate several processes obsd. in neuropsychiatric disorders and brain tumors, such as activation of neuroinflammatory response, stimulation of glutamate release and neuroplasticity impairment.  Moreover, P2X7 receptor gene polymorphisms have been assocd. to depression, and isoforms of P2X7 receptors are implicated in neuropsychiatric diseases.  In view of that, the P2X7 receptor has been proposed to be a potential target for therapeutic intervention in brain diseases.  This review discusses the mol. mechanisms underlying P2X7 receptor-mediated signaling in neurodegenerative diseases, psychiatric disorders, and brain tumors.  In addn., it highlights the recent advances in the development of P2X7 receptor antagonists that are able of penetrating the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk3bSo6D37f7Vg90H21EOLACvtfcHk0ljgqIDvlgWTbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFyisL7E&md5=565648d0ecb4e7adefb366ad24affd77</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2020.00124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2020.00124%26sid%3Dliteratum%253Aachs%26aulast%3DAndrejew%26aufirst%3DR.%26aulast%3DOliveira-Giacomelli%26aufirst%3DA.%26aulast%3DRibeiro%26aufirst%3DD.%2BE.%26aulast%3DGlaser%26aufirst%3DT.%26aulast%3DArnaud-Sampaio%26aufirst%3DV.%2BF.%26aulast%3DLameu%26aufirst%3DC.%26aulast%3DUlrich%26aufirst%3DH.%26atitle%3DThe%2520P2X7%2520receptor%253A%2520central%2520hub%2520of%2520brain%2520diseases%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2020%26volume%3D13%26doi%3D10.3389%2Ffnmol.2020.00124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span> <span> </span><span class="NLM_article-title">Recent advances in CNS P2x7 physiology and pharmacology: focus on neuropsychiatric disorders</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">30</span> <span class="refDoi"> DOI: 10.3389/fphar.2018.00030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.3389%2Ffphar.2018.00030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=29449810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Skt7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&author=A.+Bhattacharya&title=Recent+advances+in+CNS+P2x7+physiology+and+pharmacology%3A+focus+on+neuropsychiatric+disorders&doi=10.3389%2Ffphar.2018.00030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in CNS P2x7 physiology and pharmacology: focus on neuropsychiatric disorders</span></div><div class="casAuthors">Bhattacharya, Anindya</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">30/1-30/7</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  The ATP-gated P2X7 ion channel is an abundant microglial protein in the CNS that plays an important pathol. role in executing ATP-driven danger signal transduction.  Emerging data has generated scientific interest and excitement around targeting the P2X7 ion channel as a potential drug target for CNS disorders.  Over the past years, a wealth of data has been published on CNS P2X7 biol., in particular the role of P2X7 in microglial cells, and in vivo effects of brain-penetrant P2X7 antagonists.  Likewise, significant progress has been made around the medicinal chem. of CNS P2X7 ligands, as antagonists for I target validation in models of CNS diseases, to identification of two clin. compds. (JNJ-54175446 and JNJ-55308942) and finally, discovery of P2X7 PET ligands.  This review is an attempt to bring together the current understanding of P2X7 in the CNS with a focus on P2X7 as a drug target in neuropsychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDXBpgvW1cqbVg90H21EOLACvtfcHk0lhKAhD93LEv0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Skt7vF&md5=303be8cadeaf840559a0192f673cff0b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2018.00030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2018.00030%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DA.%26atitle%3DRecent%2520advances%2520in%2520CNS%2520P2x7%2520physiology%2520and%2520pharmacology%253A%2520focus%2520on%2520neuropsychiatric%2520disorders%26jtitle%3DFront.%2520Pharmacol.%26date%3D2018%26volume%3D9%26doi%3D10.3389%2Ffphar.2018.00030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calzaferri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Ruiz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Diego, A. M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de
Pascual, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendez-Lopez, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cano-Abad, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maneu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de los Rios, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, A. G.</span></span> <span> </span><span class="NLM_article-title">The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">2427</span>– <span class="NLM_lpage">2465</span>, <span class="refDoi"> DOI: 10.1002/med.21710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1002%2Fmed.21710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=32677086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVKlurbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2020&pages=2427-2465&author=F.+Calzaferriauthor=C.+Ruiz-Ruizauthor=A.+M.+G.+de+Diegoauthor=R.+de%0APascualauthor=I.+Mendez-Lopezauthor=M.+F.+Cano-Abadauthor=V.+Maneuauthor=C.+de+los+Riosauthor=L.+Gandiaauthor=A.+G.+Garcia&title=The+purinergic+P2X7+receptor+as+a+potential+drug+target+to+combat+neuroinflammation+in+neurodegenerative+diseases&doi=10.1002%2Fmed.21710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases</span></div><div class="casAuthors">Calzaferri, Francesco; Ruiz-Ruiz, Cristina; de Diego, Antonio M. G.; de Pascual, Ricardo; Mendez-Lopez, Iago; Cano-Abad, Maria F.; Maneu, Victoria; de los Rios, Cristobal; Gandia, Luis; Garcia, Antonio G.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2427-2465</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review of the purinergic P2X7 receptors (P2X7Rs)are gatekeepers of inflammation, they could be developed as drug targets for NDDs.  Herein, we review this challenging hypothesis and comment on the numerous studies that have investigated P2X7Rs, emphasizing their mol. structure and functions, as well as their role in inflammation.  Then, we elaborate on research undertaken in the field of medicinal chem. to det. potential P2X7R antagonists.  Subsequently, we review the state of neuroinflammation and P2X7R expression in the brain, in animal models and patients suffering from AD, Parkinson's disease, amyotrophic lateral sclerosis, Huntington disease, multiple sclerosis, and retinal degeneration.  Next, we summarize the in vivo studies testing the hypothesis that by mitigating neuroinflammation, P2X7R blockers afford neuroprotection, increasing neuroplasticity and neuronal repair in animal models of NDDs.  Finally, we reviewed previous and ongoing CTs investigating compds. directed toward targets assocd. with NDDs; we propose that CTs with P2X7R antagonists should be initiated.  Despite the high expectations for putative P2X7Rs antagonists in various central nervous system diseases, the field is moving forward at a relatively slow pace, presumably due to the complexity of P2X7Rs.  A better pharmacol. approach to combat NDDs would be a dual strategy, combining P2X7R antagonism with drugs targeting a selective pathway in a given NDD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6K9cEDPmFNLVg90H21EOLACvtfcHk0lj2M1dfibhZfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVKlurbM&md5=61c929af816b30378efcdb9a89e8b56a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fmed.21710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21710%26sid%3Dliteratum%253Aachs%26aulast%3DCalzaferri%26aufirst%3DF.%26aulast%3DRuiz-Ruiz%26aufirst%3DC.%26aulast%3Dde%2BDiego%26aufirst%3DA.%2BM.%2BG.%26aulast%3Dde%2BPascual%26aufirst%3DR.%26aulast%3DMendez-Lopez%26aufirst%3DI.%26aulast%3DCano-Abad%26aufirst%3DM.%2BF.%26aulast%3DManeu%26aufirst%3DV.%26aulast%3Dde%2Blos%2BRios%26aufirst%3DC.%26aulast%3DGandia%26aufirst%3DL.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26atitle%3DThe%2520purinergic%2520P2X7%2520receptor%2520as%2520a%2520potential%2520drug%2520target%2520to%2520combat%2520neuroinflammation%2520in%2520neurodegenerative%2520diseases%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2020%26volume%3D40%26spage%3D2427%26epage%3D2465%26doi%3D10.1002%2Fmed.21710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chessell, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatcher, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bountra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michel, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egerton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murfin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peck, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grahames, C. B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casula, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yiangou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anand, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buell, G. N.</span></span> <span> </span><span class="NLM_article-title">Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">386</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2005.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.pain.2005.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=15777864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitlCiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2005&pages=386-396&author=I.+P.+Chessellauthor=J.+P.+Hatcherauthor=C.+Bountraauthor=A.+D.+Michelauthor=J.+P.+Hughesauthor=P.+Greenauthor=J.+Egertonauthor=M.+Murfinauthor=J.+Richardsonauthor=W.+L.+Peckauthor=C.+B.+A.+Grahamesauthor=M.+A.+Casulaauthor=Y.+Yiangouauthor=R.+Birchauthor=P.+Anandauthor=G.+N.+Buell&title=Disruption+of+the+P2X7+purinoceptor+gene+abolishes+chronic+inflammatory+and+neuropathic+pain&doi=10.1016%2Fj.pain.2005.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain</span></div><div class="casAuthors">Chessell, Iain P.; Hatcher, Jonathan P.; Bountra, Chas; Michel, Anton D.; Hughes, Jane P.; Green, Paula; Egerton, Julie; Murfin, Melanie; Richardson, Jill; Peck, Wendy L.; Grahames, Caroline B. A.; Casula, Maria Anna; Yiangou, Yiangos; Birch, Rolfe; Anand, Praveen; Buell, Gary N.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">386-396</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The P2X7 purinoceptor is a ligand-gated cation channel, expressed predominantly by cells of immune origin, with a unique phenotype which includes release of biol. active inflammatory cytokine, interleukin (IL)-1β following activation, and unique ion channel biophysics obsd. only in this receptor family.  In mice lacking this receptor, inflammatory (in an adjuvant-induced model) and neuropathic (in a partial nerve ligation model) hypersensitivity is completely absent to both mech. and thermal stimuli, while normal nociceptive processing is preserved.  The knockout animals were unimpaired in their ability to produce mRNA for pro-IL-1β, and cytometric anal. of paw and systemic cytokines from knockout and wild-type animals following adjuvant insult suggests a selective effect of the gene deletion on release of IL-1β and IL-10, with systemic redns. in adjuvant-induced increases in IL-6 and MCP-1.  In addn., the authors show that this receptor is upregulated in human dorsal root ganglia and injured nerves obtained from chronic neuropathic pain patients.  The authors hypothesize that the P2X7 receptor, via regulation of mature IL-1β prodn., plays a common upstream transductional role in the development of pain of neuropathic and inflammatory origin.  Drugs which block this target may have the potential to deliver broad-spectrum analgesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-BHrUu6ak17Vg90H21EOLACvtfcHk0lj2M1dfibhZfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitlCiu78%253D&md5=883f5bdb9b8950fa97d5a69a7325b026</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2005.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2005.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DChessell%26aufirst%3DI.%2BP.%26aulast%3DHatcher%26aufirst%3DJ.%2BP.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DMichel%26aufirst%3DA.%2BD.%26aulast%3DHughes%26aufirst%3DJ.%2BP.%26aulast%3DGreen%26aufirst%3DP.%26aulast%3DEgerton%26aufirst%3DJ.%26aulast%3DMurfin%26aufirst%3DM.%26aulast%3DRichardson%26aufirst%3DJ.%26aulast%3DPeck%26aufirst%3DW.%2BL.%26aulast%3DGrahames%26aufirst%3DC.%2BB.%2BA.%26aulast%3DCasula%26aufirst%3DM.%2BA.%26aulast%3DYiangou%26aufirst%3DY.%26aulast%3DBirch%26aufirst%3DR.%26aulast%3DAnand%26aufirst%3DP.%26aulast%3DBuell%26aufirst%3DG.%2BN.%26atitle%3DDisruption%2520of%2520the%2520P2X7%2520purinoceptor%2520gene%2520abolishes%2520chronic%2520inflammatory%2520and%2520neuropathic%2520pain%26jtitle%3DPain%26date%3D2005%26volume%3D114%26spage%3D386%26epage%3D396%26doi%3D10.1016%2Fj.pain.2005.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derecki, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovenberg, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drevets, W. C.</span></span> <span> </span><span class="NLM_article-title">Role of neuro-immunological factors in the pathophysiology of mood disorders</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>233</i></span>,  <span class="NLM_fpage">1623</span>– <span class="NLM_lpage">1636</span>, <span class="refDoi"> DOI: 10.1007/s00213-016-4214-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1007%2Fs00213-016-4214-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=26803500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=2016&pages=1623-1636&author=A.+Bhattacharyaauthor=N.+C.+Dereckiauthor=T.+W.+Lovenbergauthor=W.+C.+Drevets&title=Role+of+neuro-immunological+factors+in+the+pathophysiology+of+mood+disorders&doi=10.1007%2Fs00213-016-4214-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Role of neuro-immunological factors in the pathophysiology of mood disorders</span></div><div class="casAuthors">Bhattacharya, Anindya; Derecki, Noel C.; Lovenberg, Timothy W.; Drevets, Wayne C.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">233</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1623-1636</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Mood disorders, despite the widespread availability of monoamine-based antidepressant treatments, are assocd. with persistently high rates of disability, together with elevated rates of mortality due to suicide, cardiovascular disease, and other causes.  The development of more effective treatments has been hindered by the lack of knowledge about the etiol. and pathogenesis of mood disorders.  An emerging area of science that promises novel pathways to antidepressant and mood stabilizing therapies surrounds evidence that immune cells and their signaling play a major role in the pathophysiol. of major depressive disorder (MDD) and bipolar disorder (BD).  Here, we review evidence that the release of neuroactive cytokines, particularly interleukins such as IL-1β, IL-6, and TNF-α, is altered in these disorders and discuss mechanisms such as the ATP-gated ion channel P2X7, through which cytokine signaling can influence neuro-glial interactions.  Brain P2X7, an emerging target and antagonism of P2X7 holds promise as a novel mechanism for targeting treatment-resistant depression.  We further discuss the role of microglia and astroglia in central neuroinflammation and their interaction with the peripheral immune system.  We present extant clin. evidence that bolsters the role of neuroinflammation and neuroactive cytokines in mood disorders.  To that end, the role of clin. imaging by probing neuroinflammatory markers is also discussed briefly.  Finally, we present data using preclin. neuroinflammation models that produce depression-like behaviors in exptl. animals to identify neuroinflammatory mechanisms which may aid in novel neuroimmune target identification for the development of exciting pharmacol. interventions in mood disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3LHj0rffjabVg90H21EOLACvtfcHk0ljrlcv82awD5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKgs7c%253D&md5=94cfc55223e0c7c21dad372c00e502cb</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs00213-016-4214-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-016-4214-0%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DDerecki%26aufirst%3DN.%2BC.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DDrevets%26aufirst%3DW.%2BC.%26atitle%3DRole%2520of%2520neuro-immunological%2520factors%2520in%2520the%2520pathophysiology%2520of%2520mood%2520disorders%26jtitle%3DPsychopharmacology%26date%3D2016%26volume%3D233%26spage%3D1623%26epage%3D1636%26doi%3D10.1007%2Fs00213-016-4214-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grigoleit, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aluisio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O′Connor, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrovian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carruthers, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovenberg, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span> <span> </span><span class="NLM_article-title">Neuropsychopharmacology of JNJ-55308942: evaluation of a clinical candidate targeting P2X7 ion channels in animal models of neuroinflammation and anhedonia</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2586</span>– <span class="NLM_lpage">2596</span>, <span class="refDoi"> DOI: 10.1038/s41386-018-0141-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1038%2Fs41386-018-0141-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=30026598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlyrsLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2018&pages=2586-2596&author=A.+Bhattacharyaauthor=B.+Lordauthor=J.-S.+Grigoleitauthor=Y.+Heauthor=I.+Fraserauthor=S.+N.+Campbellauthor=N.+Taylorauthor=L.+Aluisioauthor=J.+C.+O%E2%80%B2Connorauthor=M.+Pappauthor=C.+Chrovianauthor=N.+Carruthersauthor=T.+W.+Lovenbergauthor=M.+A.+Letavic&title=Neuropsychopharmacology+of+JNJ-55308942%3A+evaluation+of+a+clinical+candidate+targeting+P2X7+ion+channels+in+animal+models+of+neuroinflammation+and+anhedonia&doi=10.1038%2Fs41386-018-0141-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropsychopharmacology of JNJ-55308942: evaluation of a clinical candidate targeting P2X7 ion channels in animal models of neuroinflammation and anhedonia</span></div><div class="casAuthors">Bhattacharya, Anindya; Lord, Brian; Grigoleit, Jan-Sebastian; He, Yingbo; Fraser, Ian; Campbell, Shannon N.; Taylor, Natalie; Aluisio, Leah; O'Connor, Jason C.; Papp, Mariusz; Chrovian, Christa; Carruthers, Nicholas; Lovenberg, Timothy W.; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2586-2596</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">This study describes the in-vitro and in-vivo neuropharmacol. of a novel brain-penetrant P2X7 antagonist, JNJ-55308942, currently in clin. development.  In human blood and in mouse blood and microglia, JNJ-55308942 attenuated IL-1β release in a potent and concn.-dependent manner.  After oral dosing, the compd. exhibited both dose and concn.-dependent occupancy of rat brain P2X7 with an ED50 of 0.07 mg/kg.  The P2X7 antagonist (3 mg/kg, oral) blocked Bz-ATP-induced brain IL-1β release in conscious rats, demonstrating functional effects of target engagement in the brain.  JNJ-55308942 (30 mg/kg, oral) attenuated LPS-induced microglial activation in mice, assessed at day 2 after a single systemic LPS injection (0.8 mg/kg, i.p.), suggesting a role for P2X7 in microglial activation.  In a model of BCG-induced depression, JNJ-55308942 dosed orally, reversed the BCG-induced deficits of sucrose preference and social interaction, indicating for the first time a role of P2X7 in the BCG model of depression, probably due to the neuroinflammatory component induced by BCG inoculation.  Finally, in a rat model of chronic stress induced sucrose intake deficit, JNJ-55308942 reversed the deficit with concurrent high P2X7 brain occupancy as measured by autoradiog.  This body of data demonstrates that JNJ-55308942 is a potent P2X7 antagonist, engages the target in brain, modulates IL-1β release and microglial activation leading to efficacy in two models of anhedonia in rodents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGZTSe0OICSLVg90H21EOLACvtfcHk0ljEW4y2mGyKRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlyrsLrM&md5=55178bf0da9e58ef818367d78f1d6b50</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fs41386-018-0141-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41386-018-0141-6%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DGrigoleit%26aufirst%3DJ.-S.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DFraser%26aufirst%3DI.%26aulast%3DCampbell%26aufirst%3DS.%2BN.%26aulast%3DTaylor%26aufirst%3DN.%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DO%25E2%2580%25B2Connor%26aufirst%3DJ.%2BC.%26aulast%3DPapp%26aufirst%3DM.%26aulast%3DChrovian%26aufirst%3DC.%26aulast%3DCarruthers%26aufirst%3DN.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DNeuropsychopharmacology%2520of%2520JNJ-55308942%253A%2520evaluation%2520of%2520a%2520clinical%2520candidate%2520targeting%2520P2X7%2520ion%2520channels%2520in%2520animal%2520models%2520of%2520neuroinflammation%2520and%2520anhedonia%26jtitle%3DNeuropsychopharmacology%26date%3D2018%26volume%3D43%26spage%3D2586%26epage%3D2596%26doi%3D10.1038%2Fs41386-018-0141-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chrovian, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rech, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span> <span> </span><span class="NLM_article-title">P2X7 antagonists as potential therapeutic agents for the treatment of CNS disorders</span>. <i>Prog. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1016/B978-0-444-63380-4.00002-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2FB978-0-444-63380-4.00002-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=24418608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVWnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=65-100&author=C.+C.+Chrovianauthor=J.+C.+Rechauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=P2X7+antagonists+as+potential+therapeutic+agents+for+the+treatment+of+CNS+disorders&doi=10.1016%2FB978-0-444-63380-4.00002-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">P2X7 antagonists as potential therapeutic agents for the treatment of CNS disorders</span></div><div class="casAuthors">Chrovian, Christa C.; Rech, Jason C.; Bhattacharya, Anindya; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">65-100</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  This paper discusses the P2X7 antagonists as potential therapeutic agents for treatment of CNS disorders.  No. of recent patent applications and medicinal chem. pub-applications have described novel compds. and their activity as P2X7 antagonists; many of these reports highlight the compds.' efficacy in pre-clin. in vivo models of pain, inflammation and arthritis were discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqALhHJWaw5D7Vg90H21EOLACvtfcHk0ljEW4y2mGyKRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVWnt7k%253D&md5=1fe5fd0796848db27e67aee05602f3e6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FB978-0-444-63380-4.00002-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-444-63380-4.00002-0%26sid%3Dliteratum%253Aachs%26aulast%3DChrovian%26aufirst%3DC.%2BC.%26aulast%3DRech%26aufirst%3DJ.%2BC.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DP2X7%2520antagonists%2520as%2520potential%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520CNS%2520disorders%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D53%26spage%3D65%26epage%3D100%26doi%3D10.1016%2FB978-0-444-63380-4.00002-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savall, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoetens, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koudriakova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaptason, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rech, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Angelis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepassi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovenberg, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carruthers, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span> <span> </span><span class="NLM_article-title">Identification of (R)-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-dihydro-1H-imidazo[4,5-c]pyridin-5(4H)-yl)methanone (JNJ 54166060), a Small Molecule Antagonist of the P2X7 receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8535</span>– <span class="NLM_lpage">8548</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00989</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00989" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlyqsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8535-8548&author=D.+M.+Swansonauthor=B.+M.+Savallauthor=K.+J.+Coeauthor=F.+Schoetensauthor=T.+Koudriakovaauthor=J.+Skaptasonauthor=J.+Wallauthor=J.+Rechauthor=X.+Dengauthor=M.+De+Angelisauthor=A.+Eversonauthor=B.+Lordauthor=Q.+Wangauthor=H.+Aoauthor=B.+Scottauthor=K.+Sepassiauthor=T.+W.+Lovenbergauthor=N.+I.+Carruthersauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=Identification+of+%28R%29-%282-Chloro-3-%28trifluoromethyl%29phenyl%29%281-%285-fluoropyridin-2-yl%29-4-methyl-6%2C7-dihydro-1H-imidazo%5B4%2C5-c%5Dpyridin-5%284H%29-yl%29methanone+%28JNJ+54166060%29%2C+a+Small+Molecule+Antagonist+of+the+P2X7+receptor&doi=10.1021%2Facs.jmedchem.6b00989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of (R)-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-dihydro-1H-imidazo[4,5-c]pyridin-5(4H)-yl)methanone (JNJ 54166060), a Small Molecule Antagonist of the P2X7 receptor</span></div><div class="casAuthors">Swanson, Devin M.; Savall, Brad M.; Coe, Kevin J.; Schoetens, Freddy; Koudriakova, Tatiana; Skaptason, Judith; Wall, Jessica; Rech, Jason; Deng, Xiahou; De Angelis, Meri; Everson, Anita; Lord, Brian; Wang, Qi; Ao, Hong; Scott, Brian; Sepassi, Kia; Lovenberg, Timothy W.; Carruthers, Nicholas I.; Bhattacharya, Anindya; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8535-8548</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and SAR of a series of 4,5,6,7-tetrahydro-imidazo[4,5-c]pyridine P2X7 antagonists are described.  Addressing P2X7 affinity and liver microsomal stability issues encountered with this template afforded Me substituted 4,5,6,7-tetrahydro-imidazo[4,5-c]pyridines ultimately leading to the identification of JNJ 54166060.  JNJ 54166060 is a potent P2X7 antagonist with an ED50=2.3 mg/kg in rat, high oral bioavailability and low-moderate clearance in pre-clin. species, acceptable safety margins in rat, and a predicted human dose of 120 mg QD.  Addnl., JNJ 54166060 possesses a unique CYP profile and was found to be a regioselective inhibitor of midazolam CYP3A metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQfT4dUZEP6bVg90H21EOLACvtfcHk0lg_sWsgQ1b5lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlyqsr%252FO&md5=a48451477fca4bec1fd13df7d5a22ea8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00989%26sid%3Dliteratum%253Aachs%26aulast%3DSwanson%26aufirst%3DD.%2BM.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DCoe%26aufirst%3DK.%2BJ.%26aulast%3DSchoetens%26aufirst%3DF.%26aulast%3DKoudriakova%26aufirst%3DT.%26aulast%3DSkaptason%26aufirst%3DJ.%26aulast%3DWall%26aufirst%3DJ.%26aulast%3DRech%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DEverson%26aufirst%3DA.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DScott%26aufirst%3DB.%26aulast%3DSepassi%26aufirst%3DK.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DIdentification%2520of%2520%2528R%2529-%25282-Chloro-3-%2528trifluoromethyl%2529phenyl%2529%25281-%25285-fluoropyridin-2-yl%2529-4-methyl-6%252C7-dihydro-1H-imidazo%255B4%252C5-c%255Dpyridin-5%25284H%2529-yl%2529methanone%2520%2528JNJ%252054166060%2529%252C%2520a%2520Small%2520Molecule%2520Antagonist%2520of%2520the%2520P2X7%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8535%26epage%3D8548%26doi%3D10.1021%2Facs.jmedchem.6b00989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span>; <span class="NLM_string-name">Yuan, J.</span>; <span class="NLM_string-name">Bakthavatchalam, R.</span>; <span class="NLM_string-name">Hodgetts, K. J.</span>; <span class="NLM_string-name">Capitosti, S. M.</span>; <span class="NLM_string-name">Mao, J.</span>; <span class="NLM_string-name">Wustrow, D. J.</span>; <span class="NLM_string-name">Guo, Q.</span></span> <span> </span><span class="NLM_article-title">Preparation of 5-membered Heterocyclic Amides and Related Compounds as Specific Receptor Activity Modulators</span>. WO Patent <span class="NLM_patent">WO2009012482</span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=H.+Li&author=J.+Yuan&author=R.+Bakthavatchalam&author=K.+J.+Hodgetts&author=S.+M.+Capitosti&author=J.+Mao&author=D.+J.+Wustrow&author=Q.+Guo&title=Preparation+of+5-membered+Heterocyclic+Amides+and+Related+Compounds+as+Specific+Receptor+Activity+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26atitle%3DPreparation%2520of%25205-membered%2520Heterocyclic%2520Amides%2520and%2520Related%2520Compounds%2520as%2520Specific%2520Receptor%2520Activity%2520Modulators%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kilburn, J. P.</span>; <span class="NLM_string-name">Hopper, A. T.</span>; <span class="NLM_string-name">Juhl, M.</span></span> <span> </span><span class="NLM_article-title">Enantiomeric Synthesis of (S)-N-[2-(4-Chlorophenyl)-2-morpholinoethyl]-2-(pyrimidin-2-yl)-4-(trifluoromethyl)thiazole-5-carboxamide as a Potent P2X7 Purinergic Receptor Inhibitor</span>. WO Patent <span class="NLM_patent">WO2017076825</span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+P.+Kilburn&author=A.+T.+Hopper&author=M.+Juhl&title=Enantiomeric+Synthesis+of+%28S%29-N-%5B2-%284-Chlorophenyl%29-2-morpholinoethyl%5D-2-%28pyrimidin-2-yl%29-4-%28trifluoromethyl%29thiazole-5-carboxamide+as+a+Potent+P2X7+Purinergic+Receptor+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKilburn%26aufirst%3DJ.%2BP.%26atitle%3DEnantiomeric%2520Synthesis%2520of%2520%2528S%2529-N-%255B2-%25284-Chlorophenyl%2529-2-morpholinoethyl%255D-2-%2528pyrimidin-2-yl%2529-4-%2528trifluoromethyl%2529thiazole-5-carboxamide%2520as%2520a%2520Potent%2520P2X7%2520Purinergic%2520Receptor%2520Inhibitor%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rech, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savall, B. M.</span></span> <span> </span><span class="NLM_article-title">The evolution of P2X7 antagonists with a focus on CNS indications</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3838</span>– <span class="NLM_lpage">3845</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.06.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.bmcl.2016.06.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=27426304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOitL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3838-3845&author=J.+C.+Rechauthor=A.+Bhattacharyaauthor=M.+A.+Letavicauthor=B.+M.+Savall&title=The+evolution+of+P2X7+antagonists+with+a+focus+on+CNS+indications&doi=10.1016%2Fj.bmcl.2016.06.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of P2X7 antagonists with a focus on CNS indications</span></div><div class="casAuthors">Rech, Jason C.; Bhattacharya, Anindya; Letavic, Michael A.; Savall, Brad M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3838-3845</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The P2X7 receptor is an ATP-gated nonselective cation channel that has been linked to a no. of inflammatory diseases.  Activation of the P2X7 receptor by elevated levels of ATP results in the release of proinflammatory cytokines and elevated levels of these cytokines has been assocd. with a variety of disease states.  A no. of research groups in both industry and academia have explored the identification of P2X7R antagonists as therapeutic agents.  Much of this early effort focused on the treatment of diseases related to peripheral inflammation and resulted in several clin. candidates, none of which were advanced to market.  The emerging role of the P2X7 receptor in neuroinflammation and related diseases has resulted in a shift in medicinal chem. efforts toward the development of centrally penetrant antagonists.  This review will highlight the biol. supporting the role of P2X7 in diseases related to neuroinflammation and review the recent medicinal chem. efforts to identify centrally penetrant antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdaLGUAKgul7Vg90H21EOLACvtfcHk0lh2st1mHwiczA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOitL3L&md5=04046ec16457c856c96dd50632b96efe</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.06.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.06.048%26sid%3Dliteratum%253Aachs%26aulast%3DRech%26aufirst%3DJ.%2BC.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26atitle%3DThe%2520evolution%2520of%2520P2X7%2520antagonists%2520with%2520a%2520focus%2520on%2520CNS%2520indications%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3838%26epage%3D3845%26doi%3D10.1016%2Fj.bmcl.2016.06.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savall, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aluisio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andres, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Angelis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonaventure, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carruthers, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceusters, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvorak, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelin, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koudriakova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovenberg, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otieno, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoetens, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickenden, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span> <span> </span><span class="NLM_article-title">4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical Candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4559</span>– <span class="NLM_lpage">4572</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00408</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00408" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1Wms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4559-4572&author=M.+A.+Letavicauthor=B.+M.+Savallauthor=B.+D.+Allisonauthor=L.+Aluisioauthor=J.+I.+Andresauthor=M.+De+Angelisauthor=H.+Aoauthor=D.+A.+Beauchampauthor=P.+Bonaventureauthor=S.+Bryantauthor=N.+I.+Carruthersauthor=M.+Ceustersauthor=K.+J.+Coeauthor=C.+A.+Dvorakauthor=I.+C.+Fraserauthor=C.+F.+Gelinauthor=T.+Koudriakovaauthor=J.+Liangauthor=B.+Lordauthor=T.+W.+Lovenbergauthor=M.+A.+Otienoauthor=F.+Schoetensauthor=D.+M.+Swansonauthor=Q.+Wangauthor=A.+D.+Wickendenauthor=A.+Bhattacharya&title=4-Methyl-6%2C7-dihydro-4H-triazolo%5B4%2C5-c%5Dpyridine-Based+P2X7+Receptor+Antagonists%3A+Optimization+of+Pharmacokinetic+Properties+Leading+to+the+Identification+of+a+Clinical+Candidate&doi=10.1021%2Facs.jmedchem.7b00408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical Candidate</span></div><div class="casAuthors">Letavic, Michael A.; Savall, Brad M.; Allison, Brett D.; Aluisio, Leah; Andres, Jose Ignacio; De Angelis, Meri; Ao, Hong; Beauchamp, Derek A.; Bonaventure, Pascal; Bryant, Stewart; Carruthers, Nicholas I.; Ceusters, Marc; Coe, Kevin J.; Dvorak, Curt A.; Fraser, Ian C.; Gelin, Christine F.; Koudriakova, Tatiana; Liang, Jimmy; Lord, Brian; Lovenberg, Timothy W.; Otieno, Monicah A.; Schoetens, Freddy; Swanson, Devin M.; Wang, Qi; Wickenden, Alan D.; Bhattacharya, Anindya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4559-4572</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and preclin. characterization of novel 4-(R)-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridines that are potent and selective brain penetrant P2X7 antagonists are described.  Optimization efforts based on previously disclosed unsubstituted 6,7-dihydro-4H-triazolo[4,5-c]pyridines, Me substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrazines, and several other series lead to the identification of a series of 4-(R)-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridines that are selective P2X7 antagonists with potency at the rodent and human P2X7 ion channels.  These novel P2X7 antagonists have suitable physicochem. properties, and several analogs have an excellent pharmacokinetic profile, good partitioning into the CNS and show robust in vivo target engagement after oral dosing.  Improvements in metabolic stability led to the identification of JNJ-54175446 (I) as a candidate for clin. development.  The drug discovery efforts and strategies that resulted in the identification of the clin. candidate are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkx8e5Sq5aYbVg90H21EOLACvtfcHk0ljfq5b2rrUoxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1Wms7Y%253D&md5=5b5465d8f64d527da6647997efe34aee</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00408%26sid%3Dliteratum%253Aachs%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DAllison%26aufirst%3DB.%2BD.%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DBeauchamp%26aufirst%3DD.%2BA.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DBryant%26aufirst%3DS.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DCeusters%26aufirst%3DM.%26aulast%3DCoe%26aufirst%3DK.%2BJ.%26aulast%3DDvorak%26aufirst%3DC.%2BA.%26aulast%3DFraser%26aufirst%3DI.%2BC.%26aulast%3DGelin%26aufirst%3DC.%2BF.%26aulast%3DKoudriakova%26aufirst%3DT.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DOtieno%26aufirst%3DM.%2BA.%26aulast%3DSchoetens%26aufirst%3DF.%26aulast%3DSwanson%26aufirst%3DD.%2BM.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWickenden%26aufirst%3DA.%2BD.%26aulast%3DBhattacharya%26aufirst%3DA.%26atitle%3D4-Methyl-6%252C7-dihydro-4H-triazolo%255B4%252C5-c%255Dpyridine-Based%2520P2X7%2520Receptor%2520Antagonists%253A%2520Optimization%2520of%2520Pharmacokinetic%2520Properties%2520Leading%2520to%2520the%2520Identification%2520of%2520a%2520Clinical%2520Candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4559%26epage%3D4572%26doi%3D10.1021%2Facs.jmedchem.7b00408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ameriks, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carruthers, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravula, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rech, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savall, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span> <span> </span><span class="NLM_article-title">Preclinical characterization of substituted 6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one P2X7 receptor antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.12.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.bmcl.2015.12.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=26707399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVKrtbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=257-261&author=M.+K.+Ameriksauthor=H.+Aoauthor=N.+I.+Carruthersauthor=B.+Lordauthor=S.+Ravulaauthor=J.+C.+Rechauthor=B.+M.+Savallauthor=J.+L.+Wallauthor=Q.+Wangauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=Preclinical+characterization+of+substituted+6%2C7-dihydro-%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazin-8%285H%29-one+P2X7+receptor+antagonists&doi=10.1016%2Fj.bmcl.2015.12.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical characterization of substituted 6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one P2X7 receptor antagonists</span></div><div class="casAuthors">Ameriks, Michael K.; Ao, Hong; Carruthers, Nicholas I.; Lord, Brian; Ravula, Suchitra; Rech, Jason C.; Savall, Brad M.; Wall, Jessica L.; Wang, Qi; Bhattacharya, Anindya; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">257-261</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis, SAR, and preclin. characterization of a series of substituted 6,7-dihydro[1,2,4]triazolo[4,3]pyrazin-8(5H)-one P2X7 receptor antagonists are described.  Optimized leads from this series comprise some of the most potent human P2X7R antagonists reported to date (IC50s < 1 nM).  They also exhibit sufficient potency and oral bioavailability in rat to enable extensive in vivo profiling.  Although many of the disclosed compds. are peripherally restricted, compd. I is brain penetrant and upon oral administration demonstrated dose-dependent target engagement in rat hippocampus as detd. by ex vivo receptor occupancy with radiotracer II (ED50 = 0.8 mg/kg).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre9WCgWhiM_rVg90H21EOLACvtfcHk0liYWEbrj6eIoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVKrtbjL&md5=d1a36bd7f088f4533308ad49fee7fa5b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.12.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.12.052%26sid%3Dliteratum%253Aachs%26aulast%3DAmeriks%26aufirst%3DM.%2BK.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DRavula%26aufirst%3DS.%26aulast%3DRech%26aufirst%3DJ.%2BC.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DWall%26aufirst%3DJ.%2BL.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DPreclinical%2520characterization%2520of%2520substituted%25206%252C7-dihydro-%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazin-8%25285H%2529-one%2520P2X7%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D257%26epage%3D261%26doi%3D10.1016%2Fj.bmcl.2015.12.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly-Roberts, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namovic, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surber, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaidyanathan, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Medrano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarvis, M. F.</span></span> <span> </span><span class="NLM_article-title">[3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2008.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.neuropharm.2008.06.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=18602931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2008&pages=223-229&author=D.+L.+Donnelly-Robertsauthor=M.+T.+Namovicauthor=B.+Surberauthor=S.+X.+Vaidyanathanauthor=A.+Perez-Medranoauthor=Y.+Wangauthor=W.+A.+Carrollauthor=M.+F.+Jarvis&title=%5B3H%5DA-804598+%28%5B3H%5D2-cyano-1-%5B%281S%29-1-phenylethyl%5D-3-quinolin-5-ylguanidine%29+is+a+novel%2C+potent%2C+and+selective+antagonist+radioligand+for+P2X7+receptors&doi=10.1016%2Fj.neuropharm.2008.06.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors</span></div><div class="casAuthors">Donnelly-Roberts, Diana L.; Namovic, Marian T.; Surber, Bruce; Vaidyanathan, Srirajan X.; Perez-Medrano, Arturo; Wang, Ying; Carroll, William A.; Jarvis, Michael F.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">223-229</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">ATP-sensitive P2X7 receptors are localized on cells of immunol. origin including peripheral macrophages and glial cells in the CNS.  Activation of P2X7 receptors leads to rapid changes in intracellular calcium concns., release of the pro-inflammatory cytokine IL-1β, and following prolonged agonist exposure, the formation of cytolytic pores in plasma membranes.  Data from gene knockout studies and recently described selective antagonists indicate a role for P2X7 receptor activation in inflammation and pain.  While several species selective P2X7 antagonists exist, A-804598 represents a structurally novel, competitive, and selective antagonist that has equiv. high affinity at rat (IC50 = 10 nM), mouse (IC50 = 9 nM) and human (IC50 = 11 nM) P2X7 receptors.  A-804598 also potently blocked agonist stimulated release of IL-1β and Yo-Pro uptake from differentiated THP-1 cells that natively express human P2X7 receptors.  A-804598 was tritiated ([3H]A-804598; 8.1 Ci/mmol) and utilized to study recombinant rat P2X7 receptors expressed in 1321N1 cells.  [3H]A-804598 labeled a single class of high affinity binding sites (Kd = 2.4 nM and apparent Bmax = 0.56 pmol/mg).  No specific binding was obsd. in untransfected 1321N1 cells.  The pharmacol. profile for P2X antagonists to inhibit [3H]A-804598 binding correlated with their ability to block functional activation of P2X7 receptors (r = 0.95).  These data demonstrate that A-804598 is one of the most potent and selective antagonists for mammalian P2X7 receptors described to date and [3H]A-804598 is a high affinity antagonist radioligand that specifically labels rat P2X7 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKvMcp2KKTbrVg90H21EOLACvtfcHk0lg3l9C-ehBtTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGlsg%253D%253D&md5=c69eddd94289bbb2f8161dfa69d09fa0</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2008.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2008.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DDonnelly-Roberts%26aufirst%3DD.%2BL.%26aulast%3DNamovic%26aufirst%3DM.%2BT.%26aulast%3DSurber%26aufirst%3DB.%26aulast%3DVaidyanathan%26aufirst%3DS.%2BX.%26aulast%3DPerez-Medrano%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCarroll%26aufirst%3DW.%2BA.%26aulast%3DJarvis%26aufirst%3DM.%2BF.%26atitle%3D%255B3H%255DA-804598%2520%2528%255B3H%255D2-cyano-1-%255B%25281S%2529-1-phenylethyl%255D-3-quinolin-5-ylguanidine%2529%2520is%2520a%2520novel%252C%2520potent%252C%2520and%2520selective%2520antagonist%2520radioligand%2520for%2520P2X7%2520receptors%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D56%26spage%3D223%26epage%3D229%26doi%3D10.1016%2Fj.neuropharm.2008.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duplantier, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dombroski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabel, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labasi, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mussari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perregaux, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shepard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevena, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney-Pickett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, K.</span></span> <span> </span><span class="NLM_article-title">Optimization of the physicochemical and pharmacokinetic attributes in a 6-azauracil series of P2X7 receptor antagonists leading to the discovery of the clinical candidate CE-224,535</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3708</span>– <span class="NLM_lpage">3711</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.04.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.bmcl.2011.04.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=21565499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntFKhsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3708-3711&author=A.+J.+Duplantierauthor=M.+A.+Dombroskiauthor=C.+Subramanyamauthor=A.+M.+Beaulieuauthor=S.-P.+Changauthor=C.+A.+Gabelauthor=C.+Jordanauthor=A.+S.+Kalgutkarauthor=K.+G.+Krausauthor=J.+M.+Labasiauthor=C.+Mussariauthor=D.+G.+Perregauxauthor=R.+Shepardauthor=T.+J.+Taylorauthor=K.+A.+Trevenaauthor=C.+Whitney-Pickettauthor=K.+Yoon&title=Optimization+of+the+physicochemical+and+pharmacokinetic+attributes+in+a+6-azauracil+series+of+P2X7+receptor+antagonists+leading+to+the+discovery+of+the+clinical+candidate+CE-224%2C535&doi=10.1016%2Fj.bmcl.2011.04.077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of the physicochemical and pharmacokinetic attributes in a 6-azauracil series of P2X7 receptor antagonists leading to the discovery of the clinical candidate CE-224,535</span></div><div class="casAuthors">Duplantier, Allen J.; Dombroski, Mark A.; Subramanyam, Chakrapani; Beaulieu, Aimee M.; Chang, Shang-Poa; Gabel, Christopher A.; Jordan, Crystal; Kalgutkar, Amit S.; Kraus, Kenneth G.; Labasi, Jeff M.; Mussari, Christopher; Perregaux, David G.; Shepard, Rick; Taylor, Timothy J.; Trevena, Kristen A.; Whitney-Pickett, Carrie; Yoon, Kwansik</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3708-3711</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">High throughput screening (HTS) of our compd. file provided an attractive lead compd. with modest P2X7 receptor antagonist potency and high selectivity against a panel of receptors and channels, but also with high human plasma protein binding and a predicted short half-life in humans.  Multi-parameter optimization was used to address the potency, physicochem. and pharmacokinetic properties which led to potent P2X7R antagonists with good disposition properties.  Compd. 33 (CE-224,535, I) was advanced to clin. studies for the treatment of rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKwcSH1ohcU7Vg90H21EOLACvtfcHk0lg3l9C-ehBtTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntFKhsLc%253D&md5=8833590dff93be295f4604891eae853b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.077%26sid%3Dliteratum%253Aachs%26aulast%3DDuplantier%26aufirst%3DA.%2BJ.%26aulast%3DDombroski%26aufirst%3DM.%2BA.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DBeaulieu%26aufirst%3DA.%2BM.%26aulast%3DChang%26aufirst%3DS.-P.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26aulast%3DJordan%26aufirst%3DC.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKraus%26aufirst%3DK.%2BG.%26aulast%3DLabasi%26aufirst%3DJ.%2BM.%26aulast%3DMussari%26aufirst%3DC.%26aulast%3DPerregaux%26aufirst%3DD.%2BG.%26aulast%3DShepard%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DT.%2BJ.%26aulast%3DTrevena%26aufirst%3DK.%2BA.%26aulast%3DWhitney-Pickett%26aufirst%3DC.%26aulast%3DYoon%26aufirst%3DK.%26atitle%3DOptimization%2520of%2520the%2520physicochemical%2520and%2520pharmacokinetic%2520attributes%2520in%2520a%25206-azauracil%2520series%2520of%2520P2X7%2520receptor%2520antagonists%2520leading%2520to%2520the%2520discovery%2520of%2520the%2520clinical%2520candidate%2520CE-224%252C535%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3708%26epage%3D3711%26doi%3D10.1016%2Fj.bmcl.2011.04.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keystone, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McInnes, I. B.</span></span> <span> </span><span class="NLM_article-title">Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine</span>. <i>Ann. Rheum. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1630</span>– <span class="NLM_lpage">1635</span>, <span class="refDoi"> DOI: 10.1136/annrheumdis-2011-143578</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1136%2Fannrheumdis-2011-143578" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=22966146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1SqurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2012&pages=1630-1635&author=E.+C.+Keystoneauthor=M.+M.+Wangauthor=M.+Laytonauthor=S.+Hollisauthor=I.+B.+McInnes&title=Clinical+evaluation+of+the+efficacy+of+the+P2X7+purinergic+receptor+antagonist+AZD9056+on+the+signs+and+symptoms+of+rheumatoid+arthritis+in+patients+with+active+disease+despite+treatment+with+methotrexate+or+sulphasalazine&doi=10.1136%2Fannrheumdis-2011-143578"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine</span></div><div class="casAuthors">Keystone, Edward C.; Wang, Millie M.; Layton, Mark; Hollis, Sally; McInnes, Iain B.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1630-1635</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Objectives: The P2X7 purinergic receptor antagonist AZD9056 was evaluated in a phase IIa study and subsequently in a phase IIb study to assess the effects of orally administered AZD9056 on the signs/symptoms of rheumatoid arthritis (RA), with American College of Rheumatol. 20% response criteria (ACR20) as the primary outcome.  Methods: Both studies were randomized, double-blind, placebo-controlled, parallel-group studies in patients with RA receiving methotrexate or sulphasalazine.  Phase IIa was an ascending-dose trial in two cohorts (n=75) using AZD9056 administered daily over 4 wk.  Phase IIb included an open-label etanercept treatment group.  Patients were randomized to receive treatment for 6 mo with 50, 100, 200 or 400 mg AZD9056 (oral, once a day) or matching placebo (oral, once a day), or s.c. etanercept (50 mg once a week).  Results: In phase IIa, 65% of AZD9056 recipients at 400 mg/day responded at the ACR20 level compared with 27% of placebo-treated patients.  A significant redn. in swollen and tender joint count was obsd. in the actively treated group compared with placebo, whereas no effect on acute-phase response was obsd.  Of 385 randomized patients in the phase IIb study, 383 received treatment.  AZD9056 (all doses) had no clin. or statistically significant effect on RA relative to placebo as measured by the proportion of patients meeting the ACR20 criteria at 6 mo and further supported by secondary end points.  In both studies AZD9056 was well tolerated up to 400 mg/day.  Conclusions: AZD9056 does not have significant efficacy in the treatment of RA, and the P2X7 receptor does not appear to be a therapeutically useful target in RA.  Trial registration no. ClinicalTrials.gov NCT00520572.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzCebkc5d0gLVg90H21EOLACvtfcHk0liAHC3PceBWYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1SqurzL&md5=97ca48663327aa8578f11001fa96d8c0</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1136%2Fannrheumdis-2011-143578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fannrheumdis-2011-143578%26sid%3Dliteratum%253Aachs%26aulast%3DKeystone%26aufirst%3DE.%2BC.%26aulast%3DWang%26aufirst%3DM.%2BM.%26aulast%3DLayton%26aufirst%3DM.%26aulast%3DHollis%26aufirst%3DS.%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26atitle%3DClinical%2520evaluation%2520of%2520the%2520efficacy%2520of%2520the%2520P2X7%2520purinergic%2520receptor%2520antagonist%2520AZD9056%2520on%2520the%2520signs%2520and%2520symptoms%2520of%2520rheumatoid%2520arthritis%2520in%2520patients%2520with%2520active%2520disease%2520despite%2520treatment%2520with%2520methotrexate%2520or%2520sulphasalazine%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2012%26volume%3D71%26spage%3D1630%26epage%3D1635%26doi%3D10.1136%2Fannrheumdis-2011-143578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ali, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurijssens, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostenfeld, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHugh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stylianou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott-Stevens, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosking, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewit, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2125.2012.04320.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1111%2Fj.1365-2125.2012.04320.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=22568863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVGmsbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2013&pages=197-207&author=Z.+Aliauthor=B.+Laurijssensauthor=T.+Ostenfeldauthor=S.+McHughauthor=A.+Stylianouauthor=P.+Scott-Stevensauthor=L.+Hoskingauthor=O.+Dewitauthor=J.+C.+Richardsonauthor=C.+Chen&title=Pharmacokinetic+and+pharmacodynamic+profiling+of+a+P2X7+receptor+allosteric+modulator+GSK1482160+in+healthy+human+subjects&doi=10.1111%2Fj.1365-2125.2012.04320.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects</span></div><div class="casAuthors">Ali, Zahid; Laurijssens, Bart; Ostenfeld, Thor; McHugh, Simon; Stylianou, Anastasia; Scott-Stevens, Paul; Hosking, Louise; Dewit, Odile; Richardson, Jill C.; Chen, Chao</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">197-207</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • P2X7 receptors are involved in the prodn. of pro-inflammatory cytokines, such as Il-1β, by central and peripheral immune cells.  Il-1β has been implicated as an important mediator of inflammation.  Therefore, the P2X7 receptor is an attractive therapeutic target for inflammatory diseases.  WHAT THIS STUDY ADDS • Findings in pharmacokinetics, pharmacodynamics, safety and tolerability of a P2X7 receptor modulator, GSK1482160, from the first human study for the mol. are described.  A pharmacokinetic/pharmacodynamic model for LPS-stimulated ATP-induced Il-1β prodn. in blood allowed the integration of all relevant data and provided in vivo evidence of the nature of the drug-receptor interaction.  The model has the potential to be used to simulate future trials.  AIMS This paper describes findings from the first-in-human study for GSK1482160, an orally available allosteric P2X7 receptor modulator.  The study aimed to assess the pharmacokinetics (PK), pharmacodynamics (PD), safety and tolerability of the compd. in healthy subjects.  METHODS Escalating single doses of up to 1 g were administered to healthy subjects in a single-blind and placebo-controlled fashion.  Safety, tolerability, blood drug concns. and ex vivo Il-1β prodn. in blood were evaluated.  RESULTS. Drug concn. peaked within 3.5 h of dosing under fasting conditions and declined thereafter with a relatively short half-life of less than 4.5 h.  Exposure was proportional to dose with between subject variability of less than 60%.  A PK/PD model quantified Il-1β as a function of drug exposure.  The model allowed simulation of in vivo pharmacol. for various untested dose levels and regimens.  Furthermore, the mechanistic model supported the hypothesis that the compd. reduces the efficacy of ATP at the P2X7 receptor without affecting its affinity.  No major safety or tolerability concerns were identified in this small study (n= 29), except for one case of asymptomatic accelerated idioventricular rhythm at the top dose.  CONCLUSION. The model-based approach maximized anal. power by integrating all biomarker data and revealed mechanistic insight into the pharmacol. of P2X7 modulation by GSK1482160.  Simulations by this model ultimately led to the discontinuation of the development of this compd.  The therapeutic relevance of the P2X7 receptor remains to be tested in patients.  The mechanistic-model-based approach can be applied widely to drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr41Bz54gV-qLVg90H21EOLACvtfcHk0lgVaTbNsxfFmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVGmsbnF&md5=835023636e0c5b039245344c2a9a207a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2012.04320.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2012.04320.x%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DZ.%26aulast%3DLaurijssens%26aufirst%3DB.%26aulast%3DOstenfeld%26aufirst%3DT.%26aulast%3DMcHugh%26aufirst%3DS.%26aulast%3DStylianou%26aufirst%3DA.%26aulast%3DScott-Stevens%26aufirst%3DP.%26aulast%3DHosking%26aufirst%3DL.%26aulast%3DDewit%26aufirst%3DO.%26aulast%3DRichardson%26aufirst%3DJ.%2BC.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DPharmacokinetic%2520and%2520pharmacodynamic%2520profiling%2520of%2520a%2520P2X7%2520receptor%2520allosteric%2520modulator%2520GSK1482160%2520in%2520healthy%2520human%2520subjects%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2013%26volume%3D75%26spage%3D197%26epage%3D207%26doi%3D10.1111%2Fj.1365-2125.2012.04320.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdi, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beswick, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billinton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collis, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonfria, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleave, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lejeune, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livermore, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medhurst, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michel, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moses, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slingsby, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steadman, J. G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, D. S.</span></span> <span> </span><span class="NLM_article-title">Discovery and structure-activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5080</span>– <span class="NLM_lpage">5084</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.07.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.bmcl.2010.07.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=20673717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVehsbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=5080-5084&author=M.+H.+Abdiauthor=P.+J.+Beswickauthor=A.+Billintonauthor=L.+J.+Chambersauthor=A.+Charltonauthor=S.+D.+Collinsauthor=K.+L.+Collisauthor=D.+K.+Deanauthor=E.+Fonfriaauthor=R.+J.+Gleaveauthor=C.+L.+Lejeuneauthor=D.+G.+Livermoreauthor=S.+J.+Medhurstauthor=A.+D.+Michelauthor=A.+P.+Mosesauthor=L.+Pageauthor=S.+Patelauthor=S.+A.+Romanauthor=S.+Sengerauthor=B.+Slingsbyauthor=J.+G.+A.+Steadmanauthor=A.+J.+Stevensauthor=D.+S.+Walter&title=Discovery+and+structure-activity+relationships+of+a+series+of+pyroglutamic+acid+amide+antagonists+of+the+P2X7+receptor&doi=10.1016%2Fj.bmcl.2010.07.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and structure-activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor</span></div><div class="casAuthors">Abdi, Muna H.; Beswick, Paul J.; Billinton, Andy; Chambers, Laura J.; Charlton, Andrew; Collins, Sue D.; Collis, Katharine L.; Dean, David K.; Fonfria, Elena; Gleave, Robert J.; Lejeune, Clarisse L.; Livermore, David G.; Medhurst, Stephen J.; Michel, Anton D.; Moses, Andrew P.; Page, Lee; Patel, Sadhana; Roman, Shilina A.; Senger, Stefan; Slingsby, Brian; Steadman, Jon G. A.; Stevens, Alexander J.; Walter, Daryl S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5080-5084</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A computational lead-hopping exercise identified compd. 4 (I) as a structurally distinct P2X7 receptor antagonist.  Structure-activity relationships (SAR) of a series of pyroglutamic acid amide analogs of 4 were investigated and compd. 31 was identified as a potent P2X7 antagonist with excellent in vivo activity in animal models of pain, and a profile suitable for progression to clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDVRhpk7pAFrVg90H21EOLACvtfcHk0ljrYS35HIc37w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVehsbbE&md5=7ffef75090b4baf3bba946701ec9dd8f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.07.033%26sid%3Dliteratum%253Aachs%26aulast%3DAbdi%26aufirst%3DM.%2BH.%26aulast%3DBeswick%26aufirst%3DP.%2BJ.%26aulast%3DBillinton%26aufirst%3DA.%26aulast%3DChambers%26aufirst%3DL.%2BJ.%26aulast%3DCharlton%26aufirst%3DA.%26aulast%3DCollins%26aufirst%3DS.%2BD.%26aulast%3DCollis%26aufirst%3DK.%2BL.%26aulast%3DDean%26aufirst%3DD.%2BK.%26aulast%3DFonfria%26aufirst%3DE.%26aulast%3DGleave%26aufirst%3DR.%2BJ.%26aulast%3DLejeune%26aufirst%3DC.%2BL.%26aulast%3DLivermore%26aufirst%3DD.%2BG.%26aulast%3DMedhurst%26aufirst%3DS.%2BJ.%26aulast%3DMichel%26aufirst%3DA.%2BD.%26aulast%3DMoses%26aufirst%3DA.%2BP.%26aulast%3DPage%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DRoman%26aufirst%3DS.%2BA.%26aulast%3DSenger%26aufirst%3DS.%26aulast%3DSlingsby%26aufirst%3DB.%26aulast%3DSteadman%26aufirst%3DJ.%2BG.%2BA.%26aulast%3DStevens%26aufirst%3DA.%2BJ.%26aulast%3DWalter%26aufirst%3DD.%2BS.%26atitle%3DDiscovery%2520and%2520structure-activity%2520relationships%2520of%2520a%2520series%2520of%2520pyroglutamic%2520acid%2520amide%2520antagonists%2520of%2520the%2520P2X7%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D5080%26epage%3D5084%26doi%3D10.1016%2Fj.bmcl.2010.07.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boes, M.</span></span> <span> </span><span class="NLM_article-title">Preparation of Indole-3-Carboxamide or Azaindole-3-Carboxamide Compounds as P2x7R Antagonists for Treating Multiple Sclerosis</span>. U.S. Patent <span class="NLM_patent">US20130197046</span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=M.+Boes&title=Preparation+of+Indole-3-Carboxamide+or+Azaindole-3-Carboxamide+Compounds+as+P2x7R+Antagonists+for+Treating+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoes%26aufirst%3DM.%26atitle%3DPreparation%2520of%2520Indole-3-Carboxamide%2520or%2520Azaindole-3-Carboxamide%2520Compounds%2520as%2520P2x7R%2520Antagonists%2520for%2520Treating%2520Multiple%2520Sclerosis%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, K.</span>; <span class="NLM_string-name">Hubler, F.</span>; <span class="NLM_string-name">Kimmerlin, T.</span>; <span class="NLM_string-name">Murphy, M.</span>; <span class="NLM_string-name">Renneberg, D.</span>; <span class="NLM_string-name">Stamm, S.</span></span> <span> </span><span class="NLM_article-title">Preparation of Heterocyclic Amide Derivatives as P2X7 Receptor Antagonists</span>. WO Patent <span class="NLM_patent">WO2013014587</span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=K.+Hilpert&author=F.+Hubler&author=T.+Kimmerlin&author=M.+Murphy&author=D.+Renneberg&author=S.+Stamm&title=Preparation+of+Heterocyclic+Amide+Derivatives+as+P2X7+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHilpert%26aufirst%3DK.%26atitle%3DPreparation%2520of%2520Heterocyclic%2520Amide%2520Derivatives%2520as%2520P2X7%2520Receptor%2520Antagonists%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Honore, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly-Roberts, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namovic, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikusa, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauvin, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandran, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medrano, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faltynek, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarvis, M. F.</span></span> <span> </span><span class="NLM_article-title">A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>319</i></span>,  <span class="NLM_fpage">1376</span>– <span class="NLM_lpage">1385</span>, <span class="refDoi"> DOI: 10.1124/jpet.106.111559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1124%2Fjpet.106.111559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=16982702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yltLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2006&pages=1376-1385&author=P.+Honoreauthor=D.+Donnelly-Robertsauthor=M.+T.+Namovicauthor=G.+Hsiehauthor=C.+Z.+Zhuauthor=J.+P.+Mikusaauthor=G.+Hernandezauthor=C.+Zhongauthor=D.+M.+Gauvinauthor=P.+Chandranauthor=R.+Harrisauthor=A.+P.+Medranoauthor=W.+Carrollauthor=K.+Marshauthor=J.+P.+Sullivanauthor=C.+R.+Faltynekauthor=M.+F.+Jarvis&title=A-740003+%5BN-%281-%7B%5B%28cyanoimino%29%285-quinolinylamino%29+methyl%5Damino%7D-2%2C2-dimethylpropyl%29-2-%283%2C4-dimethoxyphenyl%29acetamide%5D%2C+a+novel+and+selective+P2X7+receptor+antagonist%2C+dose-dependently+reduces+neuropathic+pain+in+the+rat&doi=10.1124%2Fjpet.106.111559"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat</span></div><div class="casAuthors">Honore, Prisca; Donnelly-Roberts, Diana; Namovic, Marian T.; Hsieh, Gin; Zhu, Chang Z.; Mikusa, Joe P.; Hernandez, Gricelda; Zhong, Chengmin; Gauvin, Donna M.; Chandran, Prasant; Harris, Richard; Medrano, Arturo Perez; Carroll, William; Marsh, Kennan; Sullivan, James P.; Faltynek, Connie R.; Jarvis, Michael F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1376-1385</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">ATP-sensitive P2X7 receptors are localized on cells of immunol. origin including glial cells in the central nervous system.  Activation of P2X7 receptors leads to rapid changes in intracellular calcium concns., release of the proinflammatory cytokine interleukin-1β (IL-1β), and following prolonged agonist exposure, cytolytic plasma membrane pore formation.  P2X7 knockout mice show reduced inflammation as well as decreased nociceptive sensitivity following peripheral nerve injury.  A-740003 (N-(1-{[(cyanoimino)(5-quinolinylamino) methyl] amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide) is a novel competitive antagonist of P2X7 receptors (IC50 values = 40 nM for human and 18 nM for rat) as measured by agonist-stimulated changes in intracellular calcium concns.  A-740003 showed weak or no activity (IC50 > 10 μM) at other P2 receptors and an array of other neurotransmitter and peptide receptors, ion channels, reuptake sites, and enzymes.  A-740003 potently blocked agonist-evoked IL-1β release (IC50 = 156 nM) and pore formation (IC50 = 92 nM) in differentiated human THP-1 cells.  Systemic administration of A-740003 produced dose-dependent antinociception in a spinal nerve ligation model (ED50 = 19 mg/kg i.p.) in the rat.  A-740003 also attenuated tactile allodynia in two other models of neuropathic pain, chronic constriction injury of the sciatic nerve and vincristine-induced neuropathy.  In addn., A-740003 effectively reduced thermal hyperalgesia obsd. following intraplantar administration of carrageenan or complete Freund's adjuvant (ED50 = 38-54 mg/kg i.p.).  A-740003 was ineffective in attenuating acute thermal nociception in normal rats and did not alter motor performance at analgesic doses.  These data demonstrate that selective blockade of P2X7 receptors in vivo produces significant antinociception in animal models of neuropathic and inflammatory pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKvrIcS3OJT7Vg90H21EOLACvtfcHk0ljwSdy2z8ksXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yltLrP&md5=a7d3bfa9cfc728ab7730ec7b351ecb1d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.111559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.111559%26sid%3Dliteratum%253Aachs%26aulast%3DHonore%26aufirst%3DP.%26aulast%3DDonnelly-Roberts%26aufirst%3DD.%26aulast%3DNamovic%26aufirst%3DM.%2BT.%26aulast%3DHsieh%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DC.%2BZ.%26aulast%3DMikusa%26aufirst%3DJ.%2BP.%26aulast%3DHernandez%26aufirst%3DG.%26aulast%3DZhong%26aufirst%3DC.%26aulast%3DGauvin%26aufirst%3DD.%2BM.%26aulast%3DChandran%26aufirst%3DP.%26aulast%3DHarris%26aufirst%3DR.%26aulast%3DMedrano%26aufirst%3DA.%2BP.%26aulast%3DCarroll%26aufirst%3DW.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26aulast%3DFaltynek%26aufirst%3DC.%2BR.%26aulast%3DJarvis%26aufirst%3DM.%2BF.%26atitle%3DA-740003%2520%255BN-%25281-%257B%255B%2528cyanoimino%2529%25285-quinolinylamino%2529%2520methyl%255Damino%257D-2%252C2-dimethylpropyl%2529-2-%25283%252C4-dimethoxyphenyl%2529acetamide%255D%252C%2520a%2520novel%2520and%2520selective%2520P2X7%2520receptor%2520antagonist%252C%2520dose-dependently%2520reduces%2520neuropathic%2520pain%2520in%2520the%2520rat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D319%26spage%3D1376%26epage%3D1385%26doi%3D10.1124%2Fjpet.106.111559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregg, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kort, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Medrano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voight, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grayson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namovic, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly-Roberts, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niforatos, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honore, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarvis, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faltynek, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, W. A.</span></span> <span> </span><span class="NLM_article-title">Structure-Activity Relationship Studies on a Series of Novel, Substituted 1-Benzyl-5-phenyltetrazole P2X7 Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3659</span>– <span class="NLM_lpage">3666</span>, <span class="refDoi"> DOI: 10.1021/jm051202e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051202e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BD28XkvVehtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3659-3666&author=D.+W.+Nelsonauthor=R.+J.+Greggauthor=M.+E.+Kortauthor=A.+Perez-Medranoauthor=E.+A.+Voightauthor=Y.+Wangauthor=G.+Graysonauthor=M.+T.+Namovicauthor=D.+L.+Donnelly-Robertsauthor=W.+Niforatosauthor=P.+Honoreauthor=M.+F.+Jarvisauthor=C.+R.+Faltynekauthor=W.+A.+Carroll&title=Structure-Activity+Relationship+Studies+on+a+Series+of+Novel%2C+Substituted+1-Benzyl-5-phenyltetrazole+P2X7+Antagonists&doi=10.1021%2Fjm051202e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship Studies on a Series of Novel, Substituted 1-Benzyl-5-phenyltetrazole P2X7 Antagonists</span></div><div class="casAuthors">Nelson, Derek W.; Gregg, Robert J.; Kort, Michael E.; Perez-Medrano, Arturo; Voight, Eric A.; Wang, Ying; Grayson, George; Namovic, Marian T.; Donnelly-Roberts, Diana L.; Niforatos, Wende; Honore, Prisca; Jarvis, Michael F.; Faltynek, Connie R.; Carroll, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3659-3666</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1-Benzyl-5-aryltetrazoles were discovered to be novel antagonists for the P2X7 receptor.  Structure-activity relationship (SAR) studies were conducted around both the benzyl and Ph moieties.  In addn., the importance of the regiochem. substitution on the tetrazole was examd.  Compds. were evaluated for activity to inhibit calcium flux in both human and rat recombinant P2X7 cell lines using fluorometric imaging plate reader technol.  Analogs were also assayed for their ability to inhibit IL-1β release and to inhibit P2X7-mediated pore formation in human THP-1 cells.  Compd. 15d was advanced to efficacy studies in a model of neuropathic pain where significant reversal of mech. allodynia was obsd. at doses that did not affect motor coordination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHB1Jk_r-cm7Vg90H21EOLACvtfcHk0liuAH0xxvFwug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkvVehtrc%253D&md5=1a5db08795350fdd48d35d4efc954cc7</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm051202e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051202e%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DD.%2BW.%26aulast%3DGregg%26aufirst%3DR.%2BJ.%26aulast%3DKort%26aufirst%3DM.%2BE.%26aulast%3DPerez-Medrano%26aufirst%3DA.%26aulast%3DVoight%26aufirst%3DE.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DGrayson%26aufirst%3DG.%26aulast%3DNamovic%26aufirst%3DM.%2BT.%26aulast%3DDonnelly-Roberts%26aufirst%3DD.%2BL.%26aulast%3DNiforatos%26aufirst%3DW.%26aulast%3DHonore%26aufirst%3DP.%26aulast%3DJarvis%26aufirst%3DM.%2BF.%26aulast%3DFaltynek%26aufirst%3DC.%2BR.%26aulast%3DCarroll%26aufirst%3DW.%2BA.%26atitle%3DStructure-Activity%2520Relationship%2520Studies%2520on%2520a%2520Series%2520of%2520Novel%252C%2520Substituted%25201-Benzyl-5-phenyltetrazole%2520P2X7%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3659%26epage%3D3666%26doi%3D10.1021%2Fjm051202e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Able, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fish, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bye, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booth, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathaniel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katugampola, S. D.</span></span> <span> </span><span class="NLM_article-title">Receptor localization, native tissue binding and ex vivo occupancy for centrally penetrant P2X7 antagonists in the rat</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">414</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.01025.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1111%2Fj.1476-5381.2010.01025.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=20840537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FivFylsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2011&pages=405-414&author=S.+L.+Ableauthor=R.+L.+Fishauthor=H.+Byeauthor=L.+Boothauthor=Y.+R.+Loganauthor=C.+Nathanielauthor=P.+Hayterauthor=S.+D.+Katugampola&title=Receptor+localization%2C+native+tissue+binding+and+ex+vivo+occupancy+for+centrally+penetrant+P2X7+antagonists+in+the+rat&doi=10.1111%2Fj.1476-5381.2010.01025.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor localization, native tissue binding and ex vivo occupancy for centrally penetrant P2X7 antagonists in the rat</span></div><div class="casAuthors">Able S L; Fish R L; Bye H; Booth L; Logan Y R; Nathaniel C; Hayter P; Katugampola S D</div><div class="citationInfo"><span class="NLM_cas:title">British journal of pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">405-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  The P2X7 receptor is implicated in inflammation and pain and is therefore a potential target for therapeutic intervention.  Here, the development of a native tissue radioligand binding, localization and ex vivo occupancy assay for centrally penetrant P2X7 receptor antagonists is described.  EXPERIMENTAL APPROACH:  Autoradiography studies using the P2X7 antagonist radioligand [3H]-A-804598 were carried out in rat brain and spinal cord.  Subsequent in vitro binding and ex vivo occupancy assays were performed using rat cortex homogenate.  KEY RESULTS:  P2X7 expression was shown to be widespread throughout the rat brain, and in the grey matter of the spinal cord.  In binding assays in rat cortex homogenate, ∼60% specific binding was achieved at equilibrium.  In kinetic binding assays, k(on) and k(off) values of 0.0021·min-1·nM-1 and 0.0070·min-1 were determined, and the K(d) derived from kinetic measurements was consistent with that derived from saturation analysis.  Novel P2X7 antagonists inhibited the binding of [3H]-A-804598 to rat cortex P2X7 receptors with K(i) values of <40 nM.  In an ex vivo occupancy assay, a P2X7 antagonist dosed orally to rats caused a concentration-dependent inhibition of the specific binding of [3H]-A-804598 to rat cortex.  CONCLUSIONS AND IMPLICATIONS:  The present study describes the development of an assay that allows localization of P2X7 receptors, the measurement of the binding affinity of P2X7 receptor antagonists in native tissue, and provides a means of determining central P2X7 receptor occupancy.  These assays could form an important part of a P2X7 drug discovery programme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXlc9eyWdycmZyxfu64m4ffW6udTcc2ebxJyPE-7BGfbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FivFylsQ%253D%253D&md5=bd39cdac52c8abe07b76a9a165bbe199</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.01025.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.01025.x%26sid%3Dliteratum%253Aachs%26aulast%3DAble%26aufirst%3DS.%2BL.%26aulast%3DFish%26aufirst%3DR.%2BL.%26aulast%3DBye%26aufirst%3DH.%26aulast%3DBooth%26aufirst%3DL.%26aulast%3DLogan%26aufirst%3DY.%2BR.%26aulast%3DNathaniel%26aufirst%3DC.%26aulast%3DHayter%26aufirst%3DP.%26aulast%3DKatugampola%26aufirst%3DS.%2BD.%26atitle%3DReceptor%2520localization%252C%2520native%2520tissue%2520binding%2520and%2520ex%2520vivo%2520occupancy%2520for%2520centrally%2520penetrant%2520P2X7%2520antagonists%2520in%2520the%2520rat%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D162%26spage%3D405%26epage%3D414%26doi%3D10.1111%2Fj.1476-5381.2010.01025.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naing, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grapperhaus, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillion, D. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of 2-chloro-N-((4,4-difluoro-1-hydroxycyclohexyl)methyl)-5-(5-fluoropyrimidin-2-yl)benzamide as a potent and CNS penetrable P2X7 receptor antagonist</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">3107</span>– <span class="NLM_lpage">3111</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.03.094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.bmcl.2010.03.094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=20392639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFGns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3107-3111&author=X.+Chenauthor=B.+Pierceauthor=W.+Naingauthor=M.+L.+Grapperhausauthor=D.+P.+Phillion&title=Discovery+of+2-chloro-N-%28%284%2C4-difluoro-1-hydroxycyclohexyl%29methyl%29-5-%285-fluoropyrimidin-2-yl%29benzamide+as+a+potent+and+CNS+penetrable+P2X7+receptor+antagonist&doi=10.1016%2Fj.bmcl.2010.03.094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-chloro-N-((4,4-difluoro-1-hydroxycyclohexyl)methyl)-5-(5-fluoropyrimidin-2-yl)benzamide as a potent and CNS penetrable P2X7 receptor antagonist</span></div><div class="casAuthors">Chen, Xiangyang; Pierce, Betsy; Naing, Win; Grapperhaus, Margaret L.; Phillion, Dennis P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3107-3111</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Focused SAR studies were carried out around 5-heteroaryl and 1-amide portions of the 2-chlorobenzamide scaffold, resulting in the discovery of a potent, metabolically stable and centrally penetrable antagonist against P2X7 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUL1qmvwKLI7Vg90H21EOLACvtfcHk0li1J-osUPrzrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFGns7k%253D&md5=b610d050a8857453c636084ddc6a96e8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.03.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.03.094%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DPierce%26aufirst%3DB.%26aulast%3DNaing%26aufirst%3DW.%26aulast%3DGrapperhaus%26aufirst%3DM.%2BL.%26aulast%3DPhillion%26aufirst%3DD.%2BP.%26atitle%3DDiscovery%2520of%25202-chloro-N-%2528%25284%252C4-difluoro-1-hydroxycyclohexyl%2529methyl%2529-5-%25285-fluoropyrimidin-2-yl%2529benzamide%2520as%2520a%2520potent%2520and%2520CNS%2520penetrable%2520P2X7%2520receptor%2520antagonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3107%26epage%3D3111%26doi%3D10.1016%2Fj.bmcl.2010.03.094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoblock, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aluisio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nepomuceno, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neff, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welty, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovenberg, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonaventure, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickenden, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span> <span> </span><span class="NLM_article-title">Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>170</i></span>,  <span class="NLM_fpage">624</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1111/bph.12314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1111%2Fbph.12314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=23889535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsV2ntrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2013&pages=624-640&author=A.+Bhattacharyaauthor=Q.+Wangauthor=H.+Aoauthor=J.+R.+Shoblockauthor=B.+Lordauthor=L.+Aluisioauthor=I.+Fraserauthor=D.+Nepomucenoauthor=R.+A.+Neffauthor=N.+Weltyauthor=T.+W.+Lovenbergauthor=P.+Bonaventureauthor=A.+D.+Wickendenauthor=M.+A.+Letavic&title=Pharmacological+characterization+of+a+novel+centrally+permeable+P2X7+receptor+antagonist%3A+JNJ-47965567&doi=10.1111%2Fbph.12314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567</span></div><div class="casAuthors">Bhattacharya, Anindya; Wang, Qi; Ao, Hong; Shoblock, James R.; Lord, Brian; Aluisio, Leah; Fraser, Ian; Nepomuceno, Diane; Neff, Robert A.; Welty, Natalie; Lovenberg, Timothy W.; Bonaventure, Pascal; Wickenden, Alan D.; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">624-640</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : An increasing body of evidence suggests that the purinergic receptor P2X, ligand-gated ion channel, 7 (P2X7) in the CNS may play a key role in neuropsychiatry, neurodegeneration and chronic pain.  In this study, we characterized JNJ-47965567, a centrally permeable, high-affinity, selective P2X7 antagonist.  Exptl. Approach : We have used a combination of in vitro assays (calcium flux, radioligand binding, electrophysiol., IL-1β release) in both recombinant and native systems.  Target engagement of JNJ-47965567 was demonstrated by ex vivo receptor binding autoradiog. and in vivo blockade of Bz-ATP induced IL-1β release in the rat brain.  Finally, the efficacy of JNJ-47965567 was tested in std. models of depression, mania and neuropathic pain.  Key Results : JNJ-47965567 is potent high affinity (pKi 7.9 ± 0.07), selective human P2X7 antagonist, with no significant obsd. speciation.  In native systems, the potency of the compd. to attenuate IL-1β release was 6.7 ± 0.07 (human blood), 7.5 ± 0.07 (human monocytes) and 7.1 ± 0.1 (rat microglia).  JNJ-47965567 exhibited target engagement in rat brain, with a brain EC50 of 78 ± 19 ng·mL-1 (P2X7 receptor autoradiog.) and functional block of Bz-ATP induced IL-1β release.  JNJ-47965567 (30 mg·kg-1) attenuated amphetamine-induced hyperactivity and exhibited modest, yet significant efficacy in the rat model of neuropathic pain.  No efficacy was obsd. in forced swim test.  Conclusion and Implications : JNJ-47965567 is centrally permeable, high affinity P2X7 antagonist that can be used to probe the role of central P2X7 in rodent models of CNS pathophysiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS_bU7fI8KzLVg90H21EOLACvtfcHk0livqcaPvOMQsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsV2ntrnI&md5=29d3bc1d3ecedda01f3d33b53d96c289</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fbph.12314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12314%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DShoblock%26aufirst%3DJ.%2BR.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DFraser%26aufirst%3DI.%26aulast%3DNepomuceno%26aufirst%3DD.%26aulast%3DNeff%26aufirst%3DR.%2BA.%26aulast%3DWelty%26aufirst%3DN.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DWickenden%26aufirst%3DA.%2BD.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DPharmacological%2520characterization%2520of%2520a%2520novel%2520centrally%2520permeable%2520P2X7%2520receptor%2520antagonist%253A%2520JNJ-47965567%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D170%26spage%3D624%26epage%3D640%26doi%3D10.1111%2Fbph.12314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lord, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aluisio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoblock, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neff, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varlinskaya, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceusters, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovenberg, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carruthers, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonaventure, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drinkenburg, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span> <span> </span><span class="NLM_article-title">Pharmacology of a novel central nervous system-penetrant P2X7 antagonist JNJ-42253432</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>351</i></span>,  <span class="NLM_fpage">628</span>– <span class="NLM_lpage">641</span>, <span class="refDoi"> DOI: 10.1124/jpet.114.218487</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1124%2Fjpet.114.218487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=25271258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFWhu7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2014&pages=628-641&author=B.+Lordauthor=L.+Aluisioauthor=J.+R.+Shoblockauthor=R.+A.+Neffauthor=E.+I.+Varlinskayaauthor=M.+Ceustersauthor=T.+W.+Lovenbergauthor=N.+Carruthersauthor=P.+Bonaventureauthor=M.+A.+Letavicauthor=T.+Deakauthor=W.+Drinkenburgauthor=A.+Bhattacharya&title=Pharmacology+of+a+novel+central+nervous+system-penetrant+P2X7+antagonist+JNJ-42253432&doi=10.1124%2Fjpet.114.218487"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of a novel central nervous system-penetrant P2X7 antagonist JNJ-42253432</span></div><div class="casAuthors">Lord, Brian; Aluisio, Leah; Shoblock, James R.; Neff, Robert A.; Varlinskaya, Elena I.; Ceusters, Marc; Lovenberg, Timothy W.; Carruthers, Nicholas; Bonaventure, Pascal; Letavic, Michael A.; Deak, Terrence; Drinkenburg, Wilhelmus; Bhattacharya, Anindya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">628-641, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">In the central nervous system, the ATP-gated Purinergic receptor P2X ligand-gated ion channel 7 (P2X7) is expressed in glial cells and modulates neurophysiol. via release of gliotransmitters, including the proinflammatory cytokine interleukin (IL)-1β.  In this study, we characterized JNJ-42253432 [2-methyl-N-([1-(4-phenylpiperazin-1-yl)cyclohexyl]methyl)-1,2,3,4-tetrahydroisoquinoline-5-carboxamide] as a centrally permeable (brain-to-plasma ratio of 1), high-affinity P2X7 antagonist with desirable pharmacokinetic and pharmacodynamic properties for in vivo testing in rodents.  JNJ-42253432 is a high-affinity antagonist for the rat (pKi 9.1 ± 0.07) and human (pKi 7.9 ± 0.08) P2X7 channel.  The compd. blocked the ATP-induced current and Bz-ATP [2'(3')-O-(4-benzoylbenzoyl)adenosine-5'-triphosphate tri(triethylammonium)]-induced release of IL-1β in a concn.-dependent manner.  When dosed in rats, JNJ-42253432 occupied the brain P2X7 channel with an ED50 of 0.3 mg/kg, corresponding to a mean plasma concn. of 42 ng/mL.  The compd. blocked the release of IL-1β induced by Bz-ATP in freely moving rat brain.  At higher doses/exposure, JNJ-42253432 also increased serotonin levels in the rat brain, which is due to antagonism of the serotonin transporter (SERT) resulting in an ED50 of 10 mg/kg for SERT occupancy.  JNJ-42253432 reduced electroencephalog. spectral power in the α-1 band in a dose-dependent manner; the compd. also attenuated amphetamine-induced hyperactivity.  JNJ-42253432 significantly increased both overall social interaction and social preference, an effect that was independent of stress induced by foot-shock.  Surprisingly, there was no effect of the compd. on either neuropathic pain or inflammatory pain behaviors.  In summary, in this study, we characterize JNJ-42253432 as a novel brain-penetrant P2X7 antagonist with high affinity and selectivity for the P2X7 channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU5MO_PDXIeLVg90H21EOLACvtfcHk0lhR79mg24aNzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFWhu7fN&md5=1ab23844891e251b37713c5cd80162a7</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.218487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.218487%26sid%3Dliteratum%253Aachs%26aulast%3DLord%26aufirst%3DB.%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DShoblock%26aufirst%3DJ.%2BR.%26aulast%3DNeff%26aufirst%3DR.%2BA.%26aulast%3DVarlinskaya%26aufirst%3DE.%2BI.%26aulast%3DCeusters%26aufirst%3DM.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DCarruthers%26aufirst%3DN.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DDeak%26aufirst%3DT.%26aulast%3DDrinkenburg%26aufirst%3DW.%26aulast%3DBhattacharya%26aufirst%3DA.%26atitle%3DPharmacology%2520of%2520a%2520novel%2520central%2520nervous%2520system-penetrant%2520P2X7%2520antagonist%2520JNJ-42253432%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D351%26spage%3D628%26epage%3D641%26doi%3D10.1124%2Fjpet.114.218487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackenzie, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">North, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surprenant, A.</span></span> <span> </span><span class="NLM_article-title">Brilliant blue G selectively blocks ATP-gated rat P2X7 receptors</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1124/mol.58.1.82</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1124%2Fmol.58.1.82" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10860929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1Kru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2000&pages=82-88&author=L.-H.+Jiangauthor=A.+B.+Mackenzieauthor=R.+A.+Northauthor=A.+Surprenant&title=Brilliant+blue+G+selectively+blocks+ATP-gated+rat+P2X7+receptors&doi=10.1124%2Fmol.58.1.82"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Brilliant blue G selectively blocks ATP-gated rat P2X7 receptors</span></div><div class="casAuthors">Jiang, Lin-Hua; Mackenzie, Amanda B.; North, R. Alan; Surprenant, Annmarie</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">82-88</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">There are few antagonists selective for subtypes of the several P2X receptors, but these are needed to identify the receptors expressed on native cells and tissues.  In particular, P2X4 and P2X7 receptor subunits are colocalized on immune, epithelial, and exocrine gland cells, but both are relatively insensitive to suramin and pyridoxal-5-phosphate-6-azo-2',4'-disulfonic acid deriv.  In this article, we show that Coomassie Brilliant Blue G selectively inhibits P2X7 receptors with nanomolar affinity.  We measured currents in response to P2X receptor activation in HEK293 cells heterologously expressing human or rat P2X1, P2X2, P2X3, P2X2/3, P2X4, P2X1/5, and P2X7 receptors.  Brilliant Blue G produced a noncompetitive inhibition of rat and human P2X7 receptors with IC50 values of 10 and 200 nM, resp.  IC50 values for inhibition of the other receptors ranged from 2 to >30 μM; the rat and human P2X4 receptors showed IC50 values of >10 and 3.2 μM.  Coomassie Blue G also blocked YO-PRO1 uptake and membrane blebbing, which are uniquely assocd. with activation of P2X7 receptors.  Thus, Brilliant Blue G is at least 1000-fold more potent at rat P2X7 receptors than at rat P2X4 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRFsnEAvo6AbVg90H21EOLACvtfcHk0liGBe0AQ7KNGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1Kru74%253D&md5=0ee3dd2e29ec0a128b834ed71580f92c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fmol.58.1.82&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.58.1.82%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DL.-H.%26aulast%3DMackenzie%26aufirst%3DA.%2BB.%26aulast%3DNorth%26aufirst%3DR.%2BA.%26aulast%3DSurprenant%26aufirst%3DA.%26atitle%3DBrilliant%2520blue%2520G%2520selectively%2520blocks%2520ATP-gated%2520rat%2520P2X7%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D58%26spage%3D82%26epage%3D88%26doi%3D10.1124%2Fmol.58.1.82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelegrin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surprenant, A.</span></span> <span> </span><span class="NLM_article-title">Amino acid residues in the P2X7 receptor that mediate differential sensitivity to ATP and BzATP</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">92</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1124/mol.106.030163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1124%2Fmol.106.030163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=17032903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1GrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=92-100&author=M.+T.+Youngauthor=P.+Pelegrinauthor=A.+Surprenant&title=Amino+acid+residues+in+the+P2X7+receptor+that+mediate+differential+sensitivity+to+ATP+and+BzATP&doi=10.1124%2Fmol.106.030163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Amino acid residues in the P2X7 receptor that mediate differential sensitivity to ATP and BzATP</span></div><div class="casAuthors">Young, Mark T.; Pelegrin, Pablo; Surprenant, Annmarie</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">92-100</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Agonist properties of the P2X7 receptor (P2X7R) differ strikingly from other P2X receptors in two main ways: high concns. of ATP (> 100 μM) are required to activate the receptor, and the ATP analog 2',3'-O-(4-benzoyl-benzoyl)ATP (BzATP) is both more potent than ATP and evokes a higher max. current.  However, there are striking species differences in these properties.  We sought to exploit the large differences in ATP and BzATP responses between rat and mouse P2X7R to delineate regions or specific residues that may be responsible for the unique actions of these agonists at the P2X7R.  We measured membrane currents in response to ATP and BzATP at wild-type rat and mouse P2X7R, at chimeric P2X7Rs, and at mouse P2X7Rs bearing point mutations.  Wild-type rat P2X7R was 10 times more sensitive to ATP and 100 times more sensitive to BzATP than wild-type mouse P2X7R.  We found that agonist EC50 values were detd. solely by the ectodomain of the P2X7R.  Two segments (residues 115-136 and 282-288), when transposed together, converted mouse sensitivities to those of rat.  Point mutations through these regions revealed a single residue, asparagine284, in the rat P2X7R that fully accounted for the 10-fold difference in ATP sensitivity, whereas the 100-fold difference in BzATP sensitivity required the transfer of both Lys127 and Asn284 from rat to mouse.  Thus, single amino acid differences between species can account for large changes in agonist effectiveness and differentiate between the two widely used agonists at P2X7 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-29lKBv4UU7Vg90H21EOLACvtfcHk0liGBe0AQ7KNGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1GrsA%253D%253D&md5=b7ceab86f26250ace786baf4640c891b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fmol.106.030163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.106.030163%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DM.%2BT.%26aulast%3DPelegrin%26aufirst%3DP.%26aulast%3DSurprenant%26aufirst%3DA.%26atitle%3DAmino%2520acid%2520residues%2520in%2520the%2520P2X7%2520receptor%2520that%2520mediate%2520differential%2520sensitivity%2520to%2520ATP%2520and%2520BzATP%26jtitle%3DMol.%2520Pharmacol.%26date%3D2007%26volume%3D71%26spage%3D92%26epage%3D100%26doi%3D10.1124%2Fmol.106.030163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pelegrin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surprenant, A.</span></span> <span> </span><span class="NLM_article-title">Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptor</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">5071</span>– <span class="NLM_lpage">5082</span>, <span class="refDoi"> DOI: 10.1038/sj.emboj.7601378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1038%2Fsj.emboj.7601378" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=17036048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFChsrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=5071-5082&author=P.+Pelegrinauthor=A.+Surprenant&title=Pannexin-1+mediates+large+pore+formation+and+interleukin-1%CE%B2+release+by+the+ATP-gated+P2X7+receptor&doi=10.1038%2Fsj.emboj.7601378"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptor</span></div><div class="casAuthors">Pelegrin, Pablo; Surprenant, Annmarie</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5071-5082</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">P2X7 receptors are ATP-gated cation channels; their activation in macrophage also leads to rapid opening of a membrane pore permeable to dyes such as ethidium, and to release of the pro-inflammatory cytokine, interleukin-1β (IL-1β).  It has not been known what this dye-uptake path is, or whether it is involved in downstream signaling to IL-1β release.  Here, we identify pannexin-1, a recently described mammalian protein that functions as a hemichannel when ectopically expressed, as this dye-uptake pathway and show that signaling through pannexin-1 is required for processing of caspase-1 and release of mature IL-1β induced by P2X7 receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgKvoL27FfqbVg90H21EOLACvtfcHk0lhW6Q_xawzQoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFChsrzM&md5=9b4bb218bde9ee4145bd3f70d900012c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7601378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7601378%26sid%3Dliteratum%253Aachs%26aulast%3DPelegrin%26aufirst%3DP.%26aulast%3DSurprenant%26aufirst%3DA.%26atitle%3DPannexin-1%2520mediates%2520large%2520pore%2520formation%2520and%2520interleukin-1%25CE%25B2%2520release%2520by%2520the%2520ATP-gated%2520P2X7%2520receptor%26jtitle%3DEMBO%2520J.%26date%3D2006%26volume%3D25%26spage%3D5071%26epage%3D5082%26doi%3D10.1038%2Fsj.emboj.7601378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilenski, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apparsundaram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weikert, R.</span></span> <span> </span><span class="NLM_article-title">Unbound brain concentration determines receptor occupancy: a correlation of drug concentration and brain serotonin and dopamine reuptake transporter occupancy for eighteen compounds in rats</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1548</span>– <span class="NLM_lpage">1556</span>, <span class="refDoi"> DOI: 10.1124/dmd.109.026674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1124%2Fdmd.109.026674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=19389861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosFems7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1548-1556&author=X.+Liuauthor=O.+Vilenskiauthor=J.+Kwanauthor=S.+Apparsundaramauthor=R.+Weikert&title=Unbound+brain+concentration+determines+receptor+occupancy%3A+a+correlation+of+drug+concentration+and+brain+serotonin+and+dopamine+reuptake+transporter+occupancy+for+eighteen+compounds+in+rats&doi=10.1124%2Fdmd.109.026674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Unbound brain concentration determines receptor occupancy: a correlation of drug concentration and brain serotonin and dopamine reuptake transporter occupancy for eighteen compounds in rats</span></div><div class="casAuthors">Liu, Xingrong; Vilenski, Olga; Kwan, Joyce; Apparsundaram, Subbu; Weikert, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1548-1556</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">It is a commonly accepted hypothesis that central nervous system (CNS) activity is detd. by the unbound brain drug concn.  However, limited exptl. data are available in the literature to support this hypothesis.  The objective of this study was to test this hypothesis by examg. the relationship between in vitro binding affinity (KI) and in vivo activity quantified as the drug concn. occupying 50% of the transporters (OC50) for 18 serotonin (SERT) and dopamine transporter (DAT) inhibitors.  In vivo rat OC50 was detd. by autoradiog. using [3H]N,N-dimethyl-2,2-amino-4-cyanophenylthiobenzylamine and [3H](-)-2-β-carbomethoxy-3-β-(4-fluorophenyl)tropane-1,5-naphthalenedisulfonate (WIN35,428) as the ligands to assess SERT and DAT occupancy, resp.  The unbound brain concns. were calcd. from total brain concns. and the unbound brain fraction, which was detd. by the brain homogenate method.  The in vivo total brain SERT and DAT OC50 values (mean ± S.D.) were 408 ± 368- and 410 ± 395-fold greater than the KI values, resp.  In contrast, the in vivo unbound brain SERT and DAT OC50 values were only 3.3 ± 2.1- and 4.1 ± 4.0-fold different from the KI values.  Therefore, prediction of the biophase drug concn. by using the unbound brain concn. rather than the total brain concn. results in an approx. 100-fold improvement for the accuracy.  In the present study, a 10-fold improvement was also obsd. by using the unbound plasma concn. rather than the total plasma concn. to predict the biophase concn. in the brain.  This study supports the hypothesis that CNS activity is more accurately detd. by the unbound brain drug concn. and not by the total brain drug concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwATPXsf2CK7Vg90H21EOLACvtfcHk0lhW6Q_xawzQoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosFems7k%253D&md5=d80077b28035f6e2c9e2e9df4b483b10</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.026674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.026674%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DVilenski%26aufirst%3DO.%26aulast%3DKwan%26aufirst%3DJ.%26aulast%3DApparsundaram%26aufirst%3DS.%26aulast%3DWeikert%26aufirst%3DR.%26atitle%3DUnbound%2520brain%2520concentration%2520determines%2520receptor%2520occupancy%253A%2520a%2520correlation%2520of%2520drug%2520concentration%2520and%2520brain%2520serotonin%2520and%2520dopamine%2520reuptake%2520transporter%2520occupancy%2520for%2520eighteen%2520compounds%2520in%2520rats%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1548%26epage%3D1556%26doi%3D10.1124%2Fdmd.109.026674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swarts, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanisch, U.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möller, T.</span></span> <span> </span><span class="NLM_article-title">Lipopolysaccharide is a frequent and significant contaminant in microglia-activating factors</span>. <i>Glia</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">16</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1002/glia.20585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1002%2Fglia.20585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=17910052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A280%3ADC%252BD2snkvVSguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2008&pages=16-26&author=J.+R.+Weinsteinauthor=S.+Swartsauthor=C.+Bishopauthor=U.-K.+Hanischauthor=T.+M%C3%B6ller&title=Lipopolysaccharide+is+a+frequent+and+significant+contaminant+in+microglia-activating+factors&doi=10.1002%2Fglia.20585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Lipopolysaccharide is a frequent and significant contaminant in microglia-activating factors</span></div><div class="casAuthors">Weinstein Jonathan R; Swarts Sarah; Bishop Caroline; Hanisch Uwe-Karsten; Moller Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Glia</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-26</span>
        ISSN:<span class="NLM_cas:issn">0894-1491</span>.
    </div><div class="casAbstract">Lipopolysaccharide (LPS/endotoxin) is a potent immunologic stimulant.  Many commercial-grade reagents used in research are not screened for LPS contamination.  LPS induces a wide spectrum of proinflammatory responses in microglia, the immune cells of the brain.  Recent studies have demonstrated that a broad range of endogenous factors including plasma-derived proteins and bioactive phospholipids can also activate microglia.  However, few of these studies have reported either the LPS levels found in the preparations used or the effect of LPS inhibitors such as polymyxin B (PMX) on factor-induced responses.  Here, we used the Limulus amoebocyte lysate assay to screen a broad range of commercial- and pharmaceutical-grade proteins, peptides, lipids, and inhibitors commonly used in microglia research for contamination with LPS.  We then characterized the ability of PMX to alter a representative set of factor-induced microglial activation parameters including surface antigen expression, metabolic activity/proliferation, and NO/cytokine/chemokine release in both the N9 microglial cell line and primary microglia.  Significant levels of LPS contamination were detected in a number of commercial-grade plasma/serum- and nonplasma/serum-derived proteins, phospholipids, and synthetic peptide preparations, but not in pharmaceutical-grade recombinant proteins or pharmacological inhibitors.  PMX had a significant inhibitory effect on the microglia-activating potential of a number of commercial-, but not pharmaceutical-grade, protein preparations.  Novel PMX-resistant responses to alpha(2)-macroglobulin and albumin were incidentally observed.  Our results indicate that LPS is a frequent and significant contaminant in commercial-grade preparations of previously reported microglia-activating factors.  Careful attention to LPS levels and appropriate controls are necessary for future studies in the neuroinflammation field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTpXqaVjdOqgYxhnOQkIHOxfW6udTcc2eYms-Jf4tyPUbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snkvVSguw%253D%253D&md5=df9cd5fe2be7eb0f617a2f4be588106f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fglia.20585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.20585%26sid%3Dliteratum%253Aachs%26aulast%3DWeinstein%26aufirst%3DJ.%2BR.%26aulast%3DSwarts%26aufirst%3DS.%26aulast%3DBishop%26aufirst%3DC.%26aulast%3DHanisch%26aufirst%3DU.-K.%26aulast%3DM%25C3%25B6ller%26aufirst%3DT.%26atitle%3DLipopolysaccharide%2520is%2520a%2520frequent%2520and%2520significant%2520contaminant%2520in%2520microglia-activating%2520factors%26jtitle%3DGlia%26date%3D2008%26volume%3D56%26spage%3D16%26epage%3D26%26doi%3D10.1002%2Fglia.20585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hornberg, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laursen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenden, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thougaard, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toft, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mow, T.</span></span> <span> </span><span class="NLM_article-title">Exploratory toxicology as an integrated part of drug discovery. Part I: Why and how</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1131</span>– <span class="NLM_lpage">1136</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2013.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.drudis.2013.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=24368175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFyrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1131-1136&author=J.+J.+Hornbergauthor=M.+Laursenauthor=N.+Brendenauthor=M.+Perssonauthor=A.+V.+Thougaardauthor=D.+B.+Toftauthor=T.+Mow&title=Exploratory+toxicology+as+an+integrated+part+of+drug+discovery.+Part+I%3A+Why+and+how&doi=10.1016%2Fj.drudis.2013.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Exploratory toxicology as an integrated part of drug discovery. Part I: Why and how</span></div><div class="casAuthors">Hornberg, Jorrit J.; Laursen, Morten; Brenden, Nina; Persson, Mikael; Thougaard, Annemette V.; Toft, Dorthe B.; Mow, Tomas</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1131-1136</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Toxicity and clin. safety have major impact on drug development success.  Moving toxicol. studies into earlier phases of the R&D chain prevents drug candidates with a safety risk from entering clin. development.  However, to identify candidates without such risk, safety has to be designed actively.  Therefore, we argue that toxicol. should be fully integrated into the discovery process.  We describe our strategy, including safety assessment of novel targets, selection of chem. series without inherent liabilities, designing out risk factors and profiling of candidates, and we discuss considerations regarding what to screen for.  We aim to provide timely go/no-go decisions (fail early) and direction to the discovery teams, by steering away from safety risk (showing what will not fail).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqa0a8DdfgYIbVg90H21EOLACvtfcHk0liq2PVVhocdzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFyrsbY%253D&md5=fcfa691b512dad747ef6fe55eeda8873</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2013.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2013.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DHornberg%26aufirst%3DJ.%2BJ.%26aulast%3DLaursen%26aufirst%3DM.%26aulast%3DBrenden%26aufirst%3DN.%26aulast%3DPersson%26aufirst%3DM.%26aulast%3DThougaard%26aufirst%3DA.%2BV.%26aulast%3DToft%26aufirst%3DD.%2BB.%26aulast%3DMow%26aufirst%3DT.%26atitle%3DExploratory%2520toxicology%2520as%2520an%2520integrated%2520part%2520of%2520drug%2520discovery.%2520Part%2520I%253A%2520Why%2520and%2520how%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D1131%26epage%3D1136%26doi%3D10.1016%2Fj.drudis.2013.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hornberg, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laursen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenden, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thougaard, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toft, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mow, T.</span></span> <span> </span><span class="NLM_article-title">Exploratory toxicology as an integrated part of drug discovery. Part II: Screening strategies</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1137</span>– <span class="NLM_lpage">1144</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2013.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.drudis.2013.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=24374152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlOrtLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1137-1144&author=J.+J.+Hornbergauthor=M.+Laursenauthor=N.+Brendenauthor=M.+Perssonauthor=A.+V.+Thougaardauthor=D.+B.+Toftauthor=T.+Mow&title=Exploratory+toxicology+as+an+integrated+part+of+drug+discovery.+Part+II%3A+Screening+strategies&doi=10.1016%2Fj.drudis.2013.12.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Exploratory toxicology as an integrated part of drug discovery. Part II: Screening strategies</span></div><div class="casAuthors">Hornberg, Jorrit J.; Laursen, Morten; Brenden, Nina; Persson, Mikael; Thougaard, Annemette V.; Toft, Dorthe B.; Mow, Tomas</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1137-1144</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In an effort to reduce toxicity-related attrition, different strategies have been implemented throughout the pharmaceutical industry.  Previously (in Part I), we have outlined our 'integrated toxicol.' strategy, which aims to provide timely go/no-go decisions (fail early) but also to show a direction to the drug discovery teams (showing what will not fail).  In this review (Part II of the series) we describe our compd. testing strategies with respect to cardiovascular safety, hepatotoxicity, genotoxicity, immunotoxicity and exploratory in vivo toxicity.  We discuss the in vitro, ex vivo and in vivo assays and models we employ to assess safety risks and optimize compd. series during the drug discovery process, including their predictivity and the decisions they generate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYRCY7sDSqWbVg90H21EOLACvtfcHk0liq2PVVhocdzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlOrtLnE&md5=7261ea8fdeac799ea63f1269091b8d34</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2013.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2013.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DHornberg%26aufirst%3DJ.%2BJ.%26aulast%3DLaursen%26aufirst%3DM.%26aulast%3DBrenden%26aufirst%3DN.%26aulast%3DPersson%26aufirst%3DM.%26aulast%3DThougaard%26aufirst%3DA.%2BV.%26aulast%3DToft%26aufirst%3DD.%2BB.%26aulast%3DMow%26aufirst%3DT.%26atitle%3DExploratory%2520toxicology%2520as%2520an%2520integrated%2520part%2520of%2520drug%2520discovery.%2520Part%2520II%253A%2520Screening%2520strategies%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D1137%26epage%3D1144%26doi%3D10.1016%2Fj.drudis.2013.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flückiger-Isler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamber, M.</span></span> <span> </span><span class="NLM_article-title">Direct comparison of the Ames microplate format (MPF) test in liquid medium with the standard Ames pre-incubation assay on agar plates by use of equivocal to weakly positive test compounds</span>. <i>Mutat. Res., Genet. Toxicol. Environ. Mutagen.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>747</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1016/j.mrgentox.2012.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.mrgentox.2012.03.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=747&publication_year=2012&pages=36-45&author=S.+Fl%C3%BCckiger-Islerauthor=M.+Kamber&title=Direct+comparison+of+the+Ames+microplate+format+%28MPF%29+test+in+liquid+medium+with+the+standard+Ames+pre-incubation+assay+on+agar+plates+by+use+of+equivocal+to+weakly+positive+test+compounds&doi=10.1016%2Fj.mrgentox.2012.03.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.mrgentox.2012.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mrgentox.2012.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DFl%25C3%25BCckiger-Isler%26aufirst%3DS.%26aulast%3DKamber%26aufirst%3DM.%26atitle%3DDirect%2520comparison%2520of%2520the%2520Ames%2520microplate%2520format%2520%2528MPF%2529%2520test%2520in%2520liquid%2520medium%2520with%2520the%2520standard%2520Ames%2520pre-incubation%2520assay%2520on%2520agar%2520plates%2520by%2520use%2520of%2520equivocal%2520to%2520weakly%2520positive%2520test%2520compounds%26jtitle%3DMutat.%2520Res.%252C%2520Genet.%2520Toxicol.%2520Environ.%2520Mutagen.%26date%3D2012%26volume%3D747%26spage%3D36%26epage%3D45%26doi%3D10.1016%2Fj.mrgentox.2012.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thougaard, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christiansen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mow, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornberg, J. J.</span></span> <span> </span><span class="NLM_article-title">Validation of a high throughput flow cytometric <i>in vitro</i> micronucleus assay including assessment of metabolic activation in TK6 cells</span>. <i>Environ. Mol. Mutagen.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">704</span>– <span class="NLM_lpage">718</span>, <span class="refDoi"> DOI: 10.1002/em.21891</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1002%2Fem.21891" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=25111698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlahtLvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=704-718&author=A.+V.+Thougaardauthor=J.+Christiansenauthor=T.+Mowauthor=J.+J.+Hornberg&title=Validation+of+a+high+throughput+flow+cytometric+in+vitro+micronucleus+assay+including+assessment+of+metabolic+activation+in+TK6+cells&doi=10.1002%2Fem.21891"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of a high throughput flow cytometric in vitro micronucleus assay including assessment of metabolic activation in TK6 cells</span></div><div class="casAuthors">Thougaard, Annemette V.; Christiansen, Joan; Mow, Tomas; Hornberg, Jorrit J.</div><div class="citationInfo"><span class="NLM_cas:title">Environmental and Molecular Mutagenesis</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">704-718</span>CODEN:
                <span class="NLM_cas:coden">EMMUEG</span>;
        ISSN:<span class="NLM_cas:issn">0893-6692</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Genotoxicity is an unacceptable property for new drug candidates and we employ three screening assays during the drug discovery process to identify genotoxicity early and optimize chem. series.  One of these methods is the flow cytometric in vitro micronucleus assay for which protocol optimizations have been described recently.  Here, we report further validation of the assay in TK6 cells including assessment of metabolic activation.  We first optimized assay conditions to allow for testing with and without metabolic activation in parallel in a 96-well plate format.  Then, we tested a set of 48 compds. carefully selected to contain known in vivo genotoxins, nongenotoxins and drugs.  Avoidance of irrelevant positives, a known issue with mammalian cell-based genotoxicity assays, is important to prevent early deselection of potentially promising compds.  Therefore, we enriched the validation set with compds. that were previously reported to produce irrelevant pos. results in mammalian cell-based genotoxicity assays.  The resulting dataset was used to set the relevant cut-off values for scoring a compd. pos. or neg., such that we obtained an optimal balance of high sensitivity (88%) and high specificity (87%).  Finally, we tested an addnl. set of 16 drugs to further probe assay performance and 14 of them were classified correctly.  To our knowledge, the present study is the most comprehensive validation of the in vitro flow cytometric micronucleus assay and the first to report parallel assessment with metabolic activation in reasonable throughput.  The assay allows for rapidly screening novel compds. for genotoxicity and is therefore well-suited for use in early drug discovery projects.  Environ.  Mol.  Mutagen., 2014. © 2014 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXWaiDTjKjW7Vg90H21EOLACvtfcHk0lhi3R-LNiOnGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlahtLvJ&md5=b6d75d5d4d62c36ffb5ccb15ab30b51f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fem.21891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fem.21891%26sid%3Dliteratum%253Aachs%26aulast%3DThougaard%26aufirst%3DA.%2BV.%26aulast%3DChristiansen%26aufirst%3DJ.%26aulast%3DMow%26aufirst%3DT.%26aulast%3DHornberg%26aufirst%3DJ.%2BJ.%26atitle%3DValidation%2520of%2520a%2520high%2520throughput%2520flow%2520cytometric%2520in%2520vitro%2520micronucleus%2520assay%2520including%2520assessment%2520of%2520metabolic%2520activation%2520in%2520TK6%2520cells%26jtitle%3DEnviron.%2520Mol.%2520Mutagen.%26date%3D2014%26volume%3D55%26spage%3D704%26epage%3D718%26doi%3D10.1002%2Fem.21891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walmsley, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, M.</span></span> <span> </span><span class="NLM_article-title">The GADD45a-GFP GreenScreen HC assay</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>817</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1007%2F978-1-61779-421-6_12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=22147576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OnsrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=817&publication_year=2012&pages=231-250&author=R.+M.+Walmsleyauthor=M.+Tate&title=The+GADD45a-GFP+GreenScreen+HC+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The GADD45a-GFP GreenScreen HC assay</span></div><div class="casAuthors">Walmsley, Richard M.; Tate, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">817</span>
        (<span class="NLM_cas:issue">Genetic Toxicology</span>),
    <span class="NLM_cas:pages">231-250</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Mutagens, clastogens, and aneugens cause increased expression of the human GADD45a gene.  This has been exploited in the GreenScreen HC genotoxicity assay in which the gene's expression is linked to the expression of green fluorescent protein (GFP).  The host for the reporter construct is the human lymphoblastoid cell line TK6.  It was chosen for its growth as a cell suspension, which allows simple pipet transfers, and for its wild-type p53 competent status.  P53 is required for proper GADD45a expression, and more generally for genome stability.  TK6 is a karyotypically stable cell line.  The GreenScreen assays were designed to facilitate screening, and this is reflected in its microplate format and low compd. requirement.  Protocols are available for testing with and without S9 as a source of exogenous metabolic activation.  Data is collected either spectrophotometrically or by flow cytometry, and a simple spreadsheet converts raw data into dose-response curves, and provides a statistically significant pos. or neg. result.  Extensive validation has demonstrated that in contrast to other in vitro mammalian genotoxicity assays, the GADD45a assays have both high sensitivity and specificity - they very rarely produce misleading pos. results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD0EqM59A-NbVg90H21EOLACvtfcHk0lhi3R-LNiOnGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OnsrrO&md5=5d7e9eea24272b838150333970e51ef8</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1007%2F978-1-61779-421-6_12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-61779-421-6_12%26sid%3Dliteratum%253Aachs%26aulast%3DWalmsley%26aufirst%3DR.%2BM.%26aulast%3DTate%26aufirst%3DM.%26atitle%3DThe%2520GADD45a-GFP%2520GreenScreen%2520HC%2520assay%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2012%26volume%3D817%26spage%3D231%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nadziejka, D. E.</span></span> <i>The ACS Style Guide: A Manual for Authors and Editors</i>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">ACS Publications</span>, <span class="NLM_year">1997</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=D.+E.+Nadziejka&title=The+ACS+Style+Guide%3A+A+Manual+for+Authors+and+Editors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNadziejka%26aufirst%3DD.%2BE.%26btitle%3DThe%2520ACS%2520Style%2520Guide%253A%2520A%2520Manual%2520for%2520Authors%2520and%2520Editors%26pub%3DACS%2520Publications%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roszkowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojtasiewicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leniewski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurin, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarnocki, Z.</span></span> <span> </span><span class="NLM_article-title">Enantioselective synthesis of 1-substituted tetrahydro-β-carboline derivatives via asymmetric transfer hydrogenation</span>. <i>J. Mol. Catal. A: Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>232</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">149</span>, <span class="refDoi"> DOI: 10.1016/j.molcata.2005.01.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1016%2Fj.molcata.2005.01.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVSjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=2005&pages=143-149&author=P.+Roszkowskiauthor=K.+Wojtasiewiczauthor=A.+Leniewskiauthor=J.+K.+Maurinauthor=T.+Lisauthor=Z.+Czarnocki&title=Enantioselective+synthesis+of+1-substituted+tetrahydro-%CE%B2-carboline+derivatives+via+asymmetric+transfer+hydrogenation&doi=10.1016%2Fj.molcata.2005.01.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Enantioselective synthesis of 1-substituted tetrahydro-β-carboline derivatives via asymmetric transfer hydrogenation</span></div><div class="casAuthors">Roszkowski, Piotr; Wojtasiewicz, Krystyna; Leniewski, Andrzej; Maurin, Jan K.; Lis, Tadeusz; Czarnocki, Zbigniew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Catalysis A: Chemical</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">232</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">143-149</span>CODEN:
                <span class="NLM_cas:coden">JMCCF2</span>;
        ISSN:<span class="NLM_cas:issn">1381-1169</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Several 1-substituted 3,4-dihydro-β-carboline derivs. were subjected to asym. transfer hydrogenation catalyzed by chiral ruthenium complexes to give both enantiomers of 1,2,3,4-tetrahydro-β-carbolines of high optical purity and in good yields.  The abs. stereochem. of the 1-octyl deriv. was established on the basis of X-ray anal. of its Mosher amide (I).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1bBKGLMCF6rVg90H21EOLACvtfcHk0lhi3R-LNiOnGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVSjtbs%253D&md5=4026897949677ddeaf3af2adffe1d54c</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.molcata.2005.01.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcata.2005.01.044%26sid%3Dliteratum%253Aachs%26aulast%3DRoszkowski%26aufirst%3DP.%26aulast%3DWojtasiewicz%26aufirst%3DK.%26aulast%3DLeniewski%26aufirst%3DA.%26aulast%3DMaurin%26aufirst%3DJ.%2BK.%26aulast%3DLis%26aufirst%3DT.%26aulast%3DCzarnocki%26aufirst%3DZ.%26atitle%3DEnantioselective%2520synthesis%2520of%25201-substituted%2520tetrahydro-%25CE%25B2-carboline%2520derivatives%2520via%2520asymmetric%2520transfer%2520hydrogenation%26jtitle%3DJ.%2520Mol.%2520Catal.%2520A%253A%2520Chem.%26date%3D2005%26volume%3D232%26spage%3D143%26epage%3D149%26doi%3D10.1016%2Fj.molcata.2005.01.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Möller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanisch, U.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransom, B. R.</span></span> <span> </span><span class="NLM_article-title">Thrombin-induced activation of cultured rodent microglia</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">1539</span>– <span class="NLM_lpage">1547</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.2000.0751539.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10.1046%2Fj.1471-4159.2000.0751539.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=10987834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmslGlt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2000&pages=1539-1547&author=T.+M%C3%B6llerauthor=U.-K.+Hanischauthor=B.+R.+Ransom&title=Thrombin-induced+activation+of+cultured+rodent+microglia&doi=10.1046%2Fj.1471-4159.2000.0751539.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Thrombin-induced activation of cultured rodent microglia</span></div><div class="casAuthors">Moller, Thomas; Hanisch, Uwe-Karsten; Ransom, Bruce R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1539-1547</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Microglia are the resident immune cells of the CNS.  Upon brain damage, these cells are rapidly activated and function as tissue macrophages.  The first steps in this activation still remain unclear, but it is widely believed that substances released from damaged brain tissue trigger this process.  In this article, the authors describe the effects of the blood coagulation factor thrombin on cultured rodent microglial cells.  Thrombin induced a transient Ca2+ increase in microglial cells, which persisted in Ca2+-free media.  It was blocked by thapsigargin, indicating that thrombin caused a Ca2+ release from internal stores.  Preincubation with pertussis toxin did not alter the thrombin-induced [Ca2+]i signal, whereas it was blocked by hirudin, a blocker of thrombin's proteolytic activity.  Incubation with thrombin led to the prodn. of nitric oxide and the release of the cytokines tumor necrosis factor-α, interleukin-6, interleukin-12, the chemokine KC, and the sol. tumor necrosis factor-α receptor II and had a significant proliferative effect.  Our findings indicate that thrombin, a mol. that enters the brain at sites of injury, rapidly triggered microglial activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHiYopP1DsVLVg90H21EOLACvtfcHk0lgYmZoMYWUvcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmslGlt78%253D&md5=d6675511cc6d2d34b77684b7d0ed65e8</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2000.0751539.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2000.0751539.x%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B6ller%26aufirst%3DT.%26aulast%3DHanisch%26aufirst%3DU.-K.%26aulast%3DRansom%26aufirst%3DB.%2BR.%26atitle%3DThrombin-induced%2520activation%2520of%2520cultured%2520rodent%2520microglia%26jtitle%3DJ.%2520Neurochem.%26date%3D2000%26volume%3D75%26spage%3D1539%26epage%3D1547%26doi%3D10.1046%2Fj.1471-4159.2000.0751539.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bayne, K.</span></span> <span> </span><span class="NLM_article-title">Revised Guide for the Care and Use of Laboratory Animals available. American Physiological Society</span>. <i>Physiologist</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">208</span>– <span class="NLM_lpage">211</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=208-211&author=K.+Bayne&title=Revised+Guide+for+the+Care+and+Use+of+Laboratory+Animals+available.+American+Physiological+Society"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBayne%26aufirst%3DK.%26atitle%3DRevised%2520Guide%2520for%2520the%2520Care%2520and%2520Use%2520of%2520Laboratory%2520Animals%2520available.%2520American%2520Physiological%2520Society%26jtitle%3DPhysiologist%26date%3D1996%26volume%3D39%26spage%3D208%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i34"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02249">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_75486"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c02249?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02249</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Scheme S1; synthesis of intermediate <b>20</b> and associated detailed synthetic methods; liver microsomal stability assay; hepatocyte stability assay; MDCK-MDR1 permeability assay; compound <b>1</b> exposure and fraction unbound in plasma, brain, and spinal cord; LC–MS/MS method for analysis of compound <b>1</b> from exposure studies; Rat PK methods; <i>in vivo</i> exploratory toxicology study methods; and Tables S1a and S1b with rat and mouse toxicokinetic exposure data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02249/suppl_file/jm0c02249_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Structure smiles (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02249/suppl_file/jm0c02249_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02249/suppl_file/jm0c02249_si_001.pdf">jm0c02249_si_001.pdf (168.31 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02249/suppl_file/jm0c02249_si_002.csv">jm0c02249_si_002.csv (1.21 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c02249&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-8%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c02249" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c02249" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a4e514dff3da6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
